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 “Although we set out primarily to study reality, it does not follow that we do not 
wish to improve it; we should judge our researches to have no worth at all if they 
were to have only speculative interest. If we separate carefully the theoretical from 
the practical problems, it is not to neglect the latter, but on the contrary, to be in a 
better position to solve them” 
- Emile Durkheim, The Division of Labour in Society 
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Abstract 
HIV, syphilis, malaria, and anaemia are major causes of adverse pregnancy outcomes 
in sub-Saharan Africa (SSA). Despite global and national policies advocating for 
screening of these conditions, only HIV testing has achieved good coverage, 
precluding early detection and appropriate management in pregnancy. Rapid point-
of-care tests (POCTs) provide an opportunity to integrate diagnosis and provide 
timely treatment of these conditions in rural antenatal care (ANC) settings.  
After an introductory chapter, a review of the literature on these four conditions in 
pregnancy is presented with a focus on SSA. The thesis then shifts attention to 
Kenya, a country that embodies many of the disease challenges and health system 
characteristics of the region. Kenyan ANC policy recommends testing for HIV, syphilis 
and anaemia and preventive strategies for malaria. The following chapters are 
comprised of three linked studies conducted in western Kenya, that use different 
methods to progressively investigate the implementation success of integrated 
point-of-care testing (POCT) for HIV, syphilis, malaria and anaemia at seven 
peripheral dispensaries.  
Baseline data confirmed that testing requirements for syphilis, malaria and anaemia 
are not currently met at dispensary level. We implemented an intervention where 
test kits were supplied and training plus supervision were provided to enable 
healthcare workers to conduct integrated POCT for pregnant women. Adoption and 
fidelity were measured quantitatively using exit interviews, antenatal registers and 
proficiency scores (Study 1: Integrating point-of-care testing (POCT) for HIV, syphilis, 
malaria and anaemia in antenatal care at dispensary level in western Kenya: an 
implementation study) while acceptability, appropriateness and feasibility were 
assessed qualitatively (Study 2: Exploring healthcare workers and pregnant women’s 
perspectives on appropriateness, acceptability and feasibility of integrating point-of-
care testing: A qualitative study). Our findings show that the innovation was highly 
adopted, meaning almost all pregnant women received the essential tests. This was 
supported by the qualitative findings where healthcare workers and pregnant 
women found the innovation acceptable and appropriate. However, fidelity to 
clinical management guidelines can still be improved. Our qualitative findings 
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provide some explanation for these gaps. One common sentiment among interviews 
with healthcare workers was that workload was perceived to be a barrier to 
providing quality care. We explored this further with discrete-event simulation 
modelling (Study 3: Investigating the operational impact of integrating HIV, syphilis, 
malaria and anaemia point-of-care testing in antenatal care clinics in western Kenya: a 
discrete event simulation model) and found the healthcare workers were actually 
under-utilized. This suggests that nurses should, in theory, have sufficient time to 
deliver essential ANC services. While integrating POCT addresses one gap, additional 
interventions to support and supervise healthcare workers are needed to ensure 
appropriate and high quality of care.  An integrated approach to health systems 
strengthening and more investment in implementation and translation research 
using multi-methods are needed.  
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1 Chapter 1 Introduction to the Thesis 
This chapter provides a brief background and justification of the thesis research, the 
research aims and objectives, my role and contribution, and lays out the contents of 
the thesis.  
1.1 Background 
1.2 Major diseases in pregnancy in sub-Saharan Africa (SSA) 
In sub-Saharan Africa (SSA), HIV, syphilis, malaria and anaemia are leading causes of 
maternal mortality and adverse pregnancy outcomes:  
1. Maternal HIV prevalence in SSA is estimated to be 5.3% (95% CI 4.2-6.6%), 
composing 92% of the world’s HIV positive pregnant women [1, 2]. Roughly 
24% of deaths in women during pregnancy or post-partum are attributable to 
untreated HIV [3]. Without antiretroviral therapy, risk of mother-to-child 
transmission cumulates over the gestation period which makes early 
detection and viral suppression critical [4].  
2. The Africa region contains 63% of global syphilis infections in pregnancy, 
representing an estimated 1.68% maternal syphilis prevalence [5]. Syphilis is 
associated with spontaneous miscarriage, stillbirth, preterm birth, low 
birthweight, neonatal death, and congenital infection in infants [6]. The 
duration of exposure in utero is a major determinant of foetal transmission 
and late treatment may be too late to reverse damage to foetal development 
caused by the bacterium [7].  
3. In malaria endemic regions, 45% of pregnancies that arise would experience 
malaria infection without preventive measures [8]. From early to late 
pregnancy, malaria infections are associated with anaemia, intrauterine 
growth restriction, preterm delivery, foetal loss, neonatal and infant mortality 
[9].   
4. Africa has the world’s highest prevalence of anaemia: among pregnant 
women, it is estimated that 46.3% (95% CI 40.6-51.0%) are anaemic and 1.5% 
(95% CI 1.0-2.3%) are severely anaemic in 2011 [10]. Anaemia during 
16  
pregnancy causes fatigue and is associated with increased risk of maternal 
mortality, low birth weight, and perinatal mortality [11]. There is also 
substantial evidence that maternal iron deficiency early in pregnancy (first 
and second trimester) contributes to higher risk of pre-term delivery and low-
birth weight than if it occurred later [12].  
5. These conditions do not exist in isolation [13-19]: malaria is more common in 
women with HIV [20]; risk of HIV transmission is increased through genital 
ulcer disease, including syphilis [21]; malaria is both associated with HIV [16, 
20] and a major risk factor for anaemia [22, 23]. Approximately 26% of severe 
anaemia in pregnant women is attributable to malaria [24].  
Because the risks of HIV, syphilis, malaria and anaemia cumulates with exposure over 
the gestation period and their propensities of co-occurring, addressing these 
conditions together, as early as possible during pregnancy is an essential goal of 
antenatal care (ANC) [25].  
 
World Health Organization (WHO) global antenatal guidelines require testing for HIV, 
syphilis, and anaemia at the first ANC contact which should occur early in the first 
trimester [26]. For malaria, in areas of stable transmission, intermittent preventive 
therapy with sulfadoxine-pyrimethamine (IPTp-SP) and the use of insecticide-treated 
bednets (ITNs) together with effective case management of clinical malaria is the 
current strategy [26].  There is currently no recommendation for screening the blood 
for parasites for women not presenting with symptoms. The exception is Tanzania, 
who recently introduced malaria testing as a strategy to manage anaemia at first 
visits into their antenatal guideline [27].  
In practice, antenatal testing, treatment and preventive strategies to protect 
pregnant women against these conditions are poorly implemented and coverage 
rates are suboptimal despite approximately 70% of pregnancies in SSA having 
contact with the healthcare system through ANC [28].   
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An integrated approach to ANC service delivery to address the multiple health needs 
and infections in pregnancy is recommended [29, 30]. The concept of ‘integration’ 
refers to “the organization and management of health services so that people get 
the care they need, when they need it, in ways that are user-friendly, achieve the 
desired results and provide value for money”[30]. One barrier to effective coverage 
of antenatal testing is the disintegration of care: women need to attend multiple 
clinics in different locations on separate occasions because many facilities lack 
testing equipment and women need to be referred to more distant facilities with 
laboratories for testing [31-33]. A potential solution to address this could be availing 
simple-to-use rapid diagnostic point-of-care tests (POCTs) at close-to-community 
facilities. They add minimal workload on the healthcare workforce, can simplify the 
diagnostic process, and can reduce the cost for pregnant women because they no 
longer need to wait long for test results or to be referred for testing elsewhere. Their 
simplicity and immediacy of results can greatly benefit resource-constrained settings 
by improving early diagnosis and allowing same-day management of conditions and 
their co-infections.  
1.3 Rationale for the study  
The promise of evidence-based practices may not always translate to 
implementation success [34]. Over the last 2 decades, researchers are increasingly 
recognizing the crucial role of implementation research “to promote the systematic 
uptake of research findings and other evidence-based practices, and hence, to 
improve the quality and effectiveness of health services and care” [35]. Rural 
facilities in low-resource settings are usually understaffed [36], and overstretched 
healthcare workers may not readily adopt or comply with an innovation when 
introduced. Data are required to understand whether an integrated testing strategy 
is an acceptable, appropriate, and a feasible service delivery approach to healthcare 
workers and pregnant women. This implementation research aims to addresses this 
gap in western Kenya.  
Kenya is a country that embodies many of the disease challenges and health system 
characteristics of the SSA region and that is why this country was chosen to 
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introduce and evaluate an integrated testing strategy for HIV, syphilis, malaria and 
anaemia.  
1.4 Aims and Objectives 
Aim: We aim to investigate the implementation outcomes and operational impact on 
service delivery of an integrated testing strategy for HIV, syphilis, malaria and 
anaemia for antenatal care in peripheral facilities in western Kenya.  
Objectives:   
1) To determine the proportion of pregnant women who receive all four tests at a 
single visit (adoption) and the proportion of pregnant women who receive 
treatment, advice or referral appropriate for the test result (fidelity).  
2) To evaluate end-user (healthcare workers and pregnant women) perceptions of 
acceptability, appropriateness and feasibility of integrated POCT for HIV, syphilis, 
malaria and anaemia.  
3) To explore the operational impact (patient wait times and nurse utilizations) of 
integrated POCT on service delivery in the facilities. 
1.5 Description of the intervention 
The research intervention was the provision all four tests together, by a single 
healthcare worker at one service delivery point, during a woman’s first ANC visit 
(Figure 1.1). All the facilities’ healthcare workers who see ANC women were trained 
either at a central location or on-site. All trainees received training manuals and 
visual aid testing placemats with step-by-step instructions (Appendix 1 Integration 
operating procedure placemat. Training included using one finger-prick blood draw 
to run all four tests concurrently per standard operating procedures, safety, and 
appropriate preventive care and clinical management of positive results following 
Kenyan guidelines. Study facilities used existing HIV drugs and HIV POCTs supplied by 
the Government of Kenya per its standard national algorithm at the time: HIV (1+2) 
Antibody Colloidal Gold (KHB, Shanghai Kehua Bio-engineering Co Ltd, China) for 
screening, First Response HIV-1-2 kits (Premier Medical Corporation Ltd., Kachigam, 
India) for confirmation and Uni-Gold™ (Trinity Biotech, Ireland) for tie-breaking. 
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Other drugs provided by the government for free antenatal care were iron, folic acid, 
SP and malaria treatment drugs. The research team supplied the facilities with 
sufficient stocks of rapid tests for syphilis (SD BIOLINE Syphilis 3.0 test for antibodies 
against Treponema pallidum, Standard Diagnostic Inc., Korea), malaria (CareStart™ 
Malaria HRP2 Pf, AccessBio, USA) and haemoglobin concentrations (HemoCue® Hb 
201+, HemoCue AB, Sweden). Batteries were also supplied for HemoCue®. Lot 
validation was done at Kenya Medical Research Institute and Centers for Disease 
Control and Prevention’s (KEMRI/CDC) reference laboratory in Kisumu by randomly 
selecting 1% of tests per lot and testing them against known positive and negative 
samples. HemoCue® machines were collected from the facilities and calibrated every 
three months at the same laboratory in Kisumu. The research team provided the 
facilities with digital BrannanTM triple timers, gloves, and benzathine penicillin for 
treating syphilis based on projected prevalence of syphilis in the area. 
    
Figure 1.1 Healthcare workers using the integrated placemat to test pregnant women during antenatal care visits 
1.6 Descriptions of research site  
The intervention was implemented within the site of KEMRI and CDC Health and 
Demographic Surveillance System (HDSS) in Siaya County, western Kenya (Figure 1.2). 
The population is 95% ethnically Luo, rural, and lives through subsistence farming 
and local trading [37]. At the time of the study, there were 37 public facilities in the 
study area: one district hospital, nine health centres and 27 dispensaries. 
Dispensaries comprise the lowest level (tier-2) of the formal health system and offer 
basic maternal and child health services, rudimentary out-patient curative care and 
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support care for HIV positive patients. In Siaya county, within the Nyanza region, 
prevention of mother-to-child transmission (PMTCT) services are integrated within 
antenatal care. The implementation partner in this region during the time of this 
research was the International Center for AIDS Care and Treatment Programs (ICAP) 
at Columbia University's Mailman School of Public Health. They provided training, 
and supervision for PMTCT activities at health facilities in Nyanza. They also 
supported lay HIV testing counsellors (HTC) whose responsibilities were to provide 
HIV testing and link test positives to antiretroviral (ART) therapy and care. ICAP 
began implementing Option B+ (providing lifelong comprehensive ART to HIV 
pregnant women regardless of CD4 count) in 2014 [38]. 
Figure 1.2 KEMRI and CDC Health and Demographic Surveillance System (HDSS) in Siaya County, western Kenya 
  
1.7 Thesis outline 
The thesis is presented in the format of three linked studies which are preluded by 
an introduction to the overall thesis, a literature review and concluded with a 
discussion that synthesized the overall findings.  
Chapter 1 Introduction is a general introduction of the thesis which includes a brief 
background on major diseases in pregnancy and antenatal care, rationale for 
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conducting the research, research aims and objectives, description of the 
intervention, information about the research site, and summary of the three studies.  
Chapter 2 Literature review discusses the literature and outlines the burden of 
disease of HIV, syphilis, malaria and anaemia in pregnancy, importance of early 
testing and treatment and global antenatal strategies. It describes the gaps in 
coverage of interventions to protect pregnant women against these conditions and 
their corresponding barriers and enablers. Then it discusses the use of POCTs in 
resource-poor contexts as a suitable innovation to reduce the coverage gap and 
available evidence on combining multiple POCTs into ANC is also presented. 
Introducing new approaches within existing systems can be challenging and a review 
of relevant conceptual frameworks that help frame implementation science and 
innovation diffusion from a health system perspective is also presented. The chapter 
then focuses on Kenya, a country that embodies many of the disease challenges and 
health system characteristics of the region. It describes Kenyan ANC policy, the 
Kenyan health system structure, and gaps in ANC policy implementation.  
 
Three studies were conducted to investigate implementation outcomes and service 
delivery impact of the intervention. Findings from one study were used to inform and 
build the next study.  
Chapter 3 (study 1) Integrating point-of-care testing (POCT) for HIV, syphilis, malaria 
and anaemia in antenatal care at dispensary level in western Kenya: an 
implementation study. Introduction of new diagnostic approaches or technologies 
has the potential to improve uptake of testing and management of pregnant women 
visiting antenatal care but implementation success can vary. This study describes the 
intervention and evaluates the adoption (proportion of women receiving all four 
tests) and fidelity (proportion of women receiving appropriate advice and treatment 
for the four conditions based on test results) of the integrated strategy. Details of the 
intervention and measurements of implementation outcomes are described in the 
chapter’s methods. The study found that integrating POCTs into ANC at dispensaries 
with established HIV testing programmes resulted in a significant increase in testing 
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rates, without disturbing HIV testing rates. While more cases were detected and 
treated, treatment fidelity still requires strengthening and an integrated monitoring 
and evaluation system needs to be established.  
Chapter 4 (study 2) Exploring healthcare workers and pregnant women’s perspectives 
on appropriateness, acceptability and feasibility of integrating point-of-care testing: A 
qualitative study. Fundamental to the uptake of and adherence to new diagnostic 
approaches are healthcare workers’ and pregnant women’s buy-in and their 
willingness to adopt the tests into their everyday practice. The study 1 found high 
rates of adoption but sub-optimal fidelity. This study evaluates end-user perceptions 
of acceptability, appropriateness and feasibility of the integrated testing strategy 
using qualitative methods that capture more textured layers of experiences in order 
to further understand the adoption and fidelity outcomes. Details of the qualitative 
approach used are given in the methods. The study found that healthcare workers 
and pregnant women thought the innovation was desirable and beneficial, but 
general health system weaknesses such as workload, stock-outs and poor working 
conditions challenged the delivery of quality ANC services and the effective 
management of the four conditions. 
Chapter 5 (study 3) Investigating the operational impact of integrating HIV, syphilis, 
malaria and anaemia point-of-care testing in antenatal care clinics in western Kenya: a 
discrete-event simulation model. Availing POCTs at peripheral dispensaries has the 
potential to improve access to essential services but could over-stretch systems that 
are usually burdened with human resource shortages and long queues. Our 
qualitative findings show that workload was perceived to be one of the major 
barriers to providing quality health services. This study applied discrete-event 
simulation (DES) modelling using detailed time-motion data to explore the impacts of 
integrating POCTs on wait times and resource utilization in ANC clinics in western 
Kenya. The study found that delivering integrated POCTs had minimal impact on wait 
times for the majority of women, while ensuring they received essential diagnostics 
for timely treatment. We also found that nurses should have sufficient time to 
deliver WHO’s required ANC activities. Resource neutral strategies should be 
explored to improve staff availability, for example through minimising off-site 
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trainings. More frequent supervision and audit feedback could help with ensuring 
essential services are performed.  
Chapter 6 Discussion summarises the main findings of all the chapters. It then draws 
important insights from these findings, and discusses their implications for health 
systems. It reflects on study strengths and limitations and gives recommendations 
for the future.  
Chapter 7 Appendices: supporting materials are provided in the appendices:  
Appendix 1 Testing placemat 
Appendix 2 Proficiency observation checklist (chapter 3) 
Appendix 3 Focus group discussion guide with pregnant women (chapter 4) 
Appendix 4 Semi-structured interview guide with healthcare workers (chapter 4) 
Appendix 5 Sample time-motion data collection form (chapter 5) 
Appendix 6 Dispensary patient pathways for women seeking maternal and child health services (chapter 5) 
Appendix 7 Screenshot of DES modelling in WITNESS© (chapter 5) 
1.8 Role in research 
The idea of using POCTs for an integrated testing approach for ANC at rural 
dispensaries in Kenya was conceived by Dr. Miriam Taegtmeyer. I designed the 
implementation study and oversaw all study activities: directing USAID/CDC funded 
budget of US $250,000, institutional review board (IRB) processes, liaising with 
Ministry of Health for effective community entry, organizing and designing the 
training of healthcare workers, creating the quality assurance tools, design of 
training and data collection tools, procuring study materials, training data collectors, 
managing database, cleaning the data, analysing the data and writing the first draft 
of manuscripts. A data manager helped with creating scannable data collection forms 
(Teleforms©), scanning them into the data base and exporting the data into excel. 
Garazi Zulaika, a co-author of the third study (chapter 5), helped with some of the 
cleaning of time-motion data.  
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I am the first and corresponding author for all three manuscripts and drove the 
process for co-authors, institutional (KEMRI and CDC) and peer reviews. At the time 
of this thesis submission, the first manuscript (chapter 3) is formally accepted and 
under production with Plos One. The second manuscript (chapter 4) is under peer 
review with BMC Health Services Research. The third manuscript is undergoing 
institutional and peer review with KEMRI and CDC before being submitted to 
journals.  Full author contributions are given in the beginning of each study (chapter 
3-5).  
 
 Reflexivity is particularly valuable to the research process, especially in qualitative 
research so as to acknowledge how the researchers’ personal experiences and biases 
may influence the research process and interpretation of data.  
I have always been curious about the natural world such as the nature of inequality, 
the processes that shape society and the interactions with the environment that 
influence health and well-being. In my social epidemiology course with Harvard 
professor Ichiri Kwachi during my Masters in Public Health, I came upon French 
sociologist Emile Durkheim’s The Division of Labour in Society in which he writes: 
“Although we set out primarily to study reality, it does not follow that we do not wish 
to improve it; we should judge our researches to have no worth at all if they were to 
have only speculative interest. If we separate carefully the theoretical from the 
practical problems, it is not to neglect the latter, but on the contrary, to be in a 
better position to solve them”. This inspired my interest in implementation work and 
the translation of our research endeavours into practical solutions to better the 
human condition.  
I grew up in a multi-cultural environment. My parents are from Hong Kong and we 
spoke Cantonese at home. We emigrated to Canada when I was five where I learned 
English and became acquainted with western culture. After five years, we moved 
back to Hong Kong where I lived until I attended university in the USA. Growing up, I 
had to navigate two diametrically different cultures that has forced me to be more 
reflective towards different archetypes and worldviews. After university, I spent two 
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years in the Sahara Desert of Morocco as a Peace Corps volunteer where I learned 
Moroccan Arabic and the Berber language of Tamazight. I worked at the town 
birthing clinic with healthcare workers and lived with host-country nationals. I hope 
these experiences have given me closer insight to low-resource environments and 
helped shed biases and prior-assumptions during the research process.  
As this was a small study, I was heavily involved with field work including introducing 
the study to the various county health management teams and health facilities, 
visiting and observing facility activities, building relationships with healthcare 
workers, and with training and supervision of the intervention.  As non-Kenyan and 
Chinese female visiting rural areas where there is very little cultural diversity, I am 
aware how I would be seen as an outsider which could influence behaviour and 
expectations. I tried to take a back-seat approach to so that participants (healthcare 
workers) can feel more autonomous. I also worked closely with Kenyan colleagues so 
participants can see the project as a collaboration. Qualitative interview guides were 
developed closely with Kenyan researchers from the Nyanza area to ensure they 
were locally adapted and appropriate. Interviews with healthcare workers and 
discussions with pregnant were also led by Kenyan researchers to maximize comfort 
and willingness to share personal experiences. Transcripts were also interpreted 
together with Kenyan researchers to reduce misunderstandings and biases.    
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2 Chapter 2 Literature review 
This chapter presents an overview of HIV, syphilis, malaria and anaemia in pregnancy 
with a focus on sub-Saharan Africa (SSA). It describes the current burden of disease, 
importance of early testing and treatment, and present-day global antenatal 
guidelines. It highlights the gaps in coverage and reviews the barriers and enablers to 
achieving high coverage of HIV, syphilis, malaria and anaemia interventions. Then it 
discusses the use of point-of-care tests (POCTs) in resource-poor contexts as a 
suitable innovation to close the coverage gap and available evidence on combining 
point-of-care tests into antenatal care is presented. Introducing new approaches 
within existing systems can be challenging and the chapter reviews several 
conceptual frameworks that help frame implementation and innovation adoption in 
health systems. The field research was conducted in Kenya and the final section 
details antenatal care in the Kenyan context.  
Box 2.1. Search terms 
Literature searches were conducted using Google, Google Scholar, PubMed and MEDLINE. 
Published papers from peer reviewed journals as well as grey literature including policy 
documents, reports by WHO and non-government organization (NGO) research groups, 
and national guidelines were identified. The bibliographies of relevant papers and reports 
found during the search were also reviewed. HIV was searched together with PMTCT [e.g. 
“HIV” OR “PMTCT”] and the syphilis was searched with congenital syphilis [e.g. “syphilis” 
OR “congenital syphilis”]. Search strings used for the various sections are as follows: 
Section 2.2 Burden and aetiology of disease  
Burden of disease in sub-Saharan Africa were mostly obtained from global reports. 
Databases were also searched with the conditions and the terms [“prevalence” OR 
“burden of disease” OR “epidemiology” OR “*etiology” OR “infection” OR “co-infection”] 
AND [“pregnan*” OR “antenatal”] AND “Africa”. 
Section 2.3 Coverage of testing and treatment  
Coverage rates of testing, treatment or prevention for HIV, syphilis, malaria and anaemia 
were mainly obtained from global reports. Databases were searched with the conditions 
and terms [“uptake” OR “coverage” OR “utilisation”] AND [“test*” OR “screen*” OR 
“treatment” OR “prevent*”] AND [“pregnan*” OR “antenatal”] AND “Africa”. Malaria was 
also further searched with [“uptake” OR “coverage” OR “accept*” OR “utilisation”] AND 
[“pregnan*” OR “antenatal”] AND [“intermittent preventive treatment” OR “sulfadoxine 
pyrimethamine” OR “bednet”].  
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Section 2.4 Barriers and enablers to coverage of testing and treatment  
[“Barriers” OR “challenges” OR “enablers” OR “facilitators” OR “factors”] AND [“antenatal 
attendance” OR “antenatal access” OR “test*” or “screen*” OR “treatment” OR 
“prevention”] AND [“pregnan*” OR “antenatal”] AND “Africa”. Malaria was further 
searched with [“Barriers” OR “challenges” OR “enablers” OR “facilitators” OR “factors”] 
AND [“pregnan*” OR “antenatal”] AND [“intermittent preventive treatment” OR 
“sulfadoxine pyrimethamine” OR “bednet”]. 
Section 2.5 Point-of-care tests  
Each of the conditions were searched with [“diagnostic” OR “point-of-care test*” OR 
“RDT” OR “rapid test” OR “blood test*”] AND [“pregnan*” OR “antenatal” OR “antenatal 
care” OR “ANC” OR “integration”].  
Section 2.6 Implementation science and operational research  
For background and frameworks on implementation, databases were searched with 
[“implementation research” OR “implementation science” OR “implementation” OR 
“implementation outcome”] AND [“models” OR “theories” OR “conceptual framework” 
OR “framework” OR “methods”]. For background on operational research, databases were 
searched with “operation* research” AND [“methods” OR “application”] AND [“health* 
services” OR “health”]. 
Section 2.7 Kenya  
Kenya national guidelines, national reports, government websites and reports from non-
government organizations were consulted for background on health burden and health 
system in Kenya. Further searches were done in databases with search string used in 
section 2.2 and “Kenya”. 
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2.1 Maternal health a key development goal in sub-Sahara Africa (SSA) 
Today, approximately 10% of the world live in extreme poverty with less than US 
$1.90 per day, improving drastically from 35% in 1990. However, much of this 
progress has been driven by recent economic developments in China and Indonesia, 
leaving half of the extreme poor in SSA [1]. The inequality gap is drastic: in 2014, 
Gross Domestic Product (GDP) and health spending per capita was US $36,741 and 
$4,739 per annum among OECD1 countries compared to just $1,450 and $98 in SSA 
countries [2]. Economic deprivation translates to lower life-expectancy and quality of 
life. 
In 2000, 191-member states of the United Nations met to establish global targets for 
improving the health and livelihood of those in the world’s poorest countries. Eight 
Millennium Development Goals (MDGs) were established, of which two centred on 
maternal and child health and one on combating HIV, malaria and other diseases. By 
2015, SSA achieved 52% reduction in child mortality, 49% reduction in maternal 
mortality, 51% reduction in new HIV infections, and 69% reduction in malaria 
mortality among under-5 age group [3]. However, many MDG targets were still 
underachieved and necessitated a new global effort to advance human 
development. A new set of 17 Sustainable Development Goals (SDGs) were created 
with health occupying a central focus [4]. The SDG effort emphasizes sustainability 
and recognizes that integrated and system wide collaborations are needed to avoid 
fragmentation and duplication of effort that was believed to have limited the MDG 
endeavour (Table 2.1) [4]. Women and children are key populations across multiple 
goals as they are especially vulnerable due to the sensitive course of pregnancy, 
dependency during the early years of an infant’s life, and long term developmental 
consequences acquired during this period.  
  
                                                     
1 OECD: The Organisation for Economic Co-operation and Development, an intergovernmental economic group of 35 high-income countries founded in 1961.  
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Table 2.1: Disease burden and maternal and child health indicators in sub-Saharan Africa: current indicators and 2030 goals MDG Indicator  2015 burden in SSA SDG goals for 2030 [4] Maternal mortality  546 per 100,000 live births [5] Reduce global maternal mortality ratio to less than 70 per 100,000 live births Neonatal mortality  29 per 1000 live births [6] Reduce neonatal mortality to 12 per 1000 live births Under-5 mortality  83 per 1000 live births [6] Reduce under-5 mortality to 25 per 1000 live births HIV, TB, malaria [4]  2.6 new HIV infections per 1000 uninfected* 281 new TB cases per 100,000 population* 246 new malaria cases per 1000 persons at risk 
End the epidemics of AIDS, TB, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases 
*2014 data for WHO Africa region 
 
2.2 Burden and aetiology of major diseases in pregnancy in sub-Saharan Africa 
Fertility rate in SSA is high with about 4.8 births per woman, compared to 1.7 in high 
income countries (2016 data) [2]. This means women in SSA may spend several years 
in pregnancy, rendering them especially vulnerable to the risks of adverse pregnancy 
and child health outcomes. In fact, the region carries the world’s greatest burden of 
maternal and child deaths [4] as well as the greatest disease burden of HIV, syphilis, 
malaria and anaemia [3]. They and their co-occurrences are some of the area’s major 
contributors to poor maternal and child health [4, 7, 8]. The following sections 
describe the burden and aetiology of these diseases and conditions in pregnancy. 
 
Sub-Saharan Africa is home to 92% of the world’s HIV positive pregnant women and 
the maternal HIV prevalence is estimated to be 5.3% (95%        CI 4.2-6.6%) [9, 10]. 
Women with untreated HIV infection are 8 times more likely to die during pregnancy 
or post-partum and roughly 24% of deaths in women during this period are 
attributable to untreated HIV [11].The risk of transmitting the virus to the baby varies 
over the gestation period with the highest risk during delivery (10-20%) and 
breastfeeding (10-20%), followed by the intrauterine period (5-10%) [12]. Without 
antiretroviral therapy, the risk cumulates with length of exposure and reaches 25-
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45% over the whole intrauterine, intrapartum and breastfeeding periods [12]. In 
addition, high maternal plasma viral load is a key determinant for transmission [12]. 
This makes early detection and viral suppression a key strategy in reducing HIV 
exposure and vertical transmission. Testing is therefore recommended at the first 
contact with ANC in the first trimester (Figure 2.1).  
 
Maternal syphilis prevalence in the African region is estimated to be 1.68%, 
representing 63.1% of global syphilis infections in pregnancy in 2012 [7]. Syphilis, 
caused by the bacteria Treponema pallidum is sexually transmitted disease that can 
also be passed vertically from mother-to-child.  The disease has 4 stages (primary, 
secondary, latent and tertiary) with different symptoms and characteristics at each 
stage.[13]. Most syphilis infections are latent and asymptomatic, but can still 
contribute to substantial adverse pregnancy outcomes [7]. A mother with untreated 
syphilis risks vertical transmission to the foetus which occurs through 
haematogenous spread: 70-100% for primary syphilis, 40% for early latent syphilis 
(latent syphilis occurring before 1 year of infection) and 10% for late latent syphilis 
(latent syphilis occurring after 1 year of infection) [13]. Thus, the newly infected are 
the most infectious and the longer the lag between initial infection and pregnancy, 
the less likely the foetus will be affected: most infants born to women with late 
latent syphilis are uninfected [13-15]. 
The stage of maternal syphilis and the duration of exposure in utero affect the 
probability of foetal transmission [15]. Early in pregnancy, the foetus is protected 
because syphilis spirochaetes cannot penetrate the placental barrier[15]. The foetus 
becomes vulnerable from 9-14 weeks onwards and accumulates infection risk over 
time with most infections occurring after the 6th month [14, 16]. Thus, the earlier the 
treatment the more effective it is against congenital disease.  Although later 
treatment will cure the infection, it may be too late to reverse damages of foetal 
development caused by the disease. Therefore, it is important to test in the first 
trimester at the first contact with ANC (Figure 2.1).  
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Syphilis-associated adverse pregnancy outcomes include spontaneous miscarriage, 
stillbirth, preterm birth, low birthweight, neonatal death, and congenital infection in 
infants.  Congenital syphilis has been estimated to occur in 15% of sero-reactive 
mothers [17].  
 
In malaria endemic regions, about 27.6 million pregnancies arise that result in live 
births annually and 45% of these pregnancies would experience malaria infection 
[18, 19]. Reviews of studies that have reported on the prevalence of peripheral and 
placental parasitaemia in Africa estimates that approximately 1 in 4 have evidence of 
infection at the time of delivery [19]. Malaria infection is defined by the presence of 
Plasmodium falciparum parasites in the blood and has a very unique epidemiological 
profile in pregnancy. First, pregnant women are more likely to be infected than non-
pregnant women and men [19-21]. Second, the manifestation of infection differs 
geographically: in high transmission areas, where most adults have acquired 
immunity, infections are rarely symptomatic, thus eluding clinical detection and 
treatment [19]. Third, primigravidae and secundigravidae are more predisposed than 
multigravidae in high transmission areas whereas this relationship becomes more 
tenuous in unstable or epidemic areas [19-21]. Fourth, young maternal age is an 
independent risk factor for malaria in pregnancy and this may interact with gravidity 
to produce more severe infections [19]. Fifth, there is evidence that the prevalence 
of parasite changes during a woman’s pregnancy with peak prevalence occurring at 
the second trimester and decrease with gestation [20]. Malaria parasitic infection 
during pregnancy is associated with severe anaemia, intrauterine growth restriction, 
preterm delivery, neonatal and infant mortality [18-22].   
 
Africa region has the highest prevalence of anaemia [8] and among pregnant women 
it is estimated that 46.3% (95% CI 40.6-51.0%) are anaemic and 1.5% (95% CI 1.0-
2.3%) are severely anaemic in 2011 [23]. It occurs when there are low concentrations 
of haemoglobin in the blood which can be caused by infectious diseases, nutrition 
and genetics [8]. The condition is also socially patterned and affects those with low 
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socioeconomic status, poor education and rural residence more [8]. About 50% of 
anaemia cases are due to iron deficiency [23]. Haemoglobin concentrations drop 
naturally during pregnancy because of physiological changes and the large amounts 
of iron needed to support placenta and foetal growth. Haemoglobin concentrations 
drop 1-2 g/dL by late second trimester before re-stabilizing in the third trimester 
[24].  
Anaemia during pregnancy causes fatigue and is associated with low-birth weight, 
pre-term birth and maternal mortality. [8, 25]. There is substantial evidence that 
maternal iron deficiency early in pregnancy (first and second trimester) contributes 
to higher risk of pre-term delivery and low-birth weight than if iron deficiency 
occurred in the third trimester [26]. It is therefore important to ensure iron is 
supplemented early in pregnancy. Daily iron supplements during the antenatal 
period increases haemoglobin levels in maternal blood and reduces the likelihood of 
iron-deficiency anaemia at term [27]. It is estimated that about half of the anaemia 
found in pregnant women can be improved by iron supplementation; however, this 
may vary by location and lower in areas with higher proportions of malaria induced 
anaemia [23, 27].  
 
HIV, syphilis, malaria and anaemia do not exist in isolation and often overlap in 
pregnant women [28-34]; having one disease or condition may also be a risk factor 
for another. Malaria is more common in women with HIV [31]; one study estimated 
that in places with high Plasmodium falciparum parasite rates, the odds of acquiring 
HIV increase by 2.44 (95% CI 1.85–3.21) for women [35]. Risk of HIV transmission is 
increased through genital ulcer disease and the odds of having HIV is 3.3-fold higher 
in women presenting with syphilis [36]. Malaria is a major risk factor for anaemia [37, 
38]. It is estimated that 26% of severe anaemia in pregnant women is attributable to 
malaria and successful prevention of Plasmodium falciparum infection in pregnancy 
can reduce severe maternal anaemia by 38% [19]. Because of their individual and 
combined contribution to illness, interventions on their prevention and treatment in 
antenatal care would have great impact towards mortality and morbidity reduction 
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in women and children. Moreover, optimal management relies on adapting 
treatment to account for co-occurrences and possible adverse reactions.  
2.3 ANC guidelines for HIV, syphilis, malaria and anaemia  
The ill consequences of HIV, syphilis, malaria and anaemia can be prevented through 
prophylaxis, early diagnosis and treatment. It is important to do this as early as 
possible because, in all four conditions, risk cumulates with exposure over the 
gestation period. WHO global antenatal guidelines recommend screening and 
management of HIV, syphilis, and anaemia at the first ANC visit, ideally in the first 
trimester [39]. For malaria, in areas of stable transmission, there is currently no 
global recommendation for screening the blood for parasites for nonclinical cases 
but the current strategy recommends intermittent preventive therapy with 
sulfadoxine-pyrimethamine (IPTp-SP) and the use of insecticide-treated bednets 
(ITNs) together with effective case management of clinical malaria. The exception is 
Tanzania who recently introduced malaria testing at first visits into their antenatal 
guideline [40]. Table 2.2 summarizes the latest WHO antenatal guidelines for the four 
conditions. 
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Table 2.2: Summary of WHO antenatal guidelines for testing, treatment and prevention of HIV, syphilis, malaria and anaemia: recommendations for sub-Saharan Africa HIV Testing In high prevalence settings, provider-initiated testing and counselling (PITC) for HIV should be considered a routine component of the package of care for pregnant women in all antenatal care settings. Retest all HIV-negative pregnant women in the third trimester, during labour or postpartum because of the high risk of acquiring HIV infection during pregnancy. On testing strategies: In settings with greater than 5% HIV prevalence in the population being tested, a diagnosis of HIV-positive should be issued to people with two sequential reactive tests [39]. Treatment ART, following national regimen for combination therapy, should be initiated in all pregnant women diagnosed with HIV at any CD4 count and continued lifelong. This recommendation is based on evidence that shows that providing ART to all pregnant and breastfeeding women living with HIV improves individual health outcomes, prevents mother-to-child transmission of HIV, and prevents horizontal transmission of HIV from the mother to an uninfected sexual partner [39]. Prevention Oral pre-exposure prophylaxis (PREP) containing tenofovir disoproxil fumarate should be offered as an additional prevention choice for HIV negative pregnant women at substantial risk of HIV infection as part of combination prevention approaches [39].  Syphilis  Testing To prevent mother-to-child transmission of syphilis, all pregnant women should be screened for syphilis with on-site RPR or other available rapid test at the first ANC visit in the first trimester (ideally before 16 weeks gestation) to prevent congenital infection and again in the third trimester of pregnancy. Review syphilis test results at subsequent visits and at time of delivery. If the woman was not tested during pregnancy, syphilis screening should be offered after delivery [39, 41]. Treatment Treat all sero-reactive women with benzathine benzylpenicillin at the recommended dosage of at least 2.4 million units (MU) intramuscularly as a single dose, after having excluded allergy to penicillin. In the case of penicillin allergy, the attendant should desensitize and treat with penicillin if trained to do so, or refer the patient to a higher level of care. Advise women who test positive that their partner(s) must also be treated with the same regimen, as well as the baby as soon as possible after birth [41]. When benzathine or procaine penicillin cannot be used (e.g. due to penicillin allergy where penicillin desensitization is not possible) or are not available (e.g. due to stock-outs), the WHO sexually transmitted infections (STI) guideline suggests using, with caution, erythromycin 500 mg orally four times daily for 14 days or ceftriaxone 1 g intramuscularly once daily for 10–14 days or azithromycin 2g once orally [42].  Malaria Testing In malaria-endemic areas, malaria should be suspected in any patient presenting with a history of fever or temperature ≥37.5oC. In all settings, suspected malaria should be confirmed with a parasitological test. Malaria RDTs should be used if quality-assured malaria miscroscopy is not readily available. In settings where parasitological diagnosis is not possible, a decision to provide antimalarial treatment must be based on the probability that the illness is malaria [43].  Treatment Treat pregnant women with uncomplicated P. falciparum malaria during the first trimester with 7 days quinine plus clindamycin. Treat uncomplicated P. 
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falciparum malaria during the second and third trimesters with artemisinin-based combination therapies (ACT). Treat severe malaria with intravenous or intramuscular artesunate for at least 24 hrs. Once a patient has received at least 24 hrs of parenteral therapy and can tolerate oral therapy, complete treatment with 3 days of ACT [43].  Prevention In moderate-to-high malaria transmission areas of Africa, WHO recommends a package of interventions for all pregnant women, which includes promotion and use of insecticide-treated nets (ITNs), as well as intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP). IPTp-SP dosing should start in the second trimester, and doses should be given at least one month apart, with the objective of ensuring that at least three doses are received. To ensure that pregnant women in endemic areas start IPTp-SP as early as possible in the second trimester, policy-makers should ensure health system contact with women at 13 weeks of gestation. Policy-makers could also consider supplying women with their first SP dose at the first ANC visit with instructions about the date (corresponding to 13 weeks of gestation) on which the medicine should be taken. Women on cotrimoxazole should not be given IPTp-SP [39].  Anaemia Testing  Full blood count testing is the recommended method for diagnosing anaemia in pregnancy. In settings where full blood count testing is not available, on-site haemoglobin testing with a haemoglobinometer is recommended over the use of the haemoglobin colour scale as the method for diagnosing anaemia in pregnancy [39]. Treatment If a woman is diagnosed with anaemia (Hb < 110 g/L) during ANC, she should be given 120 mg of elemental iron and 400 μg (0.4 mg) of folic acid daily until her Hb concentration rises to normal (Hb 110 g/L or higher). Thereafter, she can continue with the standard daily antenatal iron and folic acid dose (or the intermittent regimen if daily iron is not acceptable due to side-effects) to prevent recurrence of anaemia [39]. Prevention Daily oral iron and folic acid supplementation with 30 mg to 60 mg of elemental iron and 400 µg (0.4 mg) of folic acid is recommended for pregnant women. In settings where anaemia in pregnant women is a severe public health problem (i.e. > 40% of pregnant women have a blood haemoglobin [Hb] concentration < 110 g/L), a daily dose of 60 mg of elemental iron is preferred over a lower dose. Intermittent oral iron and folic acid supplementation with 120 mg of elemental iron and 2800 μg (2.8 mg) of folic acid once weekly is recommended for pregnant women to improve maternal and neonatal outcomes if daily iron is not acceptable due to side-effects, and in populations with anaemia prevalence among pregnant women < 20% [39]. ART: antiretroviral therapy; RPR: rapid plasma reagin test; RDT: rapid diagnostic test 
 
 
In 2002, the WHO put forth a focused antenatal care (FANC) model that reduced the 
number of required visits from 12 to four, making visiting schedules more suitable to 
health systems in developing countries where facilities may be hard to reach and 
human resources strained [44]. Recently, evidence has suggested that risk of 
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perinatal death is significantly higher in the four-visit model compared to models 
with eight or more visits. Therefore, in 2016, the WHO changed the recommendation 
to eight ‘contacts’, where contacts imply any exchange with a healthcare provider 
irrespective of the setting [39]. Figure 2.1 shows when strategies for HIV, syphilis, 
malaria and anaemia should to be delivered in the old four-visit and new eight-
contact models.   
Figure 2.1 Comparison of ANC schedules from 2002 FANC model with four visits and 2016 ANC model with eight contacts and timing of blood testing adapted from WHO antenatal guidelines  [39]  
      Blood test       Suggested malaria blood test schedule ANC: antenatal care; FANC: focused antenatal care 
 
 
An integrated disease approach to antenatal service delivery is recommended as the 
best strategy to address the various health needs and infections in pregnancy [45]. 
Integration can be thought of as a concept that means “the organization and 
management of health services so that people get the care they need, when they 
need it, in ways that are user-friendly, achieve the desired results and provide value 
for money”[45]. This could refer to several things: 1) for users (e.g. pregnant 
women), integration could mean receiving all required services packaged together at 
a one-stop shop and avoiding referrals or separate visits [45]; 2) it could also mean 
specifically for the user to remain at one service delivery point during a visit and 
receives all the interventions from one healthcare provider in order to achieve more 
co-ordinated care [45]; 3) integration can also refer to continuum of individual care 
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over time for chronic conditions like HIV or over life-cycles stages like antenatal, 
postnatal and child care in order to ensure linkages and reduce loss to follow-up [46]; 
4) integration can also happen at the level of policy-making, financing and 
management so there is co-ordination across sectors for joint decision-making, 
monitoring and supervision. However integration occurs, the common idea is to 
improve user access to health services and to create synergies among the 
investments in health programmes [45]. Implementation experiences have shown 
that integrating services into a one-stop shop for maternal health allows women to 
receive comprehensive diagnostic and appropriate treatment in a single visit, 
avoiding the need to visit the facility at multiple occasions or at different locations 
which costs money and takes time away from parenting or work [47-50]. Integrating 
services has been shown to encourage more pregnant women to attend ANC, 
increase the number of women who receives test results, shorten time to receiving 
results, and increase the number of women who initiate and adhere to HIV 
treatment [48-54]. PMTCT programmes integrated into ANC also give better 
confidentiality and improve patient-provider relationships [52].  
2.4 Coverage of ANC guidelines 
Populations in SSA have been widely reached through antenatal care channels, with 
approximately 70% of pregnancies having had contact with the healthcare system 
[55].  Despite this, not all those who have had contact receive the preventive and 
curative services necessary for preventing adverse pregnancy outcomes. Missed 
opportunities for ANC to deliver comprehensive and integrated care to women are 
still widespread. The following section will describe the current state of coverage in 
ANC for HIV, syphilis, malaria and anaemia interventions. 
 
Testing coverage for HIV among pregnant women in the African Region has been 
gradually expanding over the years, from 9% in 2005 to 51% in 2013, but still short of 
95% universal testing target (Figure 2.2). Not all regions have improved testing 
coverage at the same rate and regional differences exist: in the most severely 
prevalent areas of eastern and southern Africa, 74% of pregnant women were tested 
for HIV and know their results compared to only 35% in western and central Africa 
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[56]. Antenatal care is a vital opportunity for HIV testing which is a critical entry point 
into PMTCT care, but not all women who attend ANC receive an HIV test, 
underachieving ANC’s potential to reach HIV positive pregnant women [57]. 
Demographic Health Survey (DHS) data from 2011 to 2013 for four countries show 
that Ugandan women had 81.5% HIV testing rate at ANC, compared with 69.4% in 
Mozambique, 54.4% in Nigeria and 45.4% in Congo [57]. Kenya’s HIV testing 
coverage at ANC is relatively high and has improved greatly over the years: 93.1% of 
women who attended ANC from 2008 to 2012 for their last live birth were tested 
compared to only 64.9% in 2002-2007 period [58].  
Figure 2.2: Estimated HIV testing and counselling coverage among pregnant women, low- and middle-income countries overall and by WHO region, 2005 and 2009–2013 [56] 
Sources: number of pregnant women tested reported by countries: Global AIDS Response Progress Reporting (WHO/UNICEF/UNAIDS); estimated number of live births as a proxy for the number of pregnant women: Population Division, United Nations Department of Economic and Social Affairs. 
Treatment coverage is also short of the global target of having 90% of pregnant 
women living with HIV to be on ART. Overall in the Africa Region, 68% (range 62-
74%) of HIV positive pregnant women were receiving ARV medicines in 2013. This 
also varies considerably among different countries: coverage of pregnant women 
living with HIV receiving ARV medicines for PMTCT ranges from 27% in Nigeria to 
over 95% in Botswana and Swaziland.  58% in Burundi to 90% in South Africa [56]. 
 
Coverage of syphilis testing and treatment is suboptimal in countries within the WHO 
African region. Of those that reported data in 2013 for the Global AIDS Response 
Progress Report (WHO/UNICEF/ UNAIDS), 58% of women in antenatal care were 
43  
tested for syphilis during their first visit and about 2.2% of these women tested 
positive. Of women tested positive, 96% reported receiving treatment [56]. 
Proportion of women tested for syphilis in ANC has not improved much from 59% in 
2008 (Table 2.3). These are higher than estimates from a 2001 survey of 22 countries 
in SSA which found 38% of pregnant women who received ANC were screened for 
syphilis [59].  
Table 2.3 Proportions of pregnant women in antenatal care who were tested for syphilis, who 
tested positive and who received treatment, 2008/2010 and 2013 [56] 
 Indicator 1: Percentage of antenatal care attendees tested for syphilis  
Indicator 2: Percentage of antenatal care attendees tested who are positive for syphilis 
Indicator 3: Percentage of antenatal care attendees who tested positive for syphilis and who received treatment  2008 2013 2008 2013 2010 2013 
 No. of reporting countries 
Median value reported 
No. of reporting countries 
Median value reported 
No. of reporting countries 
Median value reported 
No. of reporting countries 
Median value reported 
No. of reporting countries 
Median value reported 
No. of reporting countries 
Median value reported 
Africa region 18 59% 23 58% 30 2.3% 30 2.2% 15 100% 16 96% 
Source: Global AIDS Response Progress Reporting (WHO/UNICEF/UNAIDS) 
 
 
Malaria prevention strategies in pregnancy are mainly delivered through ANC clinics 
but they have not been very effective in providing IPTp and ITNs to pregnant women 
[60, 61]: among approximately 80% of those who attend ANC, 30% did not receive a 
single dose of IPTp in 2015 estimates [62]. It is also estimated that only 31% (UI: 29-
32%) of eligible pregnant women received at least three doses of IPTp among the 36 
African countries that reported data in 2015 (Figure 2.3) [62]. Some countries 
achieved better coverage than others: 24 reported that more than 50% of pregnant 
women received at least 1 dose, and 17 reported that more than 50% received at 
least 2 doses and 3 countries reported that more than 50% received at least 3 doses 
of IPTp [62]. Zambia has one of the highest IPTp coverages in Africa, with 72% of 
pregnant women who attend ANCs receiving a second dose of SP in 2012 [63]. For 
ITN strategy, the median use of an ITN the previous night among pregnant women 
was only 35.3% (range 5.2%–75.5%) among 37 reporting countries in the period 
between 2009-2011 [60, 61].  
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Figure 2.3: Proportion of pregnant women receiving IPTp, by dose in sub-Saharan Africa, 2010-2015 [62] 
 
IPTp: intermittent preventive treatment in pregnancy; Source- National malaria control programme reports and United Nations population estimates 
 
 
To our knowledge there is no global estimates of anaemia screening, but local 
studies in SSA have shown that screening for anaemia and haematinic 
supplementation has the poorest coverage among all the 4 conditions. A study in 16 
rural coastal clinics in Rufiji district in Tanzania found only 2 out of 10 dispensaries 
had diagnostic instruments (e.g. the Tallqvist colour scale, HaemoCue@ machines, 
etc) to assess anaemia. Of the 85 women surveyed from these facilities, 14.5% were 
assessed clinically and 6.4% were assessed using the Tallqvist method), despite a 
high prevalence of anaemia (66.5%) among women who attended these clinics [64]. 
Iron was available in 90% of the facilities [64] but frequent shortages have been 
reported in another longitudinal study in Tanzania [65, 66].  In Kenya, a community 
survey of women who had a recent birth in two sub-counties in western Kenya found 
only 35% of women were tested for haemoglobin concentration, 74% received iron 
and 57% received folic acid supplementation [67].  According to Ethiopia 
Demographic Health Survey (EDHS) 2011, only 17.3% of women took the iron 
supplement during their recent pregnancy in the preceding 5 years and less, 0.4%, 
were supplemented for 90 or more days [68]. 
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2.5 Barriers and enablers to achieving high coverage for HIV, syphilis, malaria and anaemia in antenatal care 
So far, this review has described the burden and aetiology of four of the most 
deleterious illnesses for pregnant women in SSA and emphasized the importance of 
delivering strategies to protect mother and child early. It has also outlined the gaps 
and missed opportunities of ANC for delivering preventative and screen-and-treat 
strategies for pregnant women. The following section looks at some of the reasons 
for sub-optimal coverage in SSA through an implementation pathway framework. 
 
This review will look at the barriers and enablers of achieving effective coverage of 
antenatal strategies through an implementation pathway that was first described by 
Tanahashi and further adapted by Baker et al. [69, 70]. The framework breaks down 
the pathway into three conditional stages where each stage has unique 
determinants, enabling a more practical guide to devising solutions. The first 
condition requires that the target population (e.g. pregnant women) can 
geographically, financially, and socio-culturally access the location where the 
interventions are delivered which are usually the antenatal care facilities (access). 
Once pregnant women arrive at the facilities, there must be adequate human 
resources, drugs, supplies and equipment to deliver the health interventions (health 
facility readiness). The third condition is that the intervention is delivered with 
sufficient skill, equity, knowledge and quality to generate the target health outcome 
(clinical practice) [69]. Additionally, we also look at some of the broader patient and 
community socio-cultural factors that may contribute to completing the 
implementation pathway. Attrition in coverage at any stage leads to compromises in 
desired health outcomes.  
2.5.1.1 ANC attendance (Access) 
As most of the interventions to prevent adverse pregnancy outcomes are delivered 
through ANC facilities, ANC attendance is the first step to ensuring women get what 
they need for healthy pregnancies. In SSA, approximately 70% of women aged 15-49 
reported had at least one antenatal visit with a skilled attendant but less, 
approximately 54% had the recommended four visits [55]. Furthermore, women 
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often attend ANC late. Only approximately 28% attend clinic in the first trimester, 
and 40% before the third trimester leaving a third of women receiving antenatal care 
in the third trimester, too late for effective diagnostic and preventive services [55]. 
Urban dwelling, education and household wealth are consistent predictors of 
antenatal care use [55, 71]. Women who are teenagers or older compared to those 
in their 30s, and women with higher parity tend to use antenatal care less [55, 72] as 
do women with unintended pregnancies and who are single [72]. Family members 
also affect ANC usage [73] and some studies have found that husband’s refusal or 
mother-in-law’s disapproval discourages women from using ANC [72]. Long distance, 
expensive and inconvenient travel to health facilities are associated with starting 
ANC late and making less visits [72]. Poor quality of care, negative attitudes of health 
workers and punishments for late attendance have been found to stymie timely ANC 
utilization [72, 74]. Qualitative studies have suggested that some women do not start 
ANC early because they are unsure of the pregnancy status or they do not see the 
benefit of attending ANC unless there is a problem [72]. Late attendance 
compromises timely access to screening tests and treatment effectiveness. These 
socio-demographic determinants mean that rural, uneducated, and poor women are 
most disadvantaged when it comes to access coverage. 
2.5.1.2 Availability of commodities (Health facility readiness) 
Unavailability of diagnostic tools is a major barrier to achieving universal screening 
coverage for HIV, syphilis and anaemia. This was more pronounced for syphilis and 
haemoglobin testing than for HIV testing [28, 75-79]. Using household interviews and 
survey data from 122 health facilities between 2011 and 2014 in rural south-eastern 
Tanzania and eastern Uganda, ANC coverage was estimated to be near universal but 
test shortages at facilities caused 57% and 42% of those attending ANC to not 
receive testing for syphilis and haemoglobin respectively in Tanzania and 79% and 
69% in Uganda [77]. Test shortages for HIV was less severe but was still responsible 
for 17% of women not being tested in Tanzania and 39% in Uganda [77]. A 12-month 
assessment of 8 antenatal clinics in Kenya found no syphilis tests available at low-
level facilities and inconsistently available at higher-level facilities whereas HIV test 
kits were more consistently available but occasional stock-outs still occurred [78]. 
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Lack of rapid plasma reagin (RPR) test kits and benzathine penicillin to treat syphilis 
was a major obstacle in survey of 9 Tanzanian health facilities around the country in 
2000/2001 where only 3 out of 9 facilities had enough supplies to test and treat ANC 
women for syphilis for one week [80]. Stock-out of HIV testing commodities occurred 
51.4% of the time during a study of integrated maternal health services in 
Mozambique [81].  
In addition to the unavailability of test supplies, stock-outs of prevention and 
treatment commodities undermines fidelity to antenatal management guidelines. 
Directly observed treatment (DOT) of IPTp and distribution of ITNs are the current 
strategies to prevent malaria in pregnancy in most malaria endemic countries. While 
this removes the requirement for testing, periodic stock-outs of SP have undermined 
the delivery of chemoprophylaxis to pregnant women [74, 82-93]. A study in two 
rural districts in Tanzania reported that 9% of women miss IPTp because of drug 
shortages [74]. The situation is exacerbated by healthcare workers incorrectly using 
SP to treat malaria cases in the general population, leaving less for prevention in 
pregnant women [89, 94].  Consequently, women are not given the drug or are asked 
to buy it elsewhere and many do not have the funds to do so [83, 92]. Shortage of 
ITNs is a major reason women are not receiving the nets at ANC clinics [61, 89].  Iron 
and folic acid supplementation also suffers from frequent stock-outs: in 2010, only 
40% of health facilities in Kenya had ferrous sulphate and 74% had folic acid [95].  
Shortages are caused by insufficient funds, low government prioritizations, 
communication failures, poor stock quantification and management, and ineffective 
procurement systems that delay delivery of stocks [61, 87, 89, 94-97]. HIV 
programmes have received more support, and have suffered less from shortages 
after the Bush administration in the United States established the President's 
Emergency Plan for AIDS Relief (PEPFAR) programme in 2003, the largest donor to 
the global AIDS response [98]. Various other donor bodies joined the fight against 
HIV which led to substantial financial backing for vertical HIV programmes resulting 
in dramatic increases in testing and treatment coverage in the first decade of the 21st 
century [98]. These vertical programs have also been found to create parallel 
procurement and supervisory systems which lead to duplication and confusion in 
ordering stocks for other antenatal needs [59, 77, 80, 99]. Syphilis and haemoglobin 
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screening, despite the strong evidence for their clinical effectiveness [17, 59, 100-
102], lack donor advocacy and consequently achieve less coverage [59, 77, 103].  
Integration of health programmes and improving stock-availability and has vast 
potential to close the coverage gap. In addition to shortages of tests and drugs, lack 
of potable water at some facilities have precluded women from taking the drug at 
the facilities [74, 104]. Not wanting to share cups has also been reported by urban 
women in Nigeria as reasons for not taking SP under DOT [104]. These 
environmental factors need attention when designing antenatal interventions. 
2.5.1.3 Human resources (Health facility readiness) 
Critical healthcare worker shortages, skill mix imbalance and maldistribution of the 
workforce are significant barriers for scaling interventions in SSA [105-110]. Reviews 
of integrated service delivery of HIV, syphilis, and malaria programmes have 
identified staff shortages, overburden and frequent turn-overs as major limitations 
to the success of adding on new tasks [47, 49, 75, 80, 81, 87, 90, 111-115]. 
Healthcare workers are often required to fill out various paper-based registers for 
specific services, generating large amounts of paperwork that burden staff workload 
[116]. Additionally, disease-specific short training, polio eradication campaigns, and 
leave pull staff away from already strained facilities [80, 105, 117, 118], leaving sites 
understaffed and compromising quality [91].  
Despite healthcare worker shortages, the existing workforce is not always fully 
utilized [119-121] and the World Report 2010 estimates that 20-40% of health 
spending is wasted through inefficiency [122].  Time and motion studies in Tanzania 
revealed staff productivity of approximately 60% [121]. Reproductive health staff in 
one study in Cameroon were found to spend only 27% of their time on service 
provision [119]. Productivity gains from less time spent on prolonged breaks, waiting 
for patients, excessive socializing and unexplained absences have been estimated to 
be 26%, suggesting improvements in productivity through incentives to boost morale 
and better management could close the human resource requirements for universal 
coverage [121]. Low productivity has been attributed to demoralization from meagre 
and delayed salaries, lack of choice in placement, poor working conditions, job grade 
stagnation, and feeling helpless due to stock-outs of commodities and drugs [74, 
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105, 108, 110]. These frustrations lead to poor quality of care and increased 
absenteeism, dual practices (having other income generating activities) and cultures 
of predatory provider-client relationships (abusive behaviour towards clients) [123-
128]. Staff have asked women to pay for SP when they are supposed to be delivered 
freely, which deters women from accessing services [61]. Moreover, vertical well-
funded HIV programmes attract staff with higher salaries, pulling human resources 
away from other reproductive health priorities, often creating two tiers of salaried 
health workers side by side which can affect the morale of the lower paid staff [105, 
117, 129]. Better qualified staff migrate to urban areas or private practices, leaving 
rural public facilities with less skilled personnel, widening the equity gap [90, 110]. 
Improving healthcare work performance will require addressing the multiple 
determinants that affect performance [124, 130]. Integration of services has been 
shown to increase motivation and enthusiasm of healthcare workers. For example, 
integrating HIV programs with MCH have increased healthcare worker morale and 
satisfaction in Mozambique and Kenya by enabling providers to deliver more 
effective services to people [52, 81].  Integrating the use of simple syphilis POCTs 
with ANC have been shown to improve healthcare worker’s job satisfaction by 
enabling them with tools to diagnose disease [50, 78, 131]. Evidence also suggests 
that supervision and audit with feedback, as well as packages of interventions that 
address multiple factors are more effective in improving performance than just 
disseminating guidelines or single interventions [124]. Human resource management 
(HRS) and quality improvement (QI) methods should be explored to understand how 
to better manage performance low-resource health systems [130, 132].  
2.5.1.4 Training, knowledge and guidelines (Clinical practice) 
Inconsistencies in training, knowledge and guideline adherence affect staff 
competence in delivering quality ANC services. Comprehensive training on all aspects 
of integrated maternal health services should be given to ANC providers. Some of the 
gaps found in Malawi were that ANC providers were only trained in HIV counselling 
and referred women to other providers for HIV testing leading to inefficiencies and 
poor uptake [133]. In Mwanza, Tanzania, nurses and health aides who were trained 
to use RPR for diagnosing syphilis were not permitted to treat medical conditions 
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and women were frequently told to return on another day for treatment [80]. Trade-
offs between more training and pulling staff away from facilities in a resource-
strained system needs to be carefully considered and pre-service or in-house training 
may be more beneficial. 
National level policy guidelines are sometimes unclear, incomplete or inconsistent 
with WHO guidelines [61, 89, 134]. Case studies from Kenya found no specific 
guidelines on syphilis available at facilities and it is known by healthcare workers to 
be covered under genital ulcer diseases in the syndromic management of STI 
flowcharts which is inappropriate for the management of asymptomatic syphilis [75]. 
Cut-offs of haemoglobin for defining anaemia and severe anaemia are inconsistent in 
Kenyan guidelines where some guidelines use WHO haemoglobin cut-offs (non-
anaemic Hb ≥11 g/dL, mild Hb 10-10.9 g/dL, moderate Hb 7-9.9 g/dL, severe Hb <7 
g/dL) while others do not (Figure 2.4) [135, 136]. This may explain why iron dosing 
regimens given to pregnant women do not consistently adhere to prophylactic or 
treatment guidance based on anaemia status [137]. In Tanzania, two different 
guidelines with conflicting information on IPTp were found to be circulating at the 
same time [138]. 
Figure 2.4: Hand-written guideline on the diagnosis of anaemia based on haemoglobin concentrations at a dispensary in western Kenya, 2015 
 
Photo taken by Nicole Yan 
Inadequate training and inaccurate guidelines leads to poor healthcare worker 
knowledge and if healthcare workers are confused they may opt for doing nothing 
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for fear of doing harm [139]. In Tanzania, a general lack of awareness of the 
implications of untreated maternal syphilis by healthcare workers led to low 
prioritization of testing [80]. Knowledge of how to conduct penicillin desensitization 
was found to be poor in South Africa [75]. In western Kenya, correct malaria case 
management knowledge and practice was observed in less than half (45%) of health 
facilities and SP was prescribed as treatment in 3% of health facilities [140]. Poor 
knowledge of IPTp use and giving SP for treating clinical malaria cases has been 
observed in other SSA countries as well [89, 90, 94]. In Kenya, distribution of a memo 
with clear and simple instructions for IPTp administration, together with explanation 
of the guidelines in follow-up supervisory visits, resulted in significant increases in 
uptake of IPTp in the districts that received the intervention [139]. However, longer 
lasting effects of the memo have not been assessed. Kenyan government surveys on 
iron and folic supplementation conducted in 2013 reported that providers’ poor 
knowledge of dosing and duration, inadequate knowledge given to pregnant women 
about anaemia, and side effects led to low adherence of haematinic supplements by 
pregnant women [95].  
2.5.1.5 Supervision, monitoring and evaluation systems (Clinical practice) 
Supportive supervision and audit feedback, even for uncomplicated innovations, are 
essential to ensuring quality of performance [124, 141]. Lack of supportive 
supervision have been found to undermine health facility readiness to deliver 
antenatal services [96, 97]. They have been found to be infrequent and have 
suboptimal quality where officials would focus mainly on crosschecking facility 
registers rather than evaluate processes and content of ANC services [90]. Most HIV 
testing programmes in developing countries have no quality assurance programmes 
to ensure that point-of-care tests are properly performed [142]. Managers may have 
competing duties with little time left for monitoring performance [143]. Good 
supervision with feedback is an important determinant of healthcare worker 
performance [124]. It also makes them feel valued, increase their motivation, 
improve their skills and help them gain new knowledge [81].  
Clear supervisory roles are important for effective management but often in low-
resource settings, different and uncoordinated programmes, each with their own 
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agendas, are involved in the planning and monitoring of different maternal health 
interventions. In Kenya, integration of PMTCT services with ANC began in 2004 and 
was widely available in over 3000 facilities by 2007 but quality of the services was 
elusive and supervision was provided through distinct HIV teams [133]. A joint 
supervision tool was created to address disjointed supervisory roles between HIV 
and maternal health programmes and quality has improved as a result [133]. 
Supervision provided through vertical programmes was also seen in South Africa 
where TB and PMTCT services had each their own management guideline and the 
lack of co-ordinated leadership from implementing bodies undermined benefits of 
comprehensive integration [144, 145]. Horizons (an operational research programme 
tasked to identify best practices in HIV/AIDS [146]) identified separate bodies for 
providing HIV testing and counselling, ARVs and infant formula, and iron 
supplementation in Zambia [143]. These parallel systems create duplications, 
increases programme costs and add extraneous workload [117]. 
2.5.1.6 Patient pathways (Clinical practice) 
Integration on an operational level is also important to improve ease of receiving 
services by streamlining client flow and reducing wait times. Services that require 
referrals to separate rooms, laboratories, or facilities pose significant challenges to 
access and acceptability of HIV and syphilis services [47, 147-150]. HIV treatment 
provided in separate specialized ART centres increases the attrition rate between 
diagnosis and treatment [48, 151, 152]. Many countries have physically integrated 
PMTCT with ANC service delivery points and are moving away from separated 
horizontal programmes [153].  
2.5.1.7 Patient and community centred influencers of ANC uptake  
Perceived disease related stigmas and their social acceptability poses challenges to 
accepting maternal health services. In Tanzania, syphilis is stigmatized because it is 
associated with promiscuity and believed to cause infertility [50]. It is also believed to 
be a less harmful disease when compared with HIV and the lack of overt symptoms 
may lead women to underestimate its danger [50].  
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In cultures where women have low socio-economic statuses, partner support is 
influential to women’s health seeking behaviour: women have been found to want 
permission from their husbands before taking SP [104] or delay attending ANC 
because their husbands have not given them money for transport [61]. Partner 
involvement is also necessary to end the cycle of re-infection of syphilis or to protect 
sero-discordant couples. However, men have been under-targeted [73] by health 
programmes and often refuse to be tested for HIV out of fear [50].  
Lack of knowledge of the benefits of SP, why it needs to be given, the required doses 
and timing have been identified as barriers to the acceptability IPTp by pregnant 
women [61]. Experience, fear of side-effects and misconceptions that SP may cause 
abortions have led to some women to reject the intervention [104, 154-156]. Since 
IPTp needs to be started early and doses given over several visits, the reasons 
outlined above (section 2.5.1.1) for women not starting ANC early and returning for 
revisits are barriers to full protection [157-159]. For ITNs, several studies have found 
that women feel uncomfortable and hot when sleeping under them or that they are 
inconvenient to put up at night [61]. Beliefs that chemicals on the nets are harmful 
or that they do not prevent malaria also have been raised [61].  
2.6 Point-of-care tests (POCTs) to address the underachievement in antenatal care  
The barriers to universal effective coverage of antenatal HIV, syphilis, malaria and 
anaemia are varied and overcoming them will depend on multiple, system-wide 
strengthening efforts. No one intervention or solution by itself will be able to close 
the entire coverage gap. One potential solution is the use of rapid point-of-care tests 
(POCTs). POCTs that fulfil the ASSURED2 criteria and require no electricity or 
equipment are available to fulfil antenatal screening requirements [160]. Their 
simplicity means they require only basic training and add minimal workload on the 
healthcare workforce. POCTs can shorten the diagnostic process, allowing same-day 
management of conditions and their co-infections, potentially increasing 
                                                     
2 Affordable, Sensitive, Specific, User-friendly (simple to perform in a few steps with minimal training), Robust and rapid (can be stored at room temperature and results available <30 mins), Equipment-free and Deliverable to those who need them   
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client/clinician satisfaction [160] and subsequent adherence to the ANC testing 
schedules. Pregnant women no longer need to wait long for test results or to be 
referred to distant laboratories for testing, reducing time and financial costs.  
Although the current malaria strategy in pregnancy does not require testing for 
parasites in the blood, expanding malaria testing at the first ANC visit to all pregnant 
women, regardless of clinical symptoms [161-163] may be an attractive strategy in 
parts of Africa for various reasons including concerns about the impact of high-grade 
SP resistance [164], or some populations may no longer require IPTp because of 
marked reductions in malaria transmission. Furthermore, women who attend ANC in 
the first trimester are not eligible for SP, and lastly, the uptake of IPTp has been low, 
with only half of pregnant women receiving at least one of three or more 
recommended doses of SP [165, 166].  
POCTs have been instrumental in the scale-up of prevention of mother-to-child-
transmission of HIV (PMTCT) services, achieving over 90% of HIV testing coverage of 
women who attend ANC [58]. Replacing the more labour and equipment intensive 
RPR and VDRL syphilis screening methods with simpler POCTs have increased the 
number of women diagnosed and treated on the same day [50, 54, 76, 79, 103, 150]. 
POCTs are also more acceptable to women because less blood is needed to run the 
tests [50]. Healthcare workers have also appreciated their simplicity, ease-of-use and 
believe the results are more reliable [50]. The skills healthcare workers have gained 
from HIV testing can be expanded to integrate the use of POCTs for syphilis, malaria 
and anaemia at dispensaries so coverage of diagnosis and timely treatment can be 
improved. For these reasons, an integrated testing strategy would be an attractive 
intervention that would potentially improve maternal health outcomes. Moreover, 
availability of HIV/syphilis multiplex tests and their increasing popularity will likely 
lead to improved testing coverage of syphilis, and more cost-savings from 
efficiencies in procurement and service delivery [167]. 
 
Over the last 2 decades, researchers are increasingly recognizing the crucial role of 
implementation research in reducing the gap between the promise of evidence-
based practices and their implementation success[168]. Implementation research is 
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defined as the “scientific study of methods to promote the systematic uptake of 
research findings and other evidence-based practices into routine practice, and, 
hence, to improve the quality and effectiveness of health services and care” [169].  
The literature is teeming with conceptual frameworks and theories to guide 
implementation questions and of relevance to this thesis are those on the 
assessment of innovation diffusion in healthcare. Much of this work is based on 
Roger’s seminal Diffusion of Innovations theory, published in 1962 to explain how, 
why and at what rate new innovations (an intervention which can be ideas, 
technology or new ways of doing things) spread [170]. These concepts have been 
applied by many to understand service delivery of innovations in healthcare 
organizations. Glasgow et al.’s RE-AIM evaluation model from 1999 defined the 
impact of an intervention as a product of 5 functions: reach, efficacy, adoption, 
implementation and maintenance. In Greenhalgh et al.’s 2004 exhaustive systematic 
review of studies assessing innovations in health service organizations, concepts such 
as the attributes of the innovation, the social networks and system characteristics 
through which it operates, as well as the non-linear and interrupted nature of the 
implementation process, were drawn to create an inter-linking framework of 
determinants for implementation success [171]. In an attempt to consolidate the 
various models, theories, frameworks and terminologies in the published literature, a 
Consolidated Framework for Implementation Research (CFIR) was developed to 
facilitate convergence of construct ideas applied in implementation research [168]. 
The CFIR draws its foundation in Greenhalgh et al.’s work and builds upon it with 
other theories of dissemination, innovation, organizational change, knowledge 
translation and research uptake. The final structure overlaps with Greenhalgh’s and 
comprises of 5 domains with multiple constructs under them: the intervention 
characteristics (e.g. relative advantage, adaptability, trialability, complexity), outer 
setting (patient needs and resources), inner setting (culture and leadership), 
individual characteristics (e.g. knowledge and beliefs about the intervention, self-
efficacy) and the implementation process [168]. The existence of a multitude of 
frameworks speaks to the complexity of the field. Implementation science is an 
emerging field where consistency in nomenclature and conceptual distinctions are 
still evolving [172, 173].   
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Many of the discussed frameworks have used different definitions for the same 
construct while some constructs have similar definitions that could be conceptually 
sharpened [168, 174]. This lack of a common vocabulary makes it difficult to 
aggregate and cross-compare findings of different strategies [168]. Proctor et al. 
attempted to resolve this issue by combing through the literature to identify 
commonly used concepts and create a precise working taxonomy of implementation 
outcomes for researchers to measure implementation success [173, 174]. Table 2.4 
provides summary definitions for the eight implementation outcomes with the most 
consistency and use in existing literature.  
Table 2.4: Taxonomy of implementation outcomes synthesized from a narrative review approach of the literature Outcome Construct definition [173, 174] Acceptability  Extent to which implementation stakeholders perceive that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory. Adoption  The intention, initial decision, or action to try or employ an innovation or evidence-based practice. Adoption also may be referred to as ‘‘uptake.’’ Appropriateness The perceived fit, relevance, or compatibility of the innovation or evidence based practice for a given practice setting, provider, or consumer; and/or perceived fit of the innovation to address a problem.  Cost Financial impact of an implementation effort. May include costs of treatment delivery, cost of the implementation strategy, and cost of using the service setting. Feasibility The extent to which a new treatment, or an innovation, can be successfully used or carried out within a given agency or setting. Fidelity The degree to which an intervention was implemented as it was prescribed in the original protocol or as it was intended by the program developers. Penetration The integration of a practice within a service setting and its subsystems. Sustainability The extent to which a newly implemented treatment is maintained or institutionalized within a service setting’s ongoing, stable operations. 
These implementation outcomes can be described as the immediate effects of 
deliberate actions of practice and serve as indicators of success of the 
implementation process. They exist within a greater framework as intermediaries for 
clinical effectiveness and service outcomes, assuming that a well-executed 
intervention is the pre-condition for subsequent improvements in health and quality 
of care (Figure 2.5).  
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Figure 2.5: Conceptual Framework of implementation outcomes adapted from Proctor et al. [173, 174] 
 *Service outcomes are derived from six quality improvement aims: the extent to which services are safe, effective, patient-centered, timely, efficient, and equitable (Institute of Medicine Committee on Crossing the Quality Chasm 2006; Institute of Quality of Care in America 2001) 
Health systems are complex and adaptive meaning they consist of networks of 
interacting and interdependent elements (e.g. patients, providers, government 
agencies, non-government organizations), that are “bound by a common purpose 
but each acting on their own knowledge” [175]. Complex adaptive systems are 
largely self-organizing and the actors within these networks are in constant feedback 
loops, adapting to the dynamic environment which in turn are influenced by the 
actors [176]. This makes traditional methods of identifying risk factors by 
determining single exposure effects on an outcome by controlling for confounders 
limiting because they assume linear, unidirectional causal pathways [177].  
Operational research (OR) methods can be useful to aid decision making for 
implementation problems in complex systems [178]. OR is founded on the concept 
of systems thinking which is “concerned with the interrelationships between parts 
and their relationships to a functioning whole, often understood within the context 
of an even greater whole”[176]. It is an established discipline that originated in pre-
World War II British military where advanced mathematical and modelling methods 
were used to help make decisions for complex problems. It has been widely applied 
in the manufacturing sector to improve process performance and efficiency [179]. 
Since the 1950s, the healthcare sector has adopted OR methods to identify and 
improve effectiveness of programmes in real implementation settings [178]. 
Bottlenecks are identified during the implementation process and analytical 
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techniques are applied to provide answers to these challenges with direct relevance 
to solving the intervention’s healthcare delivery problems [180]. As such, its utility 
tends to be local and focused on specific aspects of service delivery [179-181]. 
Analytical techniques used in operational research include both qualitative (e.g. 
systems mapping) approaches in participatory group sessions and quantitative 
approaches (e.g. mathematical and simulation modelling) done by individual analysts 
using empirical data to represent system components [179]. Operational research 
methods are thus a very useful tool for implementation research [178]. 
2.7 Kenya 
The above sections reviewed reasons screen-and-treat strategies for HIV, syphilis, 
and anaemia and preventive strategies for malaria are delivered inadequately 
through ANC and an integrated testing approach using POCTs was suggested as a 
potential innovation to close the coverage gap. The next section describes Kenya, 
where the study took place. It shows that Kenya embodies many of the disease 
challenges and health system characteristics of the region.  
 
Kenya has a population of about 44 million. Most people in Kenya live in rural areas 
(67.7%) and a third of the population live on less than $2 a day [2]. Life expectancy 
dropped in the early 2000s to a low of 50 years, due to the impact of the HIV 
epidemic, but has since risen to 61 years in 2015 [2]. Maternal mortality is high with 
a 2015 estimate of 338 (95% CI: 261-429) deaths for 100,000 live births and 
stagnating annualised rate of change of -0.4% (95% CI: -1.6-0.8) from 1990-2015 
[182]. The under-5 mortality was estimated to be 49 (90% CI: 38-64) per 1000 live 
births in 2015 and declining at 2.9% (90% CI: 1.8-4.0%) annually from 1990-2015 [6]. 
HIV/AIDS is by far the most fatal disease, accounting for a third of the country’s 
deaths (29.3%), followed by conditions arising during the perinatal period which 
accounted for 9% [183]. Malaria is the 6th leading cause, contributing to 5.8% of 
deaths [183].  
Within the country, vast disparities exist and reproductive health problems 
disproportionately affect areas in western Kenya in the Lake Victoria basin (Figure 
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2.6). In 2012, the country’s HIV prevalence was 5.6% among those aged 15-64 but 
15.1% in Nyanza, western Kenya [58].  Among women of reproductive age in Nyanza, 
HIV prevalence was 17.6% [58]. The last nationally representative data on syphilis 
was captured in the 2007 Kenya AIDS Indicator survey and estimated the prevalence 
among adults 15-64 years old to be 1.8% and among pregnant women to be 1.6% 
[184]. Nyanza has a higher prevalence of 2.3% among women 15-64 years old [184]. 
Even higher pockets of syphilis prevalence have been found in Asembo in Nyanza 
Province where one observational study found a prevalence of 11.5% (n=282) in 
pregnant women using different treponemal and non-treponemal tests [185].  
Figure 2.6: Map of Kenya[186] 
 
 
Malaria is endemic in western Kenya and transmission intense throughout the year 
with all-age prevalence ranging from 20-50% (Figure 2.7) [186].  Malaria parasites 
were found in a third of pregnant women attending health facilities in Siaya county 
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[163]. Prevalence of anaemia (Hb  <11 g/dl) among pregnant women is estimated to 
be 55.1% in the country [95] and a similar prevalence of 58-63% was found among 
pregnant women at rural health facilities in Siaya county [163]. 
Figure 2.7: Kenya 2015 Population-adjusted P. falciparum Prevalence by County Map [186] 
 
 
 
Kenya spends 5.7% of its GDP on health [2]. The total health expenditure per capita 
was $77 in 2014, compared to an average of $98 in sub-Saharan Africa and $4739 in 
OECD countries [2]. Kenya’s healthcare is financed by a combination of government 
health expenditure (GHE), development partners (through external aid and 
borrowing), out-of-pocket (OOP) contributions from households and individuals, and 
insurance or employer contributions (Table 2.5). Public sector financing has 
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remained constant at approximately a third over the last decade whereas donors’ 
contributions have more than doubled which helped drive down OOP expenditures 
significantly.  
Table 2.5: Kenya’s health financing 2014 [2]  
THE as % of GDP  5.7% 
THE per capita (USD) $77.7  
GHE as % of THE 33.5% 
External resources as % of THE 27.5% 
OOP as % of THE 26.1% 
Other private and insurance schemes as % of THE 12.6% 
USD: US dollar; THE: total health expenditure; GDP: Gross domestic product; GHE: government health expenditure; OOP: out of pocket expenditure 
 
2.7.2.1 Devolution and new structure of government 
Kenya renewed its constitution in 2010 which introduced the devolution of the 
government’s administrative power to 47 counties under one national government 
[183]. The transfer of decision-making from central government to local bodies 
aimed to make healthcare services more tailored to the needs of local populations 
and increase access to medicines and treatment across the country through 
improved efficiency, responsiveness and accountability [187]. Under the devolved 
government, the national government holds responsibility for health policy 
formation, national referral health facilities and reference laboratories, disease 
surveillance, monitoring and evaluation, health commodity procurement, technical 
assistance, capacity building and co-ordinating partners and donors [183]. The 
national Ministry of Health is organized into five main directorates under the 
Director of Medical Services (Figure 2.8). Under one of these directorates, the 
Department of Preventive and Promotive Services, the National Malaria Control 
Programme (NMCP), the National AIDS and STIs Control Programme (NASCOP) and 
the Division of Family Health manage and create policies for malaria in pregnancy, 
PMTCT and reproductive health programmes respectively [186, 188]. There are 
inter-agency coordination committees (ICCs) and technical working groups that meet 
quarterly or on an ad hoc basis to discuss issues and promote coordinated technical 
support and policy development across programmes. However, the 2013 Health 
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Sector Strategic Plan found that there are too many ICCs, their programmes are not 
aligned to sector policies and their linkages are weak [189]. 
Figure 2.8: Organizational structure of Kenya’s national government [190] 
 SAGAS: semi-autonomous government agencies; M&E: monitoring and evaluation; PRO: Public record office; ICT: Information Communication Technology; HRD: Human Resource Development; SCMD: supply chain management division; HRM: Human Resource Management  
 
Service delivery and disease management and control are under the jurisdiction of 
the county governments. Counties have increased their budget for health from 13% 
in 2013/2014 to 21.5% in 2014/2015, suggesting increasing priority given to health 
despite competing demands from other sectors such as transportation, education 
and agriculture [191]. Siaya in particular increased their health budget allocation 
from under 10% in 2013/2014 to 31% in 2014/2015 [191]. However, a large share of 
recurring county budget allocations in 2014/2015 (70%) went to employee 
compensation and only 8% went to medical drugs and supplies [191]. Improvement 
in allocative efficiencies is needed to better match the needs and demands for 
optimal service delivery. Counties oversee curative and rehabilitative services, health 
promotion and disease prevention, sector planning, and governance and 
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administration. Each county has a health executive and director for health who 
oversees the county health management team. The county manages the first three 
hierarchal levels of service delivery [183]. It begins at the community (level 1) under 
a Comprehensive Community Strategy which focus on prevention and demand 
creation activities. This strategy is powered by community providers who are village 
members with linkages to health facilities within the area. These community 
providers identify and refer those who need services, such as pregnant women, to 
formal health infrastructures. They also give prevention and drug adherence advice, 
follow-up on ART adherence for HIV positive persons, as well as trace those who 
default on facility visits [183, 192] . Levels above the community are primary care 
units which consist of dispensaries (level 2) and health centres (level 3).  Together 
they focus on preventive and promotive services such as basic maternal and child 
health services, including antenatal services, rudimentary out-patient curative care 
and support care for HIV positive patients. Dispensaries are smaller, more pervasive 
and peripheral while health centres are slightly larger, tend to be located in hubs, 
and usually have laboratory services capable of performing diagnostic tests. Non-
state implementation partners also play a role in delivering primary care services and 
they include civil society organizations (CSOs), faith based organizations (FBOs), non-
governmental organizations (NGOs) and private sector organizations and 
development partners. Most antenatal care services are preventive and are 
delivered by primary care providers [183].  
The national government oversees levels 4-6 which consists of the primary, 
secondary and tertiary referral facilities respectively. They offers more complex and 
sophisticated services focusing on curative and rehabilitative care which are 
managed under the national government [183]. To facilitate communication and co-
ordination between national and county governments, a health sector inter-
governmental forum meets quarterly to address health issues that span across 
county and national government concerns [183]. Figure 2.9 summarizes the different 
governance bodies and linkages within the health system.  
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Figure 2.9 Health sector leadership framework [189] 
 ICC: Inter-agency coordinating committees 
 
2.7.2.2 Human resources 
Kenya’s workforce for health services delivery faces significant shortages and skewed 
distribution [189]. The number doctors, clinical officers and nurses average 20.7, 
31.6, and 159.3 per 100,000 persons in 2013 respectively [183]. While the number of 
doctors per 100,000 persons almost meets WHO’s recommended 21.7, the number 
of nurses fall below the recommendation of 228 per 100,000 [183]. This also 
translates to approximately 2.1 skilled workers per 1000 people, below the crisis 
threshold of 2.5 per 1000 which corresponds to providing 80% of pregnant women 
with a skilled birth attendance [106], placing Kenya among one of 57 countries facing 
human resource crisis [105]. Moreover, the organization of personnel deployment is 
erratic, resulting in mal-distributions that favour high socioeconomic and urban 
regions despite 70% of the population live in the rural. This leaves marginalised and 
hard-to-reach areas with shortage of staff while better-off regions report surpluses in 
staff.  In addition, healthcare workers, especially in rural areas, face remote and poor 
work environments, low remuneration, job grade stagnation, lack of essential 
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medicines and supplies leading burn out, low morale and productivity [183]. Task 
shifting to lay workers for certain services such as HIV testing and counselling is now 
recommended to relieve some workload from nurses [39, 193].  
2.7.2.3 Kenya Medical Supplies Authority (KEMSA)  
KEMSA, a state-owned logistics company that was incepted in 2000, procures drugs 
and health commodities from manufacturers and contracts private transport 
companies for distribution. Development partners such as World Bank and USAID 
provide technical support. Before devolution, health facilities directly ordered 
commodities from KEMSA using a pull system, and this was paid for by the MOH. 
Since devolution, counties became responsible for ordering and paying for medical 
supplies, including fees for warehousing and distribution, for all the facilities in the 
counties. Drugs for HIV, malaria, TB and reproductive health are financed separately 
by donors and procured by their respective programmes [194].   
2.7.2.4 Health information system (HIS) 
In 2010, Kenya has implemented the District Health Information Software (DHIS2), an 
open source, cloud web-based data infrastructure for reporting routine health data 
for monitoring and evaluation [195]. Each month, health facilities tally register data 
into several monthly summary reporting forms which are sent to the sub-county 
government offices (by 5th of each month) for inputting into the DHIS2 (by 15th of 
each month) [195, 196]. Filling out these forms is a tedious process that takes a 
considerable amount of time as facilities have multiple registers with duplicate 
information [196]. This usually interrupts normal service delivery as healthcare 
workers rush to meet reporting deadlines at the end of each month. More 
integration of tools and use of technology may alleviate the burden from data 
reporting.  
 
In Kenya, the proportion of pregnant women aged 15-54 years who attend ANC at 
least once is over 95% country-wide [58]. However, only 10% of pregnant women 
attend ANC in the first trimester and less than 40% attend before the third trimester 
[58]. Reasons for not attending ANC visits include distance, cost, cultural restrictions, 
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fear, lack of time, use of traditional birth attendants, and not feeling the need for 
ANC [58, 197]. Antenatal care services are mostly delivered by the primary care 
facilities. Within the Kenya national antenatal policy guidelines, addressing the 
conditions of HIV, syphilis, malaria and anaemia as early as possible during pregnancy 
is an essential component (Table 2.6) [135]. However, coverage of prevention, 
screening and treatment has yet to reach global targets. Dispensaries, where most 
women attend ANC, do not typically stock diagnostic tests for syphilis or anaemia 
and pregnant women are referred to distant facilities with laboratory capacity to 
complete their testing. Referrals further delay testing, narrowing the opportunity 
where treatment to prevent adverse outcomes are effective. 
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Table 2.6: Kenya’s most current national antenatal guidelines.  
HIV  Testing Serial testing of HIV (see Figure 2.10Figure 2.10) at first ANC visit and repeated every three months [198] Treatment Facilities with ability to initiate and monitor all HIV positive pregnant mothers on HAART should initiate triple ARVs (HAART) for life (uninterrupted) regardless of their WHO clinical stage or CD4 count in order to attain maximal viral load suppression WHO 
staging and CD4 testing is recommended at baseline to monitor progress [199, 200]. Syphilis   Testing Screening using non-treponemal serologic test, RPR or VDRL, at first ANC visit before 16 weeks gestation. Confirm reactive non-treponemal serologic tests treponemal-specific tests [135].  Treatment Provide single dose of 2.4 MU benzathine penicillin or if penicillin allergic and unable to access penicillin desensitization give erythromycin 500 mg three times daily for 7 days and counselling on partner notification [135]. Malaria  Prevention In malaria endemic areas, give IPTp with SP to all pregnant women at every scheduled antenatal visit commencing at the start of the second trimester. Each SP dose should be given at least one month apart and ensuring women receive a minimum of 3 doses. IPTp should be given under DOT in the antenatal clinic and can be given on an empty stomach. Pregnant women who are HIV positive and are on daily cotrimoxazole chemoprophylaxis should not be given SP for IPTp. Each pregnant woman living in a malaria risk area should receive a LLIN at the first contact visit to the ANC [201]. Testing In all pregnant women with fever or history of fever the use of parasitological diagnosis (microscopy or RDT) is recommended. At health facilities where malaria diagnostics are not available, patients suspected to have malaria should be treated for malaria [201].  Treatment For uncomplicated p. falciparum malaria, treat pregnant women in the first trimester with seven days of quinine plus clindamycin (if unavailable use an ACT). For pregnant women in second or third trimester, treat with an artemisinin-based combination therapy (ACT). The current recommended first line ACT is artemether plus lumefantrine, (AL). The second line ACT is dihydroartemisinin plus piperaquine, (DHA/PPQ) [201].  Treat all adults including pregnant women in all trimesters and children with severe p. falciparum malaria with intravenous or intramuscular artesunate for a minimum of 3 doses/or 24hrs. At health care levels where treatment of severe malaria is not possible, but injections are available, give a single dose of intramuscular artesunate 2.4mg/kg for adults and 3.0mg/kg for children <20 kg and refer to an appropriate facility for further care. Use artemether 3.2 mg /kg or quinine 20 mg/kg if artesunate is not available [201]. Anaemia  Prevention Not anaemic (Hb ≥ 10 g /dL): give 60 mg elemental iron and 0.4 mg folic acid daily [135].  Testing Hb blood test at first visit or referral if blood test not available. Repeat Hb test if Hb at previous visit was below 7.0 g/dl or signs of anaemia are detected on examination [135]. 
Treatment Mild anaemia (Hb <10 g/dL): 120 mg elemental iron daily; Moderate anaemia (Hb 5-7.9 g/dL): same as for mild and provide additional iron dextran; Severe anaemia (Hb is <5 g/dL): admit to hospital. Treat any underlying cause of anaemia as appropriate [135]. 
ANC: antenatal care; ARV: antiretrovirals; ART: antiretroviral therapy; HAART: highly active antiretroviral therapy; IPTp: Intermittent Preventive Treatment; SP: sulfadoxine pyrimthamine; RPR: Rapid Plasma Reagin; VDRL: Venereal Disease Research Laboratory; DOT: directly observed treatment; LLIN: long lasting insectide treated nets; RDT: rapid diagnostic test; Hb: haemoglobin 
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2.7.3.1 HIV and PMTCT  
In Kenya, 96% of the HIV population reside in 34 of 47 counties, and 45% are 
concentrated in the 5 high burden counties of Nairobi, Homa Bay, Kisumu, Siaya and 
Migori [202]. PEPFAR, through implementation partners, provides technical and 
financial support to these 34 counties, which covers 78% of the national PMTCT 
needs [202]. In Kenya’s eastern and Nyanza region, the International Center for AIDS 
Care and Treatment Programs (ICAP) at Columbia University's Mailman School of 
Public Health is the main implementation partner [203].  
Overall HIV testing rates in Kenya vary among the regions. In women aged 15-49, an 
overall average of 53% were tested for HIV and received results in the preceding 12 
months prior to the 2014 Health and Demographic survey. Among the same group, 
Nairobi had the highest HIV testing coverage at 90%,  Nyanza region had 60%, and 
the North-eastern counties (Garissa, Wajir, Mandera) had the lowest coverage 
between 36-53% [204]. ANC is one of the main avenues for women to learn of their 
HIV statuses in Kenya; 92.5% of women who visited an ANC in their last pregnancy 
received an HIV test there [58].  
HIV testing services in Kenya are delivered in both the community and at health 
facilities. Both facility and community based testing offer two approaches: provider 
Initiated Testing and Counselling (PITC) approach where the service provider offers 
HIV testing and the client can decline based on informed choice and the Client 
Initiated Testing and Counselling (CITC) where clients request testing services. All 
pregnant women visiting a health facility for antenatal care should be given PITC and 
repeat testing in the third trimester if the first test is done within the first trimester 
[198]. Rapid diagnostic tests have been used for point-of-care HIV testing in ANC 
since 2000 and have formed the cornerstone of rapid scale up since then. Since 2002 
and prior to 2015, serial testing with 3 rapid tests for screening, confirmation and tie-
breaking was used but the rapid tests used for this algorithm was changed several 
times. In 2013, the national algorithm changed from Determine HIV 1-2 (Alere 
Scarborough, Inc., USA), Uni-Gold™ (Trinity Biotech, Ireland), and long Eliza to HIV 1-
2 Antibody Colloidal Gold (KHB, Shanghai Kehua Bio-engineering Co Ltd, China), First 
Response HIV 1-2 kits (Premier Medical Corporation Ltd., Kachigam, India) and Uni-
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Gold [205]. In late 2015, the HIV testing algorithm was changed again to using only 2 
serial rapid tests (Determine and First Response) and the tie-breaker test was no 
longer recommended (Figure 2.10) [198]. These frequent changes have implications 
for training, guidelines and quality of care. 
Figure 2.10: Kenya’s latest HIV testing algorithm [198]  
Note: Use of tie breaker is no longer recommended as of 2015 
Providing comprehensive ART to HIV pregnant women regardless of CD4 count 
(option B+) is the recommended treatment for HIV positive pregnant women in 
settings that have the capacity to initiate and monitor triple ARV therapy [200]. ICAP 
has taken the provision of option B+ in the Nyanza region to scale beginning in 2014 
[203]. 
2.7.3.2 Syphilis and anaemia screening 
Less than half of pregnant women attending ANC are tested for syphilis in Kenya, 
even though screening is a major country policy of antenatal care. In Nyanza, 
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western Kenya, only about 8-22% of pregnant women are tested for syphilis at ANC 
[67, 78, 206]. At the time of this study the recommended screening strategy for 
syphilis was the use of non-treponemal tests, either the Rapid Plasma Reagin (RPR), 
or the Venereal Diseases Research Laboratory (VDRL) test [135].  Both these tests 
require electricity and equipment not readily available at most peripheral facilities 
most women in rural areas access ANC [79]. The RPR first requires a venous blood 
sample that needs to be centrifuged to obtain the plasma which is then mixed with 
the antigen (cardiolipin plus lecithin and cholesterol) on a rotator that will become 
agglutinated if an antibody/antigen complex is formed. The VDRL test uses the same 
antigen and the presence of antibody/antigen complex is observed under the 
microscope.   
In western Kenya, only about 30-49% of pregnant women are tested for anaemia at 
ANC [67, 206]. Without blood tests, health workers need to rely on clinical 
examinations for pallor to detect severe anaemia, a method that has been shown to 
have variable sensitivity, ranging from 53%-100% [207, 208].  
The difference in availability between tests for HIV and those for syphilis and 
anaemia may reflect the heavy reliance of healthcare expenditure on donor funding 
(almost a third) skewing priorities towards those of the international community 
[99]. The substantial donor support given to vertical HIV programmes often results in 
parallel procurement and supervisory systems developed to ensure their accessibility 
and use [59, 96, 209].  
2.1.1.1 Malaria in Pregnancy 
Kenya’s ‘Malaria in Pregnancy’ policy does not require screening for blood parasites 
(although it is practiced by many facilities in western Kenya with microscopy 
capacity) but instead emphasizes prevention and treatment (Table 2.6). Country-
wide, only 10% of pregnant women aged 15-49 with a live birth between 2012-2014 
received the minimum three doses of SP as recommended by the national guidelines 
[210]. Regional differences exist with the coastal region achieving the highest 
coverage of 32.7%, followed by western region of 26.2% and Nyanza with 9.7% 
[211].  Compliance on bednet usage is also low, despite high ownership [212]. 
Findings from the 2014 Demographic and Health survey found that only 51% of 
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pregnant women slept under an treated bednet the previous night [210]. Unclear 
guidance and stock-outs are some of the reasons for the policy’s underachievement 
[61]. Parasitic screening of malaria with POCT at the first antenatal visit may be an 
attractive strategy due to missed opportunities of the current strategy.  
2.7.3.3 Antenatal care registers 
Data on ANC services delivered are routinely collected in hand-written ANC registers. 
These include information on HIV testing and retesting, syphilis testing and 
treatment, haemoglobin concentrations, iron folic acid supplementation, IPTp and 
bednets given. For malaria, there is a column under ‘Other conditions screened for’ 
to indicate malaria testing and a column under ‘Additional treatments’ to indicate if 
treatment was given for malaria (Figure 2.11). This is usually inconsistently filled out 
and does not give accurate data on the number of women receiving malaria tests or 
treatment. 
Figure 2.11 Column headings for antenatal care registers in Kenya 
 
2.8 Conclusion 
Many of the strategies to lessen the burden of HIV, syphilis, malaria and anaemia in 
pregnancy in sub-Saharan Africa struggle at the implementation stage because of 
health system weaknesses and lack of a co-ordinated and integrated effort. For 
pregnant women who do have contact with ANC, comprehensive and quality care is 
still elusive. Stock-out of drugs and commodities, inadequate training of healthcare 
workers, lack of clear guidelines, weak supervision and monitoring systems, 
convoluted patient pathways, and the socio-cultural beliefs from the community are 
some of the things that stymie effective coverage. Addressing these challenges 
would require concerted efforts from multiple parties on a grand scale. 
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A simple strategy of introducing POCTs at dispensaries, the lowest level of the health 
system, has potential to address some of these coverage constraints by increasing 
access and improving the rates of early testing and treatment among the most hard-
to-reach women. Integrating multiple POCTs in service delivery can reduce 
redundancies among programmes and maximize synergies by bundling together 
healthcare worker training and supervision. This strategy is also a step towards 
delivering holistic antenatal care. The strategy will need to be evaluated in the health 
system to ensure that it can be adopted, accepted and that the intervention can be 
delivered as intended. Western Kenya is a suitable place to test this strategy as this is 
where an under-resourced health system meets high rates of disease. Therefore, 
three studies were designed to assess the implementation outcomes of integrated 
testing at peripheral health facilities in rural western Kenya. Chapter 3 assessed rates 
of adoption and fidelity to clinical management guidelines as well as healthcare 
worker performance of testing. Chapter 4 explored healthcare workers’ and 
pregnant women’s experiences of testing to give richer narratives of findings from 
Chapter 3. Chapter 5 explored the operational impact of introducing the strategy at a 
dispensary to elucidate effects on wait times and health resource utilization.  
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3.1 Abstract  
Background: In sub-Saharan Africa, HIV, syphilis, malaria and anaemia are leading 
preventable causes of adverse pregnancy outcomes. In Kenya, policy states women 
should be tested for all four conditions (malaria only if febrile) at first antenatal care 
(ANC) visit. In practice, while HIV screening is conducted, coverage of screening for 
the others is suboptimal and early pregnancy management of illnesses is 
compromised. This is particularly evident at rural dispensaries that lack laboratories 
and have parallel programmes for HIV, reproductive health and malaria, resulting in 
fractured and inadequate care for women.  
Methods: A longitudinal eight-month implementation study integrating point-of-care 
diagnostic tests for the four conditions into routine ANC was conducted in seven 
purposively selected dispensaries in western Kenya. Testing proficiency of healthcare 
workers was observed at initial training and at three monthly intervals thereafter. 
Adoption of testing was compared using ANC register data 8.5 months before and 
eight months during the intervention. Fidelity to clinical management guidelines was 
determined by client exit interviews with success defined as >90% adherence.  
Findings: For first ANC visits at baseline (n=529), testing rates were unavailable for 
malaria, low for syphilis (4.3%) and anaemia (27.8%), and near universal for HIV 
(99%). During intervention, over 95% of first attendees (n=586) completed four tests 
and of those tested positive, 70.6% received penicillin or erythromycin for syphilis, 
65.5% and 48.3% received cotrimoxazole and antiretrovirals respectively for HIV, and 
76.4% received artemether/lumefantrine, quinine or dihydroartemisinin–
piperaquine correctly for malaria. Iron and folic supplements were given to nearly 
90% of women but often at incorrect doses.  
Conclusions: Integrating point-of-care testing into ANC at dispensaries with 
established HIV testing programmes resulted in a significant increase in testing rates, 
without disturbing HIV testing rates. While more cases were detected and treated, 
treatment fidelity still requires strengthening and an integrated monitoring and 
evaluation system needs to be established.  
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3.2 Background 
In sub-Saharan Africa (SSA), the most preventable leading causes of maternal 
mortality and adverse pregnancy outcomes are maternal HIV, syphilis, malaria and 
anaemia [1-4], with co-infections common [5-9]. SSA has an estimated maternal HIV 
prevalence of 5.3%, representing 92% of the world’s HIV positive pregnant women 
[10, 11]. Roughly 24% of deaths in women during pregnancy or post-partum are 
attributable to untreated HIV [1]. Maternal syphilis in the African region has a 
prevalence of 1.7%, which constitutes 63.1% of infections in pregnancy globally [2]. 
Syphilis is associated with spontaneous miscarriage, stillbirth, preterm birth, low 
birthweight, neonatal death, and congenital infection in infants [2]. The risk for both 
HIV and syphilis mother-to-child transmission cumulates with duration of exposure in 
utero [12, 13] and late treatments of syphilis may not avert damage to foetal 
development [14]. Where malaria is endemic, 45% of pregnancies would be infected 
[3, 15]. Starting from early gestation throughout, malaria parasitaemia is associated 
with anaemia, intrauterine growth restriction, preterm delivery, foetal loss, neonatal 
and infant mortality [3, 15-19]. Anaemia is also most prevalent in Africa: about 46% 
of pregnant women are anaemic and 1.5% are severely anaemic [20]. Anaemia 
during pregnancy is associated with increased risk of post-partum haemorrhage, 
maternal mortality, low birth weight, and perinatal mortality [4]. There is substantial 
evidence that iron deficiency early in pregnancy (first and second trimester) 
contributes to higher risk of pre-term delivery and lower birth weight than if it 
occurred later [21, 22]. Thus, early prevention, diagnosis and treatment is key to 
protect women and their pregnancies. Many of these conditions do not exist in 
isolation and having one disease or condition may also be a risk factor for another: 
malaria is more common in women with HIV [23-25]; risk of HIV transmission is 
increased through genital ulcer disease [5]; malaria is a major risk factor for anaemia 
[26]; approximately 26% of severe anaemia in pregnant women is attributable to 
malaria and can be reduced by 38% from preventing malaria infection in pregnancy 
[3]. Because of their individual and combined contribution to disease, addressing 
these conditions together, as early as possible during pregnancy is an essential goal 
of antenatal care (ANC) [27].  
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Since 2001, Kenya has adopted the World Health Organization’s (WHO) focused ANC 
guidelines which call for a minimum of four visits [28] (recently updated to eight 
‘contacts’ by WHO [27]). For the first visit, Kenyan guidelines recommend screening 
for HIV, syphilis and anaemia, urinalysis, and blood typing (together known as the 
ANC profile). To prevent the consequences of malaria in pregnancy, the current 
strategy recommends parasitic diagnosis of malaria only if the patient is febrile, 
together with the use of insecticide-treated nets (ITNs) and ANC administered 
intermittent preventive therapy with sulfadoxine-pyrimethamine (IPTp-SP). 
Expanding malaria testing at the first ANC visit to all pregnant women, regardless of 
fever [29-31], may be an attractive strategy in parts of Africa for various reasons 
including concerns about the impact of high-grade SP resistance [32] or that some 
populations may no longer require IPTp  because of marked reductions in malaria 
transmission. Furthermore, IPTp alone may be an inadequate intervention because 
women who attend ANC in the first trimester are not eligible for SP, and the uptake 
of IPTp has been low, with only half of pregnant women receiving at least one of 
three or more recommended doses of SP [19, 33, 34].   
Rates of testing for syphilis and anaemia remain low among pregnant women in 
Kenya [35-37] even though 95% of pregnant women attend at least one ANC visit 
[35]. This is largely because most women attend ANC at dispensaries (tier-2 health 
facilities in the periphery) which do not typically stock diagnostic tests (except for 
HIV) and are referred, with additional costs and time implications, to distant facilities 
with laboratory capacity to complete their ANC profile [38, 39]. The difference in 
availability between tests for HIV and those for syphilis and anaemia reflects the high 
international priority and substantial financial support given to vertical HIV 
programmes resulting in parallel procurement and supervisory systems developed to 
ensure their accessibility and use [40, 41]. Syphilis and haemoglobin screening, 
despite the strong evidence for their clinical effectiveness [42-44], lack such donor 
advocacy and prioritization and suffer inadequate coverage [40, 41] .  
Affordable and reliable rapid point-of-care tests (POCTs) that require minimal 
training and equipment are available to fulfil antenatal screening requirements [38]. 
Their simplicity and immediacy of results greatly benefit resource-constrained 
settings by allowing same-day initiation of management of conditions and their co-
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infections. POCTs use at dispensaries thus has potential to improve early diagnosis 
and treatment of conditions that cause adverse pregnancy outcomes. POCTs have 
been instrumental in the scale-up of prevention of mother-to-child-transmission 
(PMTCT) of HIV services, achieving over 90% of HIV testing coverage in women who 
attend ANC [35]. The skills healthcare workers have gained from HIV testing can be 
expanded to integrate the use of POCTs for syphilis, malaria and anaemia at 
dispensaries so coverage of diagnosis and timely treatment can be improved. 
This longitudinal implementation study quantitatively evaluated the adoption and 
fidelity of a programme intervention integrating point-of-care testing (POCT) for HIV, 
syphilis, malaria and anaemia at ANCs in dispensaries in western Kenya. We 
evaluated whether integrated POCT can increase the proportion of pregnant women 
tested and treated correctly for each of the respective conditions at first ANC visit. 
Other implementation outcomes of appropriateness, acceptability and feasibility will 
be reported elsewhere.  
3.3 Methods  
 
The study was conducted between December 2014 and August 2015 in the site of 
the KEMRI and CDC Health and Demographic Surveillance System (HDSS) in Siaya 
County, western Kenya. The population is 95% ethnically Luo, rural, and lives through 
subsistence farming and local trading [45]. At the time of the study, there were 37 
public health facilities in the study area: one district hospital, nine health centres and 
27 dispensaries. Dispensaries comprise the lowest level (tier-2) of the formal health 
system and offer basic maternal and child health services, rudimentary out-patient 
curative care and support care for HIV positive patients. Personnel typically include 
one to two nurses trained to certificate (at least 30 months training post-secondary) 
or diploma level (at least 36 months training post-secondary), a part-time clinical 
officer (36 months training post-secondary), an HIV testing counsellor and some 
support staff. The dispensaries receive approximately 40 antenatal visits per month. 
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Initial facility assessments were conducted to assess capacity to offer POCTs in nine 
health centres and 24 dispensaries within the HDSS area (three dispensaries were 
not assessed). Facility evaluation covered information such as facility infrastructure, 
client load, number and type of antenatal health workers, testing services and client 
flow. The assessment used a survey and observation checklist adapted from the 
Demographic and Health Surveys (DHS) Program [46]. Instruments were pre-tested 
outside the catchment area and were carried out by trained data collectors.  
Seven dispensaries were then purposively selected for inclusion in the study based 
on the following criteria: absence of other ongoing studies with pregnant women, 
geographic spread within the visual map area of HDSS, the number of monthly 
antenatal visits identified through retrospective register review, and willingness of 
the facility to participate. All seven facilities’ ANC clinics routinely conducted HIV 
testing, two irregularly conducted anaemia testing, and three irregularly conducted 
malaria testing. Lack of test supplies was the main reason for not conducting ANC 
testing for syphilis and anaemia. 
 
Integration here is defined as provision of all four tests concurrently, by a single 
healthcare worker, during a woman’s first ANC visit. In facilities that have specialized 
HIV testing counsellors, the four tests may be done by the counsellor instead of the 
ANC nurse.  All the facilities’ ANC healthcare workers were given a competency-
based training either at a central location or on-site. All participants received training 
manuals and job aid testing placemats with step-by-step instructions (Appendix 1 
Integration operating procedure placemat). Training included using one finger-prick 
blood draw to run all four tests per standard operating procedures, safety, and 
appropriate preventive care and clinical management of positive results following 
Kenyan guidelines as summarised in Table 3.1: 
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Table 3.1 Appropriate clinical management for positive test results and preventive care at first ANC visit [47] 
Condition  For treatment  For prevention 
HIV Initiate PMTCT; counsel; give cotrimoxazole and start triple therapy with antiretrovirals  Syphilis Provide single dose of 2.4 MU benzathine penicillin or if penicillin allergic and unable to access penicillin desensitization, give erythromycin 500 mg three times daily for seven days and counsel on partner notification  
 
Malaria Uncomplicated malaria: give quinine in first trimester; give artemether/lumefantrine (AL), quinine or dihydroartemisinin-piperaquine (DP) in second or third trimester; clinical severe malaria: refer to hospital 
Give directly observed IPTp-SP for malaria for women in second or third trimester not on cotrimoxazole; give ITN and advise to sleep under it. Anaemia  Mild anaemia (Hb <10 g/dL): give 120 mg daily elemental iron; moderate anaemia (Hb 5-7.9 g/dL): as above and provide additional iron dextran; severe anaemia (Hb is <5 g/dL): refer to hospital 
Not anaemic (Hb >10 g/dL): give 65 mg daily elemental iron 
Neural tube defects 
 Low dose (0.4 mg) folic acid daily; if low dose folic acid is not available, high dose (5 mg) tablets should not be administered with SP but can be taken 14 days following administration of IPTp-SP. ANC: antenatal care; POCT; point-of-care testing; PMTCT: prevention of mother-to-child transmission; IPTp-SP: intermittent preventive therapy in pregnancy with sulfadoxine-pyrimethamine; ITN: insecticide-treated net 
Study facilities used existing HIV drugs and HIV POCTs supplied by the Government of 
Kenya per its standard national algorithm at the time: HIV (1+2) Antibody Colloidal 
Gold (KHB, Shanghai Kehua Bio-engineering Co Ltd, China) for screening, First 
Response HIV-1-2 kits (Premier Medical Corporation Ltd., Kachigam, India) for 
confirmation and Uni-Gold™ (Trinity Biotech, Ireland) for tie-breaking. Iron, folic acid, 
SP and malaria treatment drugs were also supplied free of charge by the 
government. The study supplied the facilities with POCTs for syphilis (SD BIOLINE 
Syphilis 3.0 test for antibodies against Treponema pallidum, Standard Diagnostic Inc., 
Korea), malaria (CareStart™ Malaria HRP2 Pf, AccessBio, USA) and haemoglobin 
concentrations (HemoCue® Hb 201+, HemoCue AB, Sweden) and ensured no stock-
outs. For each lot number, 1% of the tests were selected at random and validated at 
KEMRI/CDC’s HIV reference laboratory in Kisumu, western Kenya, using known 
positive and negative samples. HemoCue® machines were calibrated every three 
months. The study also provided Brannan™ triple timers, gloves, and benzathine 
penicillin for treating syphilis based on projected prevalence of syphilis in the area.  
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Photographs of routine ANC registers were taken for 8.5 months before and eight 
months during intervention and the data were double-entered into the study 
database. There was no distinct column for recording malaria results in the registers 
so no reliable data existed pre-intervention and a column was added to facilitate 
collection of malaria test results during the intervention. From the registers, testing 
uptake was assessed among women aged 15-49 years below 28 gestational weeks of 
pregnancy (<28gw) attending their first ANC visit. The gestational age was estimated 
using date of last menstrual period (LMP) or fundal height if LMP was unknown. The 
evaluation was done in this group of women because adverse pregnancy outcomes 
are most preventable with early treatment and so we concentrated on outcomes in 
this population.  
During the intervention, these women were also asked to participate in exit 
interviews with trained research staff following their visits. Written informed 
consents were obtained. For illiterate women, the consent forms were read to the 
women in the presence of a literate witness and verbal consents with thumb prints 
and witness signatures were obtained. Women who refused to participate or were 
unable to provide informed consent because of mental or physical disability were 
excluded. Those who consented were interviewed for 20-30 mins in a private area at 
the facility. Interviews asked whether women were given information about the 
blood tests, test results, any preventive care or treatments (including detailed 
information on type and dosage of drugs not captured by ANC registers) using 
picture cards or observed drugs by interviewers, counselling, and advice for partner 
notification. 
Quality assessments (QA) through observed proficiency testing of healthcare workers 
to correctly perform rapid tests per manufacturers’ instructions were done 
immediately after initial training and at three, six and nine months (shortly after 
eight months of the intervention) using a 57-step checklist (Appendix 2) by trained 
research staff. Those who performed ≥90% of the checklist correctly received 
reminders for any missed steps and proceeded to implement integrated POCT. Those 
who did not reach ≥90% were re-trained until proficient.  
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Endpoints for assessing programme adoption and implementation fidelity are 
summarised in Table 3.2. Adoption is defined as “the action to try or employ an 
innovation…also may be referred to as ‘uptake’” and fidelity is defined as the 
“degree to which [the] intervention was implemented as intended by program 
developers and the quality of program delivery” [48]. Success was set at >90% in line 
with global testing and treatment targets for HIV and syphilis [49, 50]. Degrees of 
under-reaching the success target were categorised as follows: under-reached 60% 
to <90%, very under-reached 40% to <60% and severely under-reached <40%. 
Because introducing new services may affect existing services, synergy of integrating 
POCT with HIV testing was determined by change of HIV testing rates before and 
after the intervention.  
Table 3.2 Indicators of adoption, fidelity, and proposed success endpoints [48] 
Indicators of adoption and fidelity Indicator measure Data source Success endpoints 
Ado
ptio
n Testing uptake and synergy into HIV programme 
% of pregnant women tested for syphilis, malaria and anaemia by POCTs; unchanged or improved % of women tested for HIV 
ANC register ≥ 90% tested; ≥0% change in HIV testing rates 
Fide
lity 
Clinical management % of pregnant women who receive appropriate: a) preventive care b) correct management for test positive cases 
Exit interviews ≥90% received 
Information giving % of pregnant women who were given: a) information about the four tests b) test results c) HIV counselling d) syphilis partner notification advice 
Exit interviews ≥90% given/counselled/advised 
Health worker proficiency of POCT  
Proficiency scores measuring the ability of the health care worker to correctly perform rapid diagnostic tests per manufacturer guidelines 
Proficiency scores (%) ≥90% on check-list 
POCTs: point-of-care tests; POCT: point-of-care testing; ANC: antenatal care 
 
 
Quantitative data were entered in Microsoft Excel 2016. Descriptive statistics and 
analyses were done in Stata 14. The command metan was used to graphically display 
before and during testing proportions. For categorical variables, proportions were 
calculated and Chi2 was used to test for associations. For non-normal distributions of 
continuous data, medians and inter-quartile ranges (IQR) were calculated and 
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Wilcoxon rank-sum tests were used to test for associations. Box and whisker plots of 
proficiency tests scores were created in Microsoft Excel 2016. Using individual and 
facility level variables collected from the study, we explored factors associated with 
women not having a complete testing profile. Relative risks of having an incomplete 
ANC profile were obtained for each variable by fitting a log-binomial generalized 
estimating equation model that took facility clustering into account. Variables that 
had a significance level of <0.20 in the univariate analysis were considered for 
inclusion. Multicollinearity of selected variables was tested by using the variance 
inflation factor (VIF) command in Stata. Variables with a tolerance value (1/VIF) <0.1 
were considered collinear with one of the other independent variables.  
 
The protocol was reviewed and approved by the scientific and ethical steering 
committees of the Kenya Medical Research Institute (protocol 2271) and the 
Liverpool School of Tropical Medicine Ethics Committee (protocol 14.017). For U.S. 
CDC, while this activity was determined to be human subjects research, CDC staff 
involvement did not constitute engagement in human subjects’ research, thus not 
requiring human subjects research review by the CDC institutional review board. 
3.4 Results  
 
During 8.5 months before the integrated POCT programme, the seven facilities 
received 2279 ANC visits (median: 37, IQR: 28-37 visits per month) and 698 of them 
(median: 11, IQR: 8-11 visits per month) were first visits. Of the first visits, 529 
(75.7%) women were <28gw and aged 15-49 years. During the eight months of 
integrated POCT programme, 2240 ANC visits were made at the seven facilities 
(median: 38, IQR: 32-38 visits per month). Of these, 728 were first ANC visits 
(median: 13, IQR: 10-13 visits per month), and 586 (80.5%) were by women <28gw 
aged 15-49. HIV testing rates remained over 90% in all facilities both before and 
during integrated POCT period. For syphilis and anaemia, overall testing proportions 
increased from 4.3% (mean: 5.4%, SD: 4.0%, range: 0-12.5%) and 27.8% (mean: 
25.9%, SD: 29.8%, range: 1.5-81.9%) respectively to over 97%. The variations in 
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syphilis and anaemia testing pre-intervention reflect the inconsistent availability of 
test supplies within and between facilities. Facility one and seven had noticeably 
higher testing rates for anaemia because they received test supplies from the district 
hospital and an external partner respectively. Malaria testing also reached over 97% 
in all facilities during the intervention (Figure 3.1). 
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Figure 3.1 Proportion tested for condition pre (n=529) and during (n=586) integrated POCT programme by facility 
 *No data on number of women tested for malaria were available from the antenatal care registers 
before the intervention and therefore pre- and post-proportions were not comparable; ^profile pre-
integrated POCT includes HIV, syphilis and anaemia; profile during integrated POCT includes HIV, 
syphilis, malaria and anaemia; POCT: point-of-care testing; RD: risk difference, interpreted as the 
difference in testing proportions before and during integrated POCT 
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Among the 529 pregnancies evaluated pre-intervention, 31 new HIV infections, no 
syphilis infections, and 58 anaemic women (Hb <10 g/dL) were detected. There were 
78 women with known HIV positive statuses.  
Among the 586 pregnancies during integrated POCT, 41 new HIV infections, 18 
syphilis infections, 177 malaria infections, and 223 anaemic women were detected. 
There were 77 women with known HIV positive statuses (Table 3). Among 118 HIV 
positive women, co-infections with syphilis were found in five (4.2%) and with 
malaria in 30 (25.4%). Among 223 anaemic women, malaria was detected in 90 
(40.4%). One woman tested positive for syphilis, malaria and anaemia while none 
tested positive for all four conditions. Among HIV known positives, one woman was 
tested syphilis positive and anaemic. 
 
Among 586 pregnancies eligible for exit interviews, 106 (18.1%) did not consent. 
Those interviewed were more likely to have had a previous miscarriage, or have been 
tested for malaria, and were less likely to be newly diagnosed HIV positive (Table 
3.3). 
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Table 3.3 Test positivity rates and demographic characteristics of women aged between 15-49 years and <28 weeks pregnant, based on data from ANC registers 8.5 months before and 8 months during study  Conditions Before integrated POCT (n=529) During integrated POCT (n=586) 
 All All Not interviewed n=106 Interviewed n=480 P-value* 
HIV n=529 n=585 n=105 n=480  known positive 78/529 (14.7%) 77/585 (13.2%) 16/105 (15.2%) 61/480 (12.7%) 0.487 tested for HIV 448/451 (99.3%) 504/508 (99.2%) 87/89 (97.8%) 417/419 (99.5) 0.087 tested positive 31/448 (6.9%) 41/504 (8.1%) 12/87 (13.8%) 29/417 (7.0%) 0.034 total HIV positive 109/526 (20.7%) 118/581 (20.3%) 28/103 (27.2%) 90/478 (18.8%)  Syphilis n=529 n= 586 n=106 n=480  tested for syphilis 23/529 (4.3%) 572/586 (97.6%) 102/106 (96.2%) 470/480 (97.9%) 0.302 tested positive 0/23 (0%) 18/572 (3.1%) 2/102 (2%) 16/470 (3.4%) 0.449 Malaria  n=562 n=105 n=457  tested for mal  554/562 (98.6%) 100/105 (95.2%) 454/457 (99.3%) 0.001 tested positive  177/554 (31.9%) 28/100 (28%) 149/454 (32.8%) 0.349 Anaemia (g/dL) n=529 n=582 n=106 n=476  tested for Hb conc. 147/529 (27.8%) 569/582 (97.8%) 101/106 (95.3%) 468/476 (98.3%) 0.056 Non-anaemic Hb > 10 g/dL  89/147 (60.5%) 346/569 (60.8%) 60/101 (59.4%) 286/468 (61.1%)  Mild Hb 8-9.9 g/dL 46/147 (31.3%) 166/569 (29.2%) 29/101 (28.7%) 137/468 (29.3%)  Moderate Hb 5-7.9 g/dL 12/147 (8.2%) 56/569 (9.8%) 11/101 (10.9%) 45/468 (9.6%)  Severe Hb <5 g/dL  0/147 (0%) 1/569 (0.2%) 1/101 (1%) 0/468 (0%) 0.185 WHO anaemic Hb <11 g/dL 91/147 (61.9%) 346/569 (60.8%) 65/101 (64.4%) 281/468 (60%)  Demographic  During integrated POCT (n=586) 
  All Not interviewed n=106 Interviewed n=480 P-value Age  n=585 n=106 n=479  <20  159 (27.2%) 30 (28.3%) 129 (26.9%)  20 to <25  208 (35.6%) 40 (37.7%) 168 (35.1%)  25 to <30  118 (20.2%) 18 (17%) 100 (20.9%)  30 to <35  64 (10.9%) 12 (11.3%) 52 (10.9%)  35+  36 (6.2%) 6 (5.7%) 30 (6.3%) 0.917* Gestation in weeks   n=583 n=106 n=477  median (IQR)  21.1 (16.9-24.1) 21.7 (17.6-24.4) 21.1 (16.9-24.1) 0.47† Gravidity  n=586 n=106 n=480  gravida 1  163 (27.9%) 38 (35.8%) 125 (26.1%)  gravida 2  134 (22.9%) 24 (22.6%) 110 (23%)  gravida 3  114 (19.5%) 14 (13.2%) 100 (20.9%)  gravida 4  70 (12%) 12 (11.3%) 58 (12.1%)  gravida 5+  105 (17.9%) 18 (17%) 87 (18.1%) 0.22* Previous miscarriage  n=586 n=106 n=480  Yes  21 (3.6%) 0 (0%) 21 (4.4%) 0.028* Marital status  n=586 n=106 n=480  married  466 (79.5%) 83 (78.3%) 383 (79.8%)  widowed  9 (1.5%) 2 (1.9%) 7 (1.5%)  single  93 (15.9%) 15 (14.2%) 78 (16.3%)  divorced/separated  18 (17.2%) 6 (5.9%) 12 (12%) 0.363* 
WHO Hb: World Health Organization standards for haemoglobin cut-offs for defining anaemia else Kenyan cut-offs; 
*p-value based on Chi2 for the difference between those interviewed and not interviewed; †p-value based on 
Wilcoxon rank-sum for the difference in median between those interviewed and not interviewed; ANC: antenatal 
care; POCT: point-of-care testing; Hb: haemoglobin concentration 
 
108  
 
Of 29 women who were newly tested positive for HIV, treatment was commenced 
that same visit for less than the 90% target: 19 (65.5%) were given CTX, and 14 
(48.3%) were given ARVs (Table 4). One woman was told to return the following day 
for treatment while seven (24.1%) women refused treatment citing reasons such as: 
they should consult their husbands; they will start therapy at other clinics; they need 
to confirm at other clinics; they did not like the nurse’s attitude.  
 
Among 441 women who self-reported receiving syphilis tests, 17 (3.9%) reported 
positive results of which 12 (70.6%) were given either penicillin (n=11) or 
erythromycin (n=1) the same day (Table 4). One woman was told to return the next 
day with her partner for couples’ treatment and the remaining four were asked to 
buy penicillin or erythromycin at a pharmacy even though the study had supplied the 
facilities with sufficient penicillin based on projected prevalence. Thirteen women 
(76.5%) said they were advised by the nurse to inform their partners (Table 3.5).  
 
Based on exit interviews, 469 women self-reported receiving malaria tests of which 
161 (34.3%) were positive. Among those with positive malaria tests, eight were in 
their first trimester of whom two (25%) were given quinine and the rest were given 
or prescribed AL or DP.  Of the 153 malaria positive pregnancies in their second 
trimester, 121 (79.1%) were given AL, DP, or quinine and the rest were given SP 
(n=2), prescribed quinine or AL (n=24) or not given or prescribed anything (n=6) 
(Table 3.4). Therefore 123/161 (76.4%) were given antimalarials in accordance with 
treatment guidelines.  
SP was out of stock for most of the integrated POCT period and only 76 women 
reported receiving SP for IPTp. Of these, seven were given high dose (5 mg) folic acid 
concurrently, which is not compliant with guidelines for women receiving IPTp-SP 
(Table 3.4). Of the women eligible for SP (in second trimester and not on 
cotrimoxazole), 19.2% (69/359) received IPTp-SP (Table 3.4).   
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Among 480 women interviewed, 434 (90.4%) received iron supplementation. 
However, the reported dosing regimen did not adhere to prophylactic or treatment 
guidance based on Hb concentrations recorded in the ANC register (Table 3.4). None 
of the interviewed women had severe anaemia and six (13.3%) of 45 with moderate 
anaemia were asked to buy iron dextran. Folic acid was given to 421 (87.7%) women 
in either 0.4 mg folic-iron combination tablets or 5 mg tablets (Table 3.4). 
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Table 3.4. Self-reported treatments for test positives, IPTp for malaria, and haematinic supplementation given at first visit ANC among 480 interviewed women  Proportion  Success threshold Target reached for correct ANC strategies? * HIV treatment    Given CTX  19/29 (65.5%) ≥90% Under-reached Given ARVs 14/29 (48.3%) ≥90% Very under-reached Syphilis treatment     Given 2.4 MU benzathine penicillin or erythromycin 12/17 (70.6%) ≥90% Under-reached Malaria intermittent preventive therapy and treatment      Given SP for IPTp among women in 2nd trimester not on CTX† 69/359 (19.2%) ≥90% Severely under-reached Given SP for IPTp among women in 1st trimester not on CTX† 5/41 (12.2%)   Given SP to women also on CTX‡   2/80 (2.5%)   Given 5 mg folic acid with SP 7/76 (9.2%)   Given AL, DP or quinine among malaria positives in 2nd trimester  121/153 (79.1%) ≥90% Under-reached Given quinine among malaria positives in 1st trimester 2/8 (25%) ≥90% Severely under-reached Haematinic supplementation for prophylaxis and treatment      Given folic acid 421/480 (87.7%) ≥90% Under-reached 
- Told to take between 0.4-1.2 mg daily 378/421 (89.8%)   
- Told to take between 5-10 mg daily 43/421 (10%)   Given iron 434/480 (90.4%) ≥90% Reached 
- Given iron and mentioned side effects 41/434 (9.4%) ≥90% Severely under-reached Iron dosing information given to women according to Hb level    Normal Hb ≥10 g/dL n=286   
- 60-65 mg elemental iron daily 193/286 (67.4%) ≥90% Under-reached 
- 120-130 mg elemental iron daily 4/286 (1.4%)   
- 180-195 mg elemental iron daily 49/286 (17.1%)   
- Not told dosing 12/286 (4.2%)   
- Not given any iron 28/286 (9.8%)   Mild anaemia Hb 8-9.9 g/dL  n= 137   
- 60-65 mg elemental iron daily 86/137 (62.8%)   
- 120-130 mg elemental iron daily 4/137 (2.9%) ≥90% Severely under-reached 
- 180-195 mg elemental iron daily 32/137 (23.4%)   
- Not told dosing 3/137 (2.2%)   
- Not given any iron    12/137 (8.8%)   Moderate anaemia Hb 5-7.9 g/dL  n=45   
- 60-65 mg elemental iron daily 20/45 (44.4%)   
- 120-130 mg elemental iron daily 9/45 (20%) ≥90% Severely under-reached 
- 180-195 mg elemental iron daily 9/45 (20%)   
- Not told dosing 2/45 (4.4%)   
- Not given any iron 5/45 (11.1%)   No Hb recorded  n=12   
- 60-65 mg elemental iron daily 8/12 (66.7%)   
- 120-130 mg elemental iron daily 1/12 (8.3%)   
- Not told dosing 2/12 (16.7%)   
- Not given any iron 1/12 (8.3%)   * ≥90% target reached; <90% to ≥60 - under-reached; <60% to ≥40 very under-reached; <40% severely under-reached; IPTp: intermittent preventive therapy in pregnancy; ANC: antenatal care; CTX: cotrimoxazole; ARV: antiretroviral; SP:sulfadoxine-pyrimethamine; AL: artemether/lumefantrine; DP: dihydroartemisinin-piperaquine (DP) ; Hb: haemoglobin concentration; †not on CTX includes women who were tested HIV negative, unknown status, and new positive but were not given CTX same day; ‡on CTX includes known HIV positives and new HIV positives who were given CTX same day   
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General information and advice given to women about the four conditions is shown 
in Table 5. Over 90% reported they received the blood tests. Furthermore, over 90% 
reported test results for HIV, syphilis and malaria that were concordant with those 
from the ANC register, while only half of those tested for Hb reported anaemia 
statuses that agreed with those from the register (Table 3.5). Women who reported 
not being told results for HIV, syphilis, or malaria were all negative for those 
conditions based on the ANC register.  
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Table 3.5 Self-reported information given about the tests at first ANC visit among 480 interviewed women  Proportion Success threshold Target reached for correct ANC strategies?* Information about HIV       Received HIV counselling  167/480 (34.8%) ≥90% Severely under-reached Reported receiving an HIV test among those who had an HIV  411/417 (98.6%) ≥90% Reached test result in ANC register    Reported told HIV status that  399/411 (97%) ≥90% Reached agree with result in ANC register    Reported told HIV status that did not  0/411 (0%)   agree with result in ANC register    Reported not told any results for HIV† 12/411 (2.9%)   Information about syphilis      Explained what syphilis is 83/475 (17.5%) ≥90% Severely under-reached Reported receiving a syphilis test among those who had a syphilis test result in ANC register 438/470 (93.2%) ≥90% Reached Reported told syphilis status that  417/438 (95.2%) ≥90% Reached agree with result in ANC register    Reported told syphilis status that did not agree  2/438 (4.6%)   with result in ANC register    Reported not told any results for syphilis† 19/438 (4.3%)   Advised to inform partners of syphilis positivity 13/17 (76.5%) ≥90% Under-reached Information about malaria    Given advice to use mosquito net to prevent malaria 346/478 (72.4%) ≥90% Under-reached Given a mosquito net (n=349) 331/349 (94.8%) ≥90% Reached Reported receiving a malaria test among those who had a malaria result in ANC register 445/454 (98%) ≥90% Reached Reported told malaria status that  420/445 (94.4%) ≥90% Reached agree with result in ANC register    Reported told malaria status that did not agree  11/445 (2.5%)   with result in ANC register    Reported not told any results for malaria† 14/445 (3.1%)   Information about anaemia     Given advice to eat food with iron 132/480 (27.5%) ≥90% Severely under-reached Explained what anaemia is 107/480 (22.3%) ≥90% Severely under-reached Reported receiving an anaemia test among those who had an Hb result in ANC register 448/468 (95.7%) ≥90% Reached Reported told an anaemia status that  235/448 (52.5%) ≥90% Very under-reached agree with Hb level in ANC register    Reported told an anaemia status that 60/448 (13.4%)   did not agree with Hb level in ANC register    Reported not told any results for anaemia test 153/448 (34.2%)   * ≥90% target reached; <90% to ≥60 under-reached; <60% to ≥40 very under-reached; <40% severely under-reached; ANC: antenatal care; Hb: haemoglobin concentration; KP: known HIV positives; †Women reported not told results for HIV, syphilis or malaria were all negative based on ANC registers    
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3.5 Healthcare worker training, turnover, and performance 
Overall 23 healthcare workers (14 nurses: eight females, six males; two clinical 
officers: two males; six HIV testing counsellors: one female, five males; and one 
laboratory technician: female) received training and underwent at least one testing 
QA. All nurses were trained to certificate or diploma level through the government 
system. Fourteen (60%) of the healthcare workers attended central trainings (eight 
were trained for five days in November and six for three days in February for those 
who were unable to make it in November), while nine (40%) received half-day on-
site trainings. Turnover of staff was high: of the 16 original healthcare workers at the 
beginning of the study, only 10 remained by the end of the eight months. Seven new 
healthcare workers transferred to the facilities during the study and remained until 
the end. The predictor model suggested that high turnover (adjusted for age, marital 
status and electricity) was associated with a three-fold increased risk of antenatal 
women not having a full screening profile (Table 3.6).  
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Table 3.6 Predictors of pregnant women not having a full antenatal screening profile at first visits    Univariate analysis Multivariate model Individual-level variables n=728 Women without full profile in ANC register 
RR (95% CI) of not having a full profile in ANC register 
p-value* RR**(95% CI) of not having a full profile in ANC register 
p-value 
     Age in years    0.003   ≥30 143 (19.6%) 6 (4.2%) Reference  Reference  ≤ 20 to <30 398 (54.7%) 46 (11.6%) 2.7 (1.5-4.8)  2.9 (1.7-4.9) <0.0001 < 20 187 (25.7%) 18 (9.6%) 2.1 (1.2-3.7)  2.9 (1.6-5.1) <0.0001      Marital status (N=727)    0.01   single 116 (16.0%) 6 (5.2%) Reference  Reference  married 579 (79.6%) 59 (10.2%) 2.4 (1.2-5.0)  2.6 (1.5-4.7) 0.001 widowed/separated 32 (4.4%) 5 (15.6%) 3.7 (1.5-9.1)  4.1 (1.7 -9.6) 0.001      Gravidity    0.89   1 194 (26.7%) 19 (9.8%) Reference    2 157 (21.6%) 17 (10.8%) 1.1 (0.5-2.4)    3+ 377 (51.8%) 34 (9.0%) 0.9 (0.7-1.3)         Previous miscarriage    0.52   no 701 (96.3%) 68 (9.7%) Reference    yes 27 (3.7%) 2 (7.4%) 0.6 (0.1-2.9)       Trimester    0.35   1st/2nd  587 (80.6%) 54 (9.2%) Reference    3rd 141 (19.4%) 16 (11.3%) 1.2 (0.8-1.9)    Facility-level variables            Staff turnoverꝉ    0.0006      low 446 (61.3%) 27 (6.1%) Reference  Reference  medium 151 (20.7%) 20 (13.3%) 2.2 (0.8-6.1)  1.9 (0.6-5.6) 0.253 high 131 (18.0%) 23 (17.6%) 2.9 (1.7-5.0)  3.0 (1.8-5.1) <0.0001      Facility volumeⱡ    0.4   low 151 (20.7%) 20 (13.2%) Reference    medium 297 (40.8%) 19 (6.4%) 0.5 (0.2-1.6)    high 280 (38.5%) 31 (11.1%) 0.9 (0.3-2.9)         Skilled staff¥    0.8   2 206 (28.3%) 16 (7.8%) Reference    3 167 (22.9%) 19 (11.4%) 1.5 (0.4-5.5)    4 355 (48.8%) 35 (9.9%) 1.2 (0.4-3.3)         Electricity    <0.0001   not present 91 (12.5%) 3 (3.3%) Reference  Reference  present 637 (87.5%) 67 (10.5%) 3.3 (2.0-5.5)  2.1 (1.2-3.7) 0.01 *Wald test; **n=727; ꝉ Staff turnover was categorized into low, medium and high defined as having 2, 1, and 0 skilled healthcare workers who received training at the start of the programme and remained for all 8 months of implementation respectively; ⱡFacility volume was split into low, medium, and high for <30, 30-40, and 50-70 monthly ANC visits respectively; ¥ Skilled staff was defined as the total number of nurses, clinical officers, and HIV testing counsellors the facility had; ANC: antenatal care; RR: relative risk 
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Due to turnover and new staff joining, 18 received at least two QAs, 16 received 
three, 13 received four and two received five. Out of a total of 72 QA scores, 20 
(28.6%), belonging to 15 healthcare workers, were below 90% and required more 
intensive re-training on the same day for steps such as obtaining enough blood from 
one finger-prick, correctly using the pipette and how to set the timer. Seven of the 
15 were evaluated again within a month. Minimum scores improved over the 
proficiency tests from 70% to 91%. Distribution of scores from the QAs are shown as 
box and whisker plots in (Figure 3.2). The results of the five QAs suggested that most 
healthcare workers could accurately conduct integrated POCT after training and 
remedial training.   
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Figure 3.2  Proficiency scores (%) of healthcare worker checklists in point-of-care testing 
 The boxes represent interquartile ranges (25% to 75% percentile); the solid line in the box is the median (50th percentile); The lower and upper whiskers represent the minimum and maximum values, excluding outlier; the dots represent outliers, defined as values less than 1.5 times the lower quartile.  
3.6 Discussion 
This is the first intervention study to evaluate the implementation success of 
integrating four POCTs into ANC in rural dispensaries in western Kenya. We showed a 
substantial increase in testing for syphilis, malaria and anaemia that provided an 
opportunity for the improved management of these conditions in a context of a well-
established HIV rapid testing programme in pregnancy. Our results suggest that 
integrated POCT increases the number of cases detected and treated at the first 
antenatal visit in these small rural dispensaries without distortion of HIV testing 
which remained near universal throughout. Despite the management of conditions 
not reaching our target of 90% fidelity to guidelines, we suspect the treatment for 
syphilis, malaria and anaemia represented a laudable improvement from baseline. By 
bringing POCTs to peripheral dispensaries, accessibility and coverage of these tests 
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for pregnant women residing in remote areas, who were otherwise not able to 
access testing at larger facilities farther away, was significantly improved. 
We found prevalence rates of 20.3%, 3.1%, 31.9%, and 60.8% for HIV, syphilis, 
malaria, and anaemia (WHO cut-off Hb <11 g/dL, or 39.2% when using Kenyan 
guideline cut-offs of <10 g/dL) respectively, consistent with those reported in other 
studies [31, 35, 36, 51, 52]. Siaya is about 1,200 meters above sea level and the 
altitude adjusted prevalence of anaemia using the WHO cut-off was 70% [53].   
The success of near universal HIV screening in ANC in Kenya, as reflected in our 
baseline and intervention data, is the result of concerted vertical program efforts 
and external partnerships [54-58]. Although WHO has endorsed an integrated 
disease approach to service delivery of antenatal care [59, 60], development 
assistance for HIV activities has risen disproportionately since 2000 compared to 
assistance for other sexual reproductive health activities [61], shifting agendas and 
priorities away from strengthening systems and building linkages between 
programmes [41, 56, 62-64]. Funds are often earmarked for specific purposes with 
deliverables defined by coverage and uptake, creating strong incentives for focused 
vertical programmes that result in rapid outputs rather than overall health system 
improvement [56, 65, 66]. In Kenya less than half of the pregnant women attending 
ANC are tested for syphilis or haemoglobin concentrations [37, 67], even though 
antenatal screening is a major country policy and over 90% of pregnant women 
attend ANC. These gaps can likely be reduced by combining funding to support 
comprehensive ANC programmes and better coordination mechanisms at national 
and county levels among the National AIDS and STI Control Programme, the 
Department for Reproductive Health and the National Malaria Control Programme 
[39, 68]. For malaria, there is currently no national recommendation for screening at 
the first antenatal clinic visit, but this is commonly practiced in most of the larger 
facilities with laboratories in the highly malaria endemic areas in western Kenya. 
Furthermore, there is an increasing interest in this hybrid strategy that combines 
IPTp-SP with testing at the first visit because of concerns about missed opportunities 
with IPTp and increasing SP resistance. 
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A quarter of newly diagnosed HIV positive women declined immediate treatment. 
This low uptake of ARVs is consistent with the finding of a meta-analysis in 2012 that 
reported only 73.5% of pregnant women in low, middle and high-income countries 
achieved optimal adherence to ARV therapy during and after pregnancy [69]. Quality 
of HIV counselling, lack of emphasis of the importance of ARV adherence at post-test 
counselling, lack of male involvement, and lack of trust of ANC staff are reasons 
reported to be associated with low adherence [69]. In our study, we found low HIV 
counselling rates, which could explain why many women were unprepared for 
positive results [70].  Dosing of iron among healthcare workers at the seven 
dispensaries was not consistent and did not follow the national guidelines for iron 
supplementation. These inconsistencies have also been highlighted in government 
surveys conducted in 2013 which reported a lack of consistency in implementation of 
haematinic supplementation at health facilities, poor knowledge of dosing and 
duration, inadequate knowledge given to pregnant women about anaemia, low 
adherence and compliance, and limited understanding of side effects leading to 
discontinuation [67]. The uptake of IPTp-SP was very low or the intervention was 
incorrectly implemented, mostly because of stock-outs and poor understanding of 
guidelines, falling well short of the target for 80% coverage by 2016 [71]. Poor IPTp-
SP program implementation by health providers, stemming from unclear guidelines, 
stock-outs, poor facility organization, and low provider knowledge, had been 
reported elsewhere [34, 72]. Case-management of malaria test-positive cases was 
much better than IPTp-SP coverage, with almost 80% of women receiving treatment 
with an ACT or quinine. Consistent with a previous study in this area by Riley et al 
[73], adherence to the national case-management guidelines for women in the first 
trimester was inadequate and most women were prescribed ACTs instead of the first 
line treatment with quinine. Starting in 2013 and during the integrated POCT study 
period, Kenya was devolving the healthcare system and transferring authority for 
decision making, finance and management of health commodities to the county 
level. This resulted in a disruption of the malaria commodity supply chain during this 
transition period and corresponding stock-outs of SP and antimalarials, which may 
explain some of these findings.   
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Ensuring all healthcare workers were trained to standard and have quality 
maintained over time was challenging. High turnover of staff meant on-site training 
of new staff would pose challenges if the intervention were to scale in real-life 
conditions unless training for POCTs were incorporated into nursing school or was 
done on a country-level. Small, focused trainings with interactions are more effective 
than didactic ones and will require time and planning [74]. Since healthcare worker 
behaviours are complex with many contextual and environmental influencers, single, 
one-off interventions such as trainings or dissemination of guidelines are less 
effective than routine supervisions and feedback to maintain high-quality 
performance [74]. Quality improvement (QI) strategies that are step-wise, iterative, 
locally grown and adapted to existing systems may be more appropriate for long-
term sustainability but context specific strategies need to be cultivated and 
effectiveness monitored in real-time [74-76].  
There are several limitations to our study. We did not randomly sample the facilities 
and therefore they may not be representative of all tier-2 facilities in the region. The 
evaluation excluded women who attended their first ANC visits in the third trimester, 
which was about 20% of first ANC attendees. While they also received the same 
services as first and second trimester women, their late attendance precludes early 
management of conditions and interventions would be needed to address this 
population. We used routinely collected ANC register data to calculate testing uptake 
but there were inconsistencies in how the registers were filled. For example, there 
were no columns for recording malaria test results in the existing ANC register and so 
we hand-drew a column during the study period. This was not always communicated 
to rotating ANC staff which resulted in 23 missing records for malaria testing. ANC 
registers do not record treatment and so we relied on interviews with women to 
obtain information on treatments and there were minor incongruences between 
self-reported and register recorded test results. More effort is needed to ensure 
accurate record keeping. Exit interviews were done with women at the facility 
immediately after an ANC visit; while this minimizes recall bias, women may be less 
inclined to report on negative experiences or give perceived acceptable responses 
without having understood the questions fully (courtesy bias). We did not assess the 
continuum of clinical management fidelity at revisits or at delivery. For example, 
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new-borns of women given erythromycin for syphilis need to be treated immediately 
with a regimen of penicillin injections [77] but this was not measured. Effort would 
be needed to ensure healthcare worker’s understanding and adherence to clinical 
management throughout the pregnancy and perinatal period. This study assessed 
clinical practice at the service delivery stage of the implementation pathway [40] 
where the conditions of having test supplies available, training and supervision were 
met through provision by the study. To effect positive health outcomes, wider health 
system concerns of supply chains, stock-outs and human resource management 
would need to be addressed. 
3.7 Conclusion  
This study showed near universal HIV testing in rural dispensaries that lack 
laboratory facilities and increased uptake of testing for syphilis, malaria and anaemia 
following training and availability of POCTs. However, poor clinical management of 
conditions, frequent staff turnover and inadequate information given to pregnant 
women remain significant challenges that will require integrated funding channels 
and a robust quality assurance programme to ensure that standards are achieved 
and maintained in these peripheral facilities.  
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4.1 Abstract  
Background: HIV, syphilis, malaria and anaemia are leading preventable causes of adverse 
pregnancy outcomes in sub-Saharan Africa. Despite global and national policies advocating 
an integrated approach to antenatal care (ANC), testing coverage for conditions other than 
HIV is low. Availing point-of-care tests (POCTs) at ANC clinics in rural health facilities has the 
potential to improve access and timely treatment. Fundamental to the adoption of and 
adherence to new diagnostic approaches are healthcare workers’ and pregnant women’s 
(the end-users) buy-in. We evaluated the acceptability, appropriateness and feasibility of 
integrating POCTs for HIV, syphilis, malaria and anaemia for ANC at seven purposively 
selected rural facilities (dispensaries) in western Kenya during an eight-month longitudinal 
implementation study.  
Methods: Semi-structured interviews were conducted with 18 healthcare workers to explore 
acceptability and relevance of POCTs to ANC, challenges with testing, training and 
supervision, and patient experience. Twelve focus group discussions with 116 pregnant 
women were conducted to explore their knowledge of these conditions, experience of ANC 
point-of-care testing services, treatments received, relationships with healthcare workers, 
and experience of talking to partners about HIV and syphilis results.  
Findings: Healthcare workers reported that they enjoyed gaining new skills, were 
enthusiastic about using POCTs, and found tests easy to use and appropriate to their 
practice. Initial concerns that integrating additional POCTs would increase their workload in 
an already strained environment were resolved with experience and proficiency. However, 
despite having the diagnostic tools, general health system weaknesses such as workload, 
stock-outs and poor working conditions challenged the delivery of quality ANC services and 
the effective management of the four conditions. Pregnant women appreciated POCTs, but 
reported poor healthcare worker attitudes, drug stock-outs, and fear of HIV disclosure to 
their partners as shortcomings to their ANC experience in general.  
Conclusion: The study provides insights on the acceptability, appropriateness, and feasibility 
of integrating POCTs into ANC services among end-users. While the innovation was desired 
and perceived as beneficial, future scale-up efforts would need to address health system 
weaknesses if integrated testing and subsequent effective management of the four 
conditions is to be achieved.   
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4.2 Background 
HIV, syphilis, malaria, anaemia, and their co-occurrences are leading preventable 
causes of adverse pregnancy outcomes in sub-Saharan Africa (SSA) [1-9]. Global 
antenatal guidelines require integrated screening and management of these four 
conditions at first antenatal care (ANC) contact in the first trimester [10]. There has 
been success in increasing antenatal HIV testing coverage [11, 12], but rates of 
testing for the other conditions are still low and few examples of integrated disease 
approaches to antenatal care exist at the programme level [13-15].  
Kenya’s ANC guidelines, which follow WHO’s recommendations, require testing for 
HIV, syphilis, febrile women for malaria, and anaemia at first ANC visits [16]. While 
over 95% of pregnant women attend ANC and over 90% of them receive HIV testing 
[17], less than 50% are tested for syphilis or anaemia [18-20]. While there is currently 
no national recommendation to screen pregnant women for malaria infection unless 
a woman has a recent history of fever, screening with microscopy is commonly 
practiced in facilities with laboratories. Recently, neighbouring Tanzania has 
introduced malaria testing at first visits to their antenatal policy as a strategy to 
manage anaemia [21]. There is also increasing interest internationally for a strategy 
that adds malaria testing to current recommendations of intermittent preventive 
therapy with sulfadoxine-pyrimethamine (IPTp-SP) and bednet use [22-28].  
Affordable and reliable point-of-care tests (POCTs) that require minimal training and 
no durable equipment are available for HIV, syphilis, malaria and anaemia and have 
been used successfully at the point-of-care [29, 30]. Such POCTs have the potential 
to improve screening coverage at peripheral facilities by shifting antenatal testing 
from laboratory technicians, who are often based at distant centrally-located 
facilities, to nurses, midwives and lay healthcare workers at peripheral facilities [31, 
32]. Task-shifting, combined with an opt-out approach, has transformed antenatal 
HIV testing in SSA over the last two decades [33], alleviating barriers of stigma, 
relieving human resource shortages, improving access and reducing the need for 
repeated visits for test results or to access laboratories [32]. This transformation has 
required the buy-in and willingness of ANC staff to conduct HIV testing and on the 
acceptability of testing among pregnant women.  
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There are concerns that donor support to HIV programmes may have drawn 
attention away from non-HIV services [34, 35].  With the new Global Fund call for 
strengthening health systems through HIV funding, more synergies and integrated 
programmes can be achieved [35-37]. Studies that have assessed the integration of 
syphilis POCTs with ANC have shown increased job satisfaction among healthcare 
workers, ease-of-use of the tests and increased trust of diagnosis among pregnant 
women [20, 38, 39].  
To examine the integration of syphilis, malaria, and anaemia POCTs with antenatal 
HIV testing, we conducted an eight-month longitudinal implementation study from 
December 2014 to August 2015 among seven purposively selected rural facilities 
(dispensaries) within the study area of the Kenya Medical Research Institute (KEMRI) 
and Centers for Disease control (CDC) Health and Demographic Surveillance System 
(HDSS) in Siaya County, western Kenya [40].  These seven were selected based on 
geographical spread within the HDSS area, no other ongoing antenatal studies, 
antenatal care visit volume, and willingness to participate. Competency-based 
training was given to 23 healthcare workers: 14 nurses, two clinical officers, seven 
HIV testing counsellors, and one laboratory technician. Training included how to run 
all four tests per standard operating procedures, safety and appropriate preventive 
and clinical management of positive results following Kenyan guidelines [16]. Quality 
assessments (QA) through observed proficiency testing of healthcare workers 
performing rapid tests compared to manufacturers’ instructions was done 
immediately after initial training and at three, six and nine months. Implementation 
outcomes of adoption and fidelity, using definitions from a conceptual framework by 
Proctor et al [41], were measured quantitatively [40]. In summary, we found that 
adoption was good as over 95% of pregnant women received all four POCTs at first 
ANC visit over the study period but treatment fidelity did not reach targets defined 
by the study. Healthcare workers’ minimum testing proficiency scores from quality 
assessments (QA) through performance observations improved from 70% to 91% 
over the study period, suggesting that most healthcare workers could accurately use 
integrated POCTs after remedial trainings and practice. 
As with the initial expansion of HIV testing, buy-in from healthcare workers and their 
ability to use four POCTs simultaneously during routine ANC visits are fundamental 
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to sustained testing adoption and subsequent clinical management of test results. 
This paper presents healthcare workers’ and pregnant women’s experiences and 
perceptions of an integrated approach to point-of-care testing (POCT) at first ANC 
visits in dispensaries in western Kenya. 
4.3 Methods 
 
This qualitative study was nested in the above main study. Qualitative methods were 
used to capture healthcare workers and pregnant women’s end-user experiences of 
the intervention in order to assess implementation outcomes of appropriateness, 
acceptability and feasibility as defined by Proctor et al. [41]. Viewpoints from 
healthcare workers and pregnant women were triangulated to create an overall 
narrative.   
One-on-one semi-structured interviews (SSI) were conducted with healthcare 
workers to capture individual experiences of providing integrated testing services. A 
structured topic guide with open questions was developed to explore areas such as 
relevance of integrating POCTs to dispensary ANC services, challenges with testing, 
experience with training and supervision, and experience with patients. Barriers to 
integration and health system constraints beyond participants’ control were also 
explored.  Interviews were designed to last 30-40 minutes. To ensure 
representativeness of ideas surrounding implementation, all healthcare workers who 
were trained, had experience doing integrated POCT, and were still working at the 
facilities 8-12 months after the intervention began were interviewed. Interviews 
were conducted in English at the facilities by trained members of the research team 
(NY and FA). FA is a social scientist from the study area and NY is a non-local 
researcher.  
Focus group discussions (FGDs) were conducted with pregnant women to stimulate 
sharing of experiences of ANC and blood testing services. Group discussions allow 
participants to communicate more naturally which can give more insight into 
knowledge, attitudes and cultural norms. They can also generate more critical 
comments perhaps because the group setting is less intimidating [42]. A topic guide 
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was developed to elicit pregnant women’s feelings and perspectives of integrated 
POCT services received. The following domains were covered: knowledge of 
conditions, experience of ANC testing services and treatments received, relationships 
with healthcare workers, and experience of talking to partners. Discussions were 
designed to be one-hour long.  Pregnant women attending ANC during the first two 
weeks of August 2015 and had ever attended a first ANC visit at the study facilities 
(147 women) during the intervention were recruited by data collectors to participate 
in the FGDs which were conducted at a location away from the facility on a later date 
within the same month. We recruited women from the last month of the study to 
allow healthcare workers enough experience with delivering the intervention. A 
trained social scientist (FA) from the study area conducted the FGDs in the local 
language (Dholuo) and a trained moderator, also from the study area, took notes. 
FGDs were led by local researchers to mitigate power dynamces and cultural 
differences among researcher and participants. One or two FGDs were held at each 
facility depending on the total number of women recruited.  
Non-English topic guides were translated and back-translated from English to Dholuo 
and piloted before use. All interviews and FGDs were digitally recorded with consent 
and transcribed verbatim. Non-English transcripts were first transcribed in Dholuo 
then translated to English by experienced translators and quality checks of the 
translation were done by FA. All transcripts were anonymized. Data collectors 
received training in data collection and ethical considerations.  
 
Regular meetings were held among the research team to review transcripts and 
notes from the interviews and update topic guides iteratively. Thematic analysis was 
used to identify emerging themes in end-user narratives to extract meaning in the 
experiences surrounding the use of POCTs. The process started with re-reading of 
transcripts to become familiar with the data. Segments of text that offered insight 
into user experiences were labeled and the interpretations of these labels were 
discussed among two researchers (NY and MT) and a set of codes each for 
healthcare workers and pregnant women interviews were agreed upon. These 
coding frameworks were then applied to the rest of the transcripts. Any new codes 
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were further discussed and incorporated into the framework. Coded data were 
collated and analyzed to form themes around appropriateness, acceptability and 
feasibility of integrated POCT, with triangulation across the participant types and 
sites. The team then interrogated the findings against several existing conceptual 
frameworks describing the adoption of innovations into health systems [41, 43-46], 
and adapted them to best reflect the findings.   
 
For SSIs, written informed consents were obtained from all interviewed healthcare 
workers. For FGDs, consent forms were read together with the group. Written 
informed consents were obtained from literate women and verbal consents with 
thumb prints and witness signatures were obtained from illiterate women. The 
protocol was reviewed and approved by the scientific and ethical steering 
committees of the Kenya Medical Research Institute (protocol number 2271) and the 
Liverpool School of Tropical Medicine Ethics Committee (14.017). While this activity 
was determined to be human subjects research, CDC staff involvement did not 
constitute engagement in human subjects’ research. 
4.4 Findings 
We interviewed 18 healthcare workers: eight females, 10 males. The lengths of time 
the healthcare workers have spent at their facilities ranged from one month to seven 
years. Healthcare workers who have spent more time with the intervention were 
generally more verbose than those who were more recently transferred to the 
intervention facilities. Twelve FGDs were conducted with 116 women who attended 
first ANC visits at the study facilities between December 2014 and August 2015 
(Table 4.1). Women who participated in the FGDs ranged from 15-46 years old, one-
nine gravida and from three weeks pregnant to recently delivered. The level of 
interaction in the focus groups was generally well engaged and relaxed. However, 
there were a few groups that were quieter and the moderator tried to stimulate 
more discussion among respondents using open-ended probes. The data were felt to 
be saturated as no new codes emerged after the first half of the data (9 SSIs, 6 FGDs) 
were analysed.  
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Table 4.1: Baseline testing services and number of semi-structured interviews (SSIs) and focus group discussions (FGDs) by facility 
Facility Testing at baseline* Healthcare worker SSIs Pregnant women FGDs  HIV Syphilis Malaria Hbꝉ   
1 Yes No Yes Yes 1 F nurse, 1 M nurse group 1: n=5; group 2: n=12 
2 Yes No Yes No 1 F nurse, 1 M nurse group 1: n=9; group 2: n=9 
3 Yes No No No 1 F nurse, 1 M nurse, 1 clinical officer group 1: n=10 4 Yes No No No 2 M nurses group 1: n=10 
5 Yes No Yes No 1 F nurse, 1 M nurse, 1 HTC counsellor group 1: n=9; group 2: n=10 
6 Yes No No No 1 F nurse, 1 M nurse group 1: n=12; group 2: n=13 
7 Yes No No Yes 1 F nurse, 1 M nurse, 1 HTC counsellor, 1 laboratory technician 
group 1: n=11; group 2: n=8 
*All seven facilities’ routinely conducted HIV testing, 2 conducted anaemia testing irregularly, and 3 conducted malaria testing irregularly for ANC. Median and interquartile range of ANC visits: 38 (32-38) per month; median and interquartile range of ANC first visits: 13 (10-13) visits per month; M: male; F: female; HTC: HIV testing counsellor; Hb: haemoglobin; ANC: antenatal care; ꝉHaemoglobin test for anaemia 
The findings were synthesized across the two participant types. Feasibility was 
inferred from participants’ views on barriers and enablers to delivering integrated 
testing and ANC services.  Three sub-themes emerged from participants’ discussions: 
sub-themes related to community culture and concerns, local service delivery issues 
at the dispensaries, and wider health system functioning (Table 4.2).  
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Table 4.2: Sub-themes of pregnant women and healthcare worker reflections on integrated point-of-
care testing’s appropriateness, acceptability and feasibility [46] 
 Service delivery at dispensaries Community context of cultures and concerns Wider health system: policy, programme and management Appropriateness  Healthcare worker’s job description and professional motivations Services pregnant women want at ANC 
Time and costs of reaching facilities  
National guideline requirements 
Acceptability Healthcare workers: Complexity of POCTs Proficiency of testing Observabilityꝉ of test results Trialabilityⱡ of POCTs Workload  Attitude towards gaining knowledge and new skills  Pregnant women:  Trust and confidence in results 
Community stigma, gender violence and partner involvement  
County level decision makers would need to value and prioritize integrated antenatal testing and allocate funds to ensure its continuity  
Feasibility  Motivation of healthcare workers Drugs and commodities for services Training and quality assurance of healthcare worker performance Pregnant women’s degree of comfort in asking for services 
Community culture and attitudes that influence timing of first ANC visit   
Procurement and funding systems for commodities and drugs Sufficiency of human resources to meet demand  Working conditions  Quality and synergy of training  
POCTs: point-of-care tests; ꝉObservability: the degree to which the results of an innovation are visible; ⱡTrialability: the degree to which an innovation can be experimented with on a limited basis so as personal meaning ca be ascribed   
 
4.4.1.1 Local service delivery and wider health system 
Intervention meets healthcare worker’s needs and policy expectations but misses 
some essential tests: All healthcare workers were excited about integrated POCT as it 
satisfied their professional goals by enabling them to meet pregnant women’s ANC 
needs in accordance with national guidelines. Some healthcare workers suggested 
enhancements to the programme such as retesting women’s haemoglobin (Hb) 
levels at revisits to monitor improvement if anaemia was detected at the first visit. 
Many were concerned that the intervention still missed urinalysis, blood grouping 
and rhesus tests and women still needed to be referred for these. 
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Healthcare workers experienced the tangible benefits of testing, which allowed them 
to manage diseases like syphilis and malaria that they were not testing for before. 
They found anaemia testing to be of importance because they saw many women 
with low haemoglobin (Hb) readings:   
“Malaria, we were not also doing it but I think integration is better because ... 
and these days you will get to find that, I usually get so many positives for 
malaria and Hb, I’ve even got Hb of 4.9. Now I was imagining if we did not 
have this Hb machine, like if you just test the mother for HIV as usual and tell 
her to go. Maybe she does not even have money to go to the District hospital 
to go for other tests, what will happen to that mother? I think that is what 
brings these maternal deaths because we do not take the precaution during 
the antenatal period.”   -female nurse (facility 6) 
Intervention meets pregnant women’s intentions for going to ANC: Some healthcare 
workers said they noticed an increase in ANC attendees during the study suggesting 
that more pregnant women visited as the community became aware of POCT 
services. This was consistent with pregnant women’s reasons for attending ANC visits 
as mentioned in the FGDs: they believe ANC services are beneficial and seek them 
for finding out the position of their babies, learning how to take care of themselves 
during pregnancy and diagnosing and treating harmful diseases.  
4.4.1.2 Community context 
Addresses community need for time and cost savings: Many healthcare workers cited 
the advantage of not having to refer pregnant women to laboratories for syphilis and 
anaemia testing as most do not go because of distance and transport costs, leaving 
vital conditions undiagnosed.  
“it was very challenging, you find the mother at the first visit, you tell them: 
go to diagnosis, go to district, go and test this and this. They don’t go. They 
don’t always go and the next day when they come it is just blank” – clinical 
officer (facility 3) 
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4.4.2.1 Local service delivery 
Complexity of POCTs is acceptable and healthcare worker proficiency improved with 
experience: All healthcare workers found POCTs easy to use. Some healthcare 
workers felt like they had some initial difficulties, such as trouble obtaining enough 
blood for all four tests from a single finger prick (which was believed to be attributed 
to women having thick blood or low haemoglobin levels), remembering how to set 
the times on the triple timer, and controlling the pipettes. These issues were felt to 
be resolved with supervisory feedback and experience as they gained proficiency in 
the testing procedures. 
Healthcare workers open to gaining knowledge and new skills: Healthcare workers 
saw the programme as an opportunity to learn new skills and were eager to receive 
support such as training and supervision. Proficiency observations and remedial 
training were especially appreciated as they served as corrective reminders for 
forgotten procedures, which supported POCTs’ continued use.  One healthcare 
workers mentioned that the attitude of the supervisors should be positive and 
constructive rather than fault-finding. Many healthcare workers were happy to learn 
how to use syphilis POCTs and the HemoCue@ machine, which they had not used 
before. One clinical officer requested more support as he felt on-site training was 
less sufficient than multi-day central training and found it difficult to perform with 
the same quality as those attended multi-day trainings. Because more conditions 
were tested for, some healthcare workers felt they needed more training on 
counselling.  
Concerns over workload: Some healthcare workers were initially sceptical about the 
intervention and raised concerns about the extra workload in an already strained 
environment. The intervention’s trialability (degree to which healthcare workers 
were able to experiment with the intervention) allowed healthcare workers to ‘try-
out’ the new testing procedures and adapt them to work under their own conditions 
which helped dispel initial uncertainty. The concerns over added workload were 
mostly appeased as testing adeptness improved. One healthcare worker re-
organized her work to see first ANC women together for group counselling and 
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group testing. She would perform the testing procedures for multiple women in an 
assembly line, starting the timer for the first woman and roughly estimating the extra 
waiting time for subsequent women.  She requested that more timers should be 
given to accommodate testing multiple women together. Some healthcare workers 
still felt the 20-minute waiting time for results was too long and the need to counsel 
for more conditions was also felt to be time-consuming.  
Observability of tests results improves trust in diagnosis: Healthcare workers liked the 
ease of observing test results as it helped them communicate the diagnoses directly:  
“but they will not take it very serious because they have seen you have not 
even tested but when I test them I always show them and tell them your Hb 
is this and you are supposed to have this. At least the mother can now 
understand because she has read it directly from [the machine] and I have 
explained they should be at what level, in fact they take it very serious.”  -
male nurse (facility 2) 
Pregnant women welcomed the POCT service. They were taught to observe their 
own results from the test cassettes which increased their trust of diagnoses. 
However, a few healthcare workers mentioned problems with the HIV tests, which 
sometimes gave faint positive lines, making women question the validity and deny 
the results.  
“we had some problem with it [HIV test] and actually…in interpreting the 
results, it used to give some faint line at the test site. It was causing a lot of 
problems with the clients. They are saying the line was faint.” -male nurse 
(facility 2) 
4.4.2.2 Community context 
Stigma and difficulties of partner involvement: Some women mentioned there is still 
stigma around HIV testing while syphilis, malaria and anaemia testing were not 
perceived to be threatening. Women suggested that more information and 
counselling would help with acceptance and treatment compliance.  
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While all women believed that partners should be tested and treated, they stated 
that most of their male partners could not be convinced to be tested because they 
feared the health facilities. Some women recounted tricking their husbands into 
going for HIV testing. Other women said some partners would assume they shared 
the same test result as their wives and some even share the women’s HIV drugs. 
Women also reported that they feared blame and violence from their husband if 
they disclosed their HIV positive status. 
 
4.4.3.1 Local service delivery and wider health system  
Healthcare workers and pregnant women talked about their direct experiences at 
facilities with implications for wider health system functioning concerns. 
Working conditions compromise the quality of care for service users: Sentiments of 
frustration and impatience were pervasive among healthcare workers which they 
believed to be due to heavy workload and chronic staff shortages. This sentiment 
was expressed by many: 
 “if you are stationed in MCH that is ok, but if you are taking care of PSC 
[patient support care for HIV positives], taking care of outpatient clients…you 
don’t give quality, let me say this.”-male nurse (facility 2) 
In addition, healthcare workers complained of demotivation from lack choice in 
postings and transfers, often requiring them to be far away from their spouse and 
children. They noted that dispensaries are remote, the emotional and physical 
hardships were not compensated adequately, job grades had stagnated without 
promotion, and salaries were often delayed for months.  From the FGDs, many 
women expressed how healthcare worker’s attitudes affected their experiences:  
“But you know when we come to the clinic we find different types of nurses 
sometimes you find her not in the moods and you get afraid of asking but if 
you find a happy one then you are also happy such that you share with her 
your problems.”-pregnant woman (facility 6) 
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Delay of facility funds and stock-outs made it difficult to provide care: Healthcare 
workers do not have control over how or when funds are allocated. Delay in facility 
maintenance funds and reimbursement for maternity services left facilities strained 
as explained by one nurse:  
 “But this was a promise by the national government...that all pregnant 
mothers will deliver free of charge, all health centers and dispensaries 
outpatient cases will be treated free of charge, ...and they were to reimburse 
but there was delay, there was delay… The whole of last year up to now as 
we speak I've not received any funds, imagine, and my casuals, we have not 
paid for the last six months, those who were helping me. I've not paid 
electricity for the last six months…You know...some are beyond me... That 
one needs managers of the county.” -male nurse (facility 2) 
Healthcare workers were frustrated about the devolution of government control and 
management to the counties and thought it to be the cause of stock-outs:  
“it has been worse…things have changed…when we were still under the 
national government, drugs used to come to facilities…and they were 
punctual…but nowadays, you can even stay for months without drugs and 
when they bring in drugs, they bring that which you are going to use for 
about two weeks.” -female nurse (facility 6) 
“Actually… personally I believe that health should have been devolved much, 
much later but it was rushed and you can see, the management is poor. Just 
the other day, health workers within the county were threatening to go on 
strike. And part of the problem is just the management. I think some of these 
staff was devolved from the national government when the county 
government had not put in the structures to manage this work force from the 
national government and probably make some input. And again also the 
input of the county government in terms of even staff employment, 
supplying of drugs … all these like I told you earlier that we have experienced 
shortage of drugs for quite a long time.” - Clinical officer (facility 4) 
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Drug shortages left pregnant women untreated because they could not afford to go 
to pharmacies to purchase drugs for themselves:  
“There is no right treatment given to us because you can be prescribed for 
drugs and you don't have money to go and buy them so there is no good 
treatment given.”- pregnant women (facility 2) 
Inadequate training and supervision: There were some healthcare workers who 
mentioned never having received training for HIV and malaria testing even though 
these are among the commonly used tests at dispensaries. One nurse said she was 
grateful for POCT training because before she would directly squeeze blood from the 
finger to the cassette for HIV testing as she did not know how to use the pipette.  
Another reported she had never used, or seen people use, timers for malaria POCTs 
and the training had enlightened her on the importance of timing so that she can 
now trust the results. 
A small minority of respondents described that currently in western Kenya, HIV and 
PMTCT services are supported by international partner programmes and receive 
frequent on-site mentorship, while other maternity services, supervised by the 
Ministry of Health, rarely receive this level of support.  
4.4.3.2 Community context 
Delayed ANC attendance: Pregnant women’s first ANC visit was often late in the 
pregnancy and the potential effectiveness of integrated POCT was thought by 
healthcare workers to be undermined by the delayed management of conditions. 
Women explained that late attendance was because they did not like to go to ANC 
before their pregnancy was certain, which was around the fourth month. 
Additionally, they stated that long distances, the cost of transport, poor staff 
attitudes, and a wish to avoid multiple revisits delayed initiation of their first visit.  
4.5 Discussion 
This study presents healthcare workers’ and pregnant women’s narratives on using 
POCT to diagnose HIV, syphilis, malaria and anaemia at dispensaries in western 
Kenya.  The POCT intervention was perceived to be highly acceptable and 
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appropriate: healthcare workers felt positive about offering POCTs and pregnant 
women appreciated the extra services. Data from elsewhere suggest that 
innovations are more likely to be adopted and implemented if they are easy to use, 
appropriate to the practice setting and accompanied by training and feedback 
support [41, 44, 46]. Overall, healthcare workers found POCTs user-friendly, aside 
from a few technical challenges that were addressed through experience and 
remedial training, which led to greater confidence in using the tests. This highlights 
the importance of supervision and audit with feedback, even for uncomplicated 
innovations, for improving performance [47, 48]. Other studies on implementation of 
POCTs have shown that healthcare workers and pregnant women appreciate their 
simplicity, which reduces diagnosis time [38, 49, 50]. A common finding from these 
studies is that the greatest bottleneck to scale-up is not in the satisfaction with the 
tests, but rather weakness of the wider health system. Test stock-outs, inadequate 
training and supervision, human resource constraints, and vertical funding structures 
have undermined scale-up of rapid syphilis testing in ANC [51-56]. Similar challenges 
with implementing malaria POCTs have also been reported [57, 58]. Sustaining a 
skilled, motivated and well-supported workforce with adequate commodities to 
effectively deliver integrated services, beyond the end of the study intervention 
period, will require effort on several levels. An integrated supervision and monitoring 
solution to support holistic ANC would also be needed.  
Despite the prominent health burden of syphilis, malaria and anaemia and the 
availability of simple cost-effective solutions, interventions to address these illnesses 
at ANC have been poorly delivered in Kenya and elsewhere in SSA [15, 27, 52, 59-63]. 
This could be due to a low prioritization of these conditions: 1) national targets and 
indicators for syphilis and anaemia are missing despite being an essential part of ANC 
policy [51, 52]; 2) national data on syphilis prevalence was captured in the 2007 
Kenya AIDs Indicator Survey but was dropped in the 2012 survey [17, 64]. Several 
factors shape the disparate prioritizations of countries’ health programmes [65]. 
International advocates play a significant role in norm promotion and shaping 
countries’ policy preferences [65, 66]. These transnational players offer technical and 
financial support for priority interventions, often outcompeting resources for other 
health problems that are just as dire but receive less attention. For example, well-
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funded donor HIV programmes attract staff with higher salaries, pulling human 
resources away from the already strained public sector and creating two tiers of 
salaried healthcare workers side by side [63, 67]. There is also a lack of an integrated 
policy community [65] and the networks of donors, government bodies, and non-
government organizations (NGOs) are siloed into domains of expertise with 
insufficient cross-communication [63].  As a result, there is no coalesced force to 
push for the integrated management of conditions. More transnational advocacy 
and co-ordination among influencers to shift the paradigm from single-focused 
programmes to comprehensive maternal health care is needed [63, 68, 69]. 
Moreover, proper governance with checks and balances is crucial to ensure limited 
funds are distributed to their target needs and not squandered or misappropriated 
[70-72].  
During the time of this study, the Kenyan government was politically motivated to 
rapidly execute the decentralization process of transferring decision-making power 
from the central government to the 47 newly-formed counties after 2013 elections 
[73]. In the devolved system, health service delivery functions are placed under the 
jurisdiction of the county governments [74]. Unfortunately, poor organization and 
rapid execution of the decentralization process resulted in widespread confusion and 
unpreparedness for the structural changes in finance and administration [73]. The 
county governments had limited technical capacity to set priorities and allocate 
funds, which created challenges in the county’s financial flows during the study 
(three years since devolution), causing stock-outs and funding delays [73].  For an 
integrated testing strategy to be sustained beyond the end of the study, county 
authorities involved with selecting priorities will need to understand the importance 
of antenatal screening, and be willing to allocate funds towards it.  Healthcare 
decisions since devolution increasingly involves local politicians and technical actors; 
it is important to engage with them, as well as women within the community, to 
highlight the equity benefits associated with an integrated testing strategy at 
peripheral facilities that can extend diagnostic services to a much larger demographic 
of women.  
Healthcare workers suffer low morale from meagre and delayed salaries, lack of 
choice in placement, job grade stagnation, and feeling helpless due to stock-outs of 
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commodities and drugs [67, 69, 75], resulting in recurring healthcare worker strikes 
to demand for better wages and working conditions [76].  Poor healthcare worker 
management, and the resulting frustrations can lead to low productivity, poor quality 
of care and cultures of predatory provider-client relationships [47, 77, 78]. Low 
morale among healthcare workers and resulting poor attitude have previously been 
found to lead to pregnant women attriting from the HIV testing and treatment 
cascade, non-disclosure of status during delivery, and knowingly forfeiting nevirapine 
for new-borns [79].  All healthcare workers interviewed expressed concerns about 
workload. This is a common problem in SSA health systems in where critical 
workforce shortages, skill mix imbalance and mal-distribution have been described 
as  a serious obstacle to scaling up priority interventions [67]. Additionally, disease-
specific short training, polio eradication campaigns, and staff leave often pull already 
strained personnel away from facilities [63, 67, 80], leaving staff ‘alone’ to manage all 
the clients.  
Late attendance to ANC precludes effective treatment to protect the foetus. Our 
research has revealed that poor relationships between pregnant women and health 
providers, pregnancy uncertainty and the number of revisits required for the full ANC 
schedule of visits were reasons given by pregnant women for delaying ANC initiation. 
Other factors such as age, parity, money for transport, ignorance of gestation age to 
start ANC, not having any perceived problems with the pregnancy, and social 
pressures have previously been reported as reasons for delaying the start of ANC 
[81-84].  Effectiveness of testing for syphilis also requires partner treatment to 
prevent reinfection from occurring. Our findings suggest stigma, fear of spouse 
violence, and beliefs that men do not participate in reproductive health programmes 
impede male partner involvement in treatment of HIV and STIs. To ensure pregnant 
women are effectively covered by antenatal guidelines, gender dynamics and health-
seeking behaviours in the community need be addressed.  
There were several limitations in this study. Our interviews and discussions were 
limited to frontline users and did not include management and implementation 
partners at county and national levels who have ultimate policy setting and 
budgeting decisions. Stakeholder insights, priorities and engagement are necessary 
to assess sustainability, readiness and intention for scale-up. Their insights will form a 
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critical area for future research. We also did not rank the interviewees’ perceived 
significance of each barrier with participatory methods, which would have been 
useful to help future programmes prioritize resources. The SSIs and FGDs were also 
conducted towards the end of the implementation study and may not have captured 
early adoption experiences. Self-reported information is inclined to have desirability 
or courtesy bias, which we tried to minimise by emphasizing anonymity and 
conducting the focus groups away from the facility. Healthcare worker interviews 
elicited several critical comments which suggests that the courtesy bias is not 
limiting. Finally, our study was small, only involving seven facilities in western Kenya, 
which may not have captured the diverse health system environments in the SSA 
region.  
4.6 Conclusions and recommendations 
The study provides insight on the acceptability, appropriateness, and feasibility as 
well as potential explanations of high adoption and low fidelity of the integrated 
POCT programme among end-users. Healthcare workers and pregnant women found 
the innovation acceptable and appropriate. Recommendations for scale-up efforts 
include the need to address vertical programming structures by engaging donors and 
programme managers to encourage horizontal thinking of disease management and 
to create synergies across programmes. Human resource constraints will need to be 
addressed and commodity supply chains strengthened to ensure no stock-outs. 
Community engagement to encourage early ANC attendance and involve male 
partners to decease stigma and threat of gender violence is important to generate 
demand and safeguard pregnant women. This will require a committed and united 
effort from county, national and international leaders.   
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5.1 Abstract  
Objectives: Despite WHO advocating an integrated approach to antenatal care (ANC), testing 
coverage for conditions other than HIV remains low because of low test availability. Using 
point-of-care tests at peripheral dispensaries could improve access and timely treatment but 
implications for human resources and client wait times are unknown. We use discrete-event 
simulation modelling to understand the intervention’s effect on service delivery and run 
‘what-if’ scenarios.  
Methods: We collected detailed time-motion data from one high volume dispensary which 
has been integrating point-of-care testing for HIV, syphilis, malaria and anaemia for 8 
months (2014-2015) in western Kenya. We constructed the model using empirical arrival 
distributions, activity times and patient pathways. We found low staff utilization and short 
antenatal consultations. We modelled a scenario where consultations were increased to 
allow sufficient delivery of all WHO recommended services and compared outcome 
distributions of wait times.  
Findings: The dispensary received 183 women for maternal and child health (MCH) services 
and 14 women received the intervention. With the intervention, wait times increased for 
26(14%) women (median increase: 12 mins, IQR: 8-22 mins). Ensuring sufficient consult 
durations resulted in wait times increasing for 60(33%) women (median increase: 31 mins, 
IQR: 17-54 mins). The two nurses’ daily utilization with sufficient consult durations was 72% 
and 75%.  
Conclusion: Integrating point-of-care tests does not greatly impact women’s wait times while 
ensuring they receive essential diagnostics. Nurses should have sufficient time to deliver 
WHO’s required ANC activities, making integration a potential resource neutral strategy to 
improve quality of care.  
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5.2 Background  
HIV, syphilis, malaria, and anaemia are leading preventable causes of adverse 
pregnancy outcomes in sub-Saharan Africa (SSA) and addressing them as early as 
possible during pregnancy is an essential goal of antenatal care (ANC) [1]. Kenyan 
guidelines require screening for HIV, syphilis, and anaemia at first ANC visit [2]. While 
over 95% of pregnant women have contact with ANC and over 90% are tested for 
HIV in Kenya [3], fewer than half are ever tested for syphilis or anaemia during their 
pregnancy [3-5]. This difference in coverage is partly due to low test availability at 
peripheral facilities (dispensaries) [6, 7]. Women who attend dispensaries for ANC 
are referred, with additional time and cost implications, to distant laboratories for 
testing. International advocacy for HIV has promoted near universal testing coverage 
[8, 9] and similar support is needed for syphilis and anaemia screening given the 
strong evidence of their clinical effectiveness in improving pregnancy outcomes [1, 
10, 11]. For malaria endemic regions, Kenya currently does not require 
parasitological screening, but microscopy is commonly practiced in facilities with 
laboratories in western Kenya; its neighbour, Tanzania has already introduced 
malaria testing at first contact for managing anaemia [12]. Furthermore, there is 
heightened interest in malaria testing and treatment at first contact during 
pregnancy because of concerns with current preventive strategies including 1) poor 
coverage of intermittent preventive therapy with sulfadoxine-pyrimethamine and 
bednet use [13], 2) increasing drug resistance [14] and 3) contra-indications to the 
use of sulfadoxine-pyrimethamine in the first trimester of pregnancy and HIV positive 
women on cotrimoxazole  [15]. 
An integrated approach where antenatal testing and appropriate treatment are 
delivered as a one-stop-shop at a single service delivery point are advocated to 
reduce missed opportunities and improve coverage of interventions [16]. No-
equipment rapid diagnostic point-of-care tests (POCTs) are available to fulfil 
antenatal testing requirements in low-resource settings [17]. Studies that have 
assessed the use of syphilis or malaria POCTs have reported ease-of-use, increased 
healthcare workers’ satisfaction and improved patients’ trust in the diagnoses due to 
the observability of results [4, 9, 18-21]. While dual HIV/syphilis tests are now 
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available and countries are beginning to adopt them [22], no study to our knowledge 
has examined  the integration of four essential POCTs for ANC at dispensaries.  
At the lowest level, dispensaries offer basic maternal and child health services, 
rudimentary out-patient curative care and support care for HIV-positive patients and 
referrals. Staff at peripheral facilities tend to be overburdened [23] and adding new 
tasks may impose additional time and resource demands on service delivery which 
can lead to longer wait times, negatively affecting patient experiences and their 
health seeking behaviour [24, 25]. Despite this, the World Health Report 2010 
estimates that 20-40% of health spending is wasted through inefficiency [26] and 
there is evidence that the existing workforce is not fully utilized [27-29]. Quantifying 
wait times and staff utilization is important to understand the likely impact of 
expanding POCT beyond HIV alone so strategies can be targeted to improve adoption 
and quality of care.  
Health systems are complex and adaptive: they are the emergence of multi-layered, 
sometimes competing, inter-relationships of the systems’ interdependent elements 
(e.g. patients, providers, government/non-government agencies) [30]. Complex 
systems are nonlinear and traditional analytic approaches, such as regression 
modelling, have limitations because they cannot account for nonlinear dynamics 
[31]. On the other hand, operational research (OR) methods, that make use of 
advanced mathematical and modelling techniques, can be more appropriate to aid 
complex decision-making [32]. Discrete-event simulation (DES) modelling is 
particularly useful for quantifying changes in wait times and resource utilization 
because it captures ‘discrete’ events such as patient pathways and can introduce 
decision logic at specific points to simulate competition for resources [33]. While DES 
has been used extensively in developed countries [34] few examples are available 
from SSA [35-37]. Using DES, we aim to explore the impact of the integrated testing 
strategy for ANC on patient wait times and resource utilization and test ‘what-if’ 
scenarios for optimization. The results of this study will also demonstrate the 
applicability of the method for understanding intervention adoption in complex 
systems.  
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5.3 Methods 
 
Modelling was nested within an 8-month longitudinal study (December 2014 to 
August 2015) that implemented an integrated testing strategy for HIV, syphilis, 
malaria, and anaemia in seven dispensaries within the KEMRI/CDC Health and 
Demographic Surveillance System (HDSS) area in Siaya County, western Kenya [7]. 
Detailed population characteristics and setting descriptions are available [38]. The 
Government of Kenya routinely supplied HIV POCTs per its standard national 
algorithm at the time: HIV (1 + 2) Antibody Colloidal Gold (KHB, Shanghai Kehua Bio-
engineering Co Ltd, China) for screening, First Response HIV-1-2 kits (Premier 
Medical Corporation Ltd., Kachigam, India) for confirmation and Uni-Gold™ (Trinity 
Biotech, Ireland) for tie-breaking. The study supplied POCTs for syphilis (SD BIOLINE 
Syphilis 3.0, Standard Diagnostic Inc., Korea), malaria (CareStart™ Malaria HRP2 Pf, 
AccessBio, USA) and haemoglobin concentrations (HemoCue® Hb 201+, HemoCue 
AB, Sweden). During implementation, the seven study dispensaries received a 
monthly median of 38 (IQR: 32-38) antenatal visits, of which a median of 13 (IQR: 10-
13) were first visits. Implementation outcomes from the study showed high adoption 
of POCTs, resulting in increased case detection and 70% treatment fidelity for syphilis 
and malaria [7]. 
Of the seven dispensaries, we conducted our modelling study in one with high 
patient volume. The facility had the typical staff of a dispensary: two nurses, one 
focused on maternal and child health (MCH) and the other on out-patients (OP); a 
part-time CO who oversaw HIV-positive patients seeking anti-retroviral treatment 
(ART) or prevention of mother-to-child transmission (PMTCT) services; and two to 
three subordinate support staff who helped with registration, weighing, and 
dispensing drugs. The facility had three main rooms, one each for MCH, OP, and 
ART/PMTCT (Figure 5.1). Staff rotated among these rooms for the respective 
services.  
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Figure 5.1  Facility floorplan 
 
 
 
 
We collected process times of all activities undergone by MCH/PMTCT women over 
four weeks in August 2015 during the intervention. Six data collectors were stationed 
across each facility service point: two by the entrance, two at MCH, one at OP, and 
one at ART/PMTCT. Any woman arriving at the facility for MCH/PMTCT purposes was 
greeted and introduced to the study. A short statement explained the study purpose 
(to measure activity and wait times), study procedures (wear a number badge and 
carry a time sheet throughout the visit), and confidentiality (no personal information 
such as name or test results would be collected). Women who disagreed would be 
free to continue their visits without timesheets and their badge numbers would be 
skipped. All facility patients’ arrival times and visit purposes were recorded on a data 
form at the entrance to inform client mix and arrival time distributions. Data 
collectors were present at each service point to record process times, service 
locations, provider type, and any blood tests done on the MCH/PMTCT women’s 
timesheets. The data were recorded with established reference codes and any 
unforeseen items were given new codes that were communicated to the team 
immediately. Watches were synchronized daily at the beginning and end. Healthcare 
worker (nurses, and CO) activities were recorded on 15-minute intervals from the 
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time of their arrival until departure. All timesheets were scanned by TeleForm® 
(Hewlett-Packard) and exported into an excel database. 
 
A DES model of the entire dispensary was built in the WITNESS© (Lanner Group 
Limited) simulation software. The core of the model is made of entities, attributes, 
resources, queues, and activities. Entities are people or items that enter the system 
(e.g. patients, paperwork) and require attention from resources (e.g. nurses, HTC, 
CO).  The resources attend to entities in activities (e.g. consultation, registration). 
Attributes are intrinsic features of entities such as the patient types, pathways and 
the time spent on activities. Queues are generated in the DES model when entities 
compete for resources who are often needed in several activities simultaneously.  
 
Model input parameters: 1) arrival times of patients; 2) sequences and durations of 
activities of women attending MCH services; 3) durations of OP and ART patient 
consultations 4) activity locations; and 5) activity resources. We made assumptions 
about OP and ART consultation times. We assumed every OP and ART patient 
arriving sees either a nurse or a CO and none of them were turned away except for 
those who came on the strike day. Their durations were estimated from those of 
MCH women who received OP or ART services with an average of 6.5 minutes for OP 
consult with nurses, 5 minutes for ART consult with nurses and 10 minutes ART 
consult with CO.  
Shifts for the two nurses and CO were collected because these were the resources 
servicing MCH women and providing the intervention. Their shifts were estimated 
based on the time they arrived and left the facility. The total wait times and length-
of-stay for MCH women were generated from the model and their distributions 
validated by comparing them with the empirical distributions using non-parametric 
Wilcoxon rank-sum tests.  
 
The intervention was defined as the additional syphilis, malaria and anaemia testing 
added onto routine antenatal HIV testing. To capture the impact of the intervention, 
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we generated process durations without integrated POCT by reducing the estimated 
durations for testing from the collected process times. This additional time was 
estimated to be 8 minutes: 5 minutes to read the syphilis test results (HIV tests 
require 15 minutes for a negative reading while the syphilis test requires 20 minutes) 
and 3 additional minutes for preparing the syphilis, malaria and anaemia tests. 
Distributions of wait times and length-of-stay were compared to those of the base-
model using the non-parametric Wilcoxon rank-sum test because of non-normality. 
Resource utilizations were also generated. 
 
We explored a ‘what-if’ scenario where each ANC consult was of sufficient duration 
to cover all recommended services, including integrated testing. Using simulated 
data from Tanzania [39], we estimated that a minimum of 58 minutes would be 
required to cover all services during first visits and 36 minutes for re-visits (Table 
5.1).  
Table 5.1 Estimated ideal times for antenatal first visit and antenatal revisit based on simulated consultations from Tanzania ACTIVITY   FIRST VISIT REVISIT Welcoming the woman 00:01 00:01 Registration 00:05 00:00 History taking/updating 00:10 00:05 Physical exam 00:08 00:08 Drugs administration  00:03 00:03 Immunization 00:01 00:01 Pre-test counselling and set up 00:05 00:00 Health education and counselling while waiting for POCTs results   00:20 00:15 Post-test results counselling and treatment  00:02 00:00 Filling ANC book and register 00:03 00:03 TOTAL TIME 00:58 00:36 POCTs: point-of-care tests   
 
 
The protocol was reviewed and approved by the scientific and ethical steering 
committees of the Kenya Medical Research Institute (protocol number 2271) and the 
Liverpool School of Tropical Medicine Ethics Committee (14.017). For U.S. CDC, while 
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this activity was determined to be human subjects research, CDC staff involvement 
did not constitute engagement in human subjects’ research.  
5.4 Results 
 
All women agreed to the time-motion study. There was a total of 838 patients over 
20 days: 13% HIV-positive patients for ART, 65% general out-patients and 22% 
MCH/PMTCT women. MCH services include ANC first and re-visits, family planning 
and under-5 child welfare services for growth monitoring and immunizations. Figure 
5.2 shows the distribution of daily arrivals. 
Figure 5.2 Facility patient arrival times over 20 working days 
 
Nurses typically arrive at 08:00 and finish their work by 16:00 contributing to an 8-
hour (480 minutes) day. The CO was part-time and present on most Thursdays which 
is the facility’s designated PMTCT/ART day. Healthcare workers were on strike on the 
first Friday and no patients were seen that day. 
 
Data exploration showed that the input distribution of OP and ART consult durations 
were best described using a negative exponential. Output distribution of wait times 
and LOS for MCH women were non-normal even after log and square 
transformations. Wilcoxon rank-sum tests show no statistically significant difference 
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between empirical and model generated distributions (Figure 5.3 and Figure 5.4). We 
concluded that the base-model was representative of the operational environment 
of the facility.  
Figure 5.3 Distribution of total wait times for MCH women (Wilcoxon rank-sum p=0.1234) 
 
Figure 5.4 Distribution of total length-of-stay for MCH women visiting (Wilcoxon rank-sum p=0.4614) 
 
 
 
The intervention was given to 14 ANC (11 first visits, 3 re-visits) women during their 
nurse consultations. For the scenario without integrated POCT testing, 11 of these 
women had their consultation times reduced by 8 minutes while 3 women did not 
have any time reduced because they were already less than 20 minutes, the 
minimum time needed for negative results to be read (positive results can be read 
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before 20 minutes). With the intervention, first visit consultations took a median 
time of 00:32 (n=11, range: 00:15-1:14, IQR: 00:23-00:36) and re-visits 00:13 (n=28, 
range: 00:05-00:55:00, IQR: 00:09-00:23). Ten out of 11 first visit consult times were 
increased to 00:58. For re-visits, 23 consultations were increased to 00:36. Wait 
times and length-of-stay under the three scenarios are shown in Table 5.2. While 
some women have increased wait times, most women’s wait times remain 
unchanged: this seems reasonable as the intervention was only given to 14 women 
and due to gains from synergies with HIV testing. The model also showed that adding 
the intervention can result in shorter wait times for some women because of system 
dynamics.  
Table 5.2 Changes in wait times and length-of-stay under the three different scenarios 
Wait times N Median Range IQR p-value 
[0] Without integrated POCT  183 00:22 00:00-04:31   00:01-01:21   
[1] With integrated POCT 183 00:24 00:00-04:31 00:01-01:13 [1] vs [0] p=0.0012 Increase 26 (14%) 00:12 00:03-00:53 00:08-00:22   
Decrease 7 (4%) 00:29 00:03-00:42 00:21-00:34   
Unchanged 150 (82%)         
[2] With integrated POCT and adequate consult times 183 00:31 00:00-05:35 00:04-01:30 [2] vs [1] p<0.0001 
Increase 60 (33%) 00:31 00:02-02:33 00:17-00:54   
Decrease 18 (10%) 00:34 00:26-3:18 00:05-01:34   
Unchanged 105 (57%)         
Length-of-stay N Median Range IQR p-value 
[0] Without integrated POCT  183 00:52 00:00 -05:54 00:23-01:55  
[1] With integrated POCT 183 00:55 00:02-05:53 00:23-01:59 [1] vs [0] p<0.0001 Increase  34 (19%) 00:11 00:05-01:18 00:08-00:20   
Decrease 5 (3%) 00:37 00:29-01:04 00:32-00:42   
Unchanged 144 (79%)         
[2] With integrated POCT  and adequate consult times 183 01:08 00:02-07:03 00:31-02:13 [2] vs [1] p<0.0001 
Increase 76 (42%) 00:33 00:02-02:33 00:23-00:59   
Decrease 17 (9%)  00:19 00:26-03:18 00:03-01:30   
Unchanged 90 (49%)          IQR: inter-quartile range 
 
 
Nurse utilization is reported as a percentage of the time they were engaged in 
activities during their shifts. For a regular 480-minute day, 80% utilization would 
leave 20% (96 minutes) for breaks and shuffling among service points. Healthcare 
worker shift patterns were irregular and rarely did two nurses work simultaneously.  
Nurse availability and daily utilization rates, with those above 80% bolded, are shown 
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in Table 5.3. Our data show that consultation times for first and re-visits were 
inadequate for completing all the recommended ANC activities and that nurses were 
under 80% utilized on most days, suggesting there is capacity to increase the time 
they spend with pregnant women. Increasing the minimal duration of first and revisit 
consultations led to higher nurse utilizations but remained under 80% on most days. 
For two days the OP nurse reached 100% utilization: one was because the nurse was 
only present part-time (300 minutes) and the other was because the nurse was alone 
on a Thursday when PMTCT/ART patients were scheduled. 
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Table 5.3: Nurse utilization under 3 scenarios 
  NURSE 1 (OP) utilization NURSE 2 (MCH) utilization 
Without integrated  POCT [0] 
With integrated  POCT[1] 
With integrated POCT & adequate consult times [2] 
Without integrated POCT [0] 
With integrated  POCT [1] 
With integrated POCT & adequate consult times [2] Tuesdayꝉ - - - 323/480 (67%) 345/480 (72%) 408/480 (85%) Wednesday - - - 232/480 (48.3%) 248/480 (52%) 326/480 (68%) Thursdayꝉ - - - 186/480 (38.7%) 186/480 (39%) 227/480 (47%) Friday - - - - - - 
Monday  293/480 (61%) 301/480 (63%) 323/480 (67%) - - - Tuesday 246/300 (82%) 246/300 (82%) 305/300 (102%)ⱡ - - - Wednesday 295/480 (61%) 295/480 (61%) 295/480 (61%) - - - Thursday 529/570 (93%) 529/570 (93%) 575/570 (101%)ⱡ - - - Friday 378/480 (79%) 378/480 (79%) 378/480 (79%) - - - Monday  302/480 (63%) 302/480 (63%) 332/480 (69%) 323/480 (67%) 323/480 (67%) 344/480 (72%) Tuesday 166/480 (35%) 166/480 (35%) 178/480 (37%) 230/360 (64%) 230/360 (64%) 293/360 (81%) Wednesday 413/480 (86%) 413/480 (86%) 422/480 (88%) 293/480 (61%) 293/480 (61%) 385/480 (80%) Thursdayꝉ 0 0 0 303/480 (63%) 314/480 (65%) 377/480 (78%) Friday 62/120 (52%) 62/120 (52%) 62/120 (52%) 331/480 (69%) 331/480 (69%) 424/480 (88%) Monday  431/480 (90%) 431/480 (90%) 431/480 (90%) 383/480 (80%) 383/480 (80%) 399/480 (83%) Tuesday - - - 369/480 (77%) 383/480 (80%) 419/480 (87%) Wednesday - - - 141/480 (30%) 141/480 (30%) 141/480 (30%) Thursdayꝉ - - - 195/480 (41%) 195/480 (41%) 211/480 (44%) Friday - - - 301/480 (61%) 301/480 (63%) 301/480 (63%) Monday  216/360 (60%) 216/360 (60%) 216/360 (60%) 275/360 (77%) 283/360 (79%) 300/360 (83%) OVERALL 3330/4710 (71%) 3338/4710 (71%) 3517/4710 (75%) 3887/6480 (60%) 3958/6480 (61%) 4556/6480 (70%) p-value ¥  [1] vs [0] p=0.3173 [2] vs [1] p=0.0148  [1] vs [0] p=0.0258 [2] vs [1] p=0.0008 Nurse 1 spent approximately 870 minutes (18.5%) and Nurse 2 spent approximately 1410 minutes (21.8%) of their utilization time on paperwork.; Clinical officer on duty- out of 390-minute shifts, the clinical officer had less than 50% utilization each day. For scenario 3, the CO was modelled to help with child immunization when he was available.  ⱡNurse utilizations can be over 100% because the resource is given an allowance to carry on processing any on-going activity after the shift has finished; ¥ Wilcoxon sign-rank test 
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5.5 Discussion 
We used DES to quantify wait times, length-of-stay and nurse utilization after 
adopting an integrated testing strategy to fulfil antenatal testing guidelines at first 
ANC visits in a rural dispensary in western Kenya. We found considerable variation in 
resource availability, consult durations and patient pathways. Using time-motion 
data, we captured the varied nature of these factors allowing high level of detail in 
our representation of the local environment not afforded by other methods to study 
time allocation [28]. This study demonstrates the applicability of simulation 
modelling to help understand the operational consequences of implementing 
priority interventions in low-resource settings to inform decision-making.  
While there are concerns about inadequate healthcare worker numbers to 
implement the workload needed to scale priority interventions in healthcare systems 
in SSA [23], our study shows an under-utilization of skilled healthcare workers, 
suggesting that current staffing numbers in small dispensaries should have sufficient 
time to deliver full ANC services, including integrated point-of-care testing. This 
suggests that improving performance of the existing workforce can have substantial 
gains in quality of care. Case studies from Tanzania and Chad found that only 55-60% 
of staff time was spent on productive activities [29]. Worse has been reported in 
Cameroon where reproductive health staff spend only 27% on service provision [27]. 
Motivation and performance have several determinants and explanatory frameworks 
but in general, salaries, prestige, work conditions, frequent high-quality supervision 
with audit feedback and multifaceted interventions have strong evidence to support 
their contribution to achieve better healthcare worker performance [40].  
We also observed high absences which creates excess workload for the healthcare 
worker on shift and this is likely to undermine the quality of care delivered [41, 42]. 
Absenteeism, whether planned or unplanned, is characteristic of facilities in low-
resource settings [41]. Staff are often pulled out of facilities to attend disease-
specific trainings, or participate in outreach campaigns [23]. Reducing parallel 
programmes, integrating training, building on synergies between disease 
programmes, ensuring appropriate skills are covered in pre-service curricula, and 
conducting on-site trainings when possible can reduce disruptions [43]. On the other 
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hand, healthcare workers may feel poorly motivated to show up because of low 
morale from meagre and delayed salaries, lack of choice in placement, workload, 
poor working conditions, job grade stagnation, and feeling helpless due to stock-outs 
of commodities and drugs [40, 41]. Frustration with the system have resulted in 
recurring healthcare worker strikes to demand for better wages and working 
conditions in Kenya [44]. Resource neutral strategies, which are more likely to be 
acceptable to service providers and adopted as national policy, need to be explored 
to address performance and absenteeism [45].  
The domain of this study was operational and its aim was to develop insight to the 
local implementation conditions of integrated POCT and thus may not be readily 
generalizable to other settings [46]. The study may also be weakened by the 
Hawthorne effect: having data collectors present at the facilities may alter 
healthcare worker’s behaviour. We also only collected data for one month and this 
may not be entirely representative of the operational environment over time. We 
focused only on women who visited the facility for MCH/PMTCT purposes and did 
not quantify wait times for OP or ART patients. While we have collected detailed data 
for MCH and PMTCT activities, we made assumptions for the model regarding OP 
and ART activities. We used an average OP consult time of 6.5 minutes which was 
similar to 7 minutes found in Nigeria [47] and slightly longer than 5.3 minutes found 
in Mozambique [48].  Another study found ART patients spend an average of 21.8 
minutes on services which included time spent in registration, with CO and in 
pharmacy [35]. Thus, our estimate for consult time of 10 minutes with the CO seems 
reasonable. These findings need to be reviewed with frontline healthcare workers 
and stakeholders to better interpret and understand their implications so that 
suitable strategies can be devised to adequately address these operational 
challenges.  
5.6 Conclusion  
Using discrete-event simulation modelling with detailed facility-level data, we 
quantified operational outcomes of wait times, length-of-stay and nurse utilization 
after integrating syphilis, malaria and anaemia point-of-care testing with HIV testing 
during ANC consultations. We showed that nurses were under-utilized on most days 
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and that sufficient time for ANC first and re-visits could be achieved within the 
current number of healthcare staff. While this would increase wait times and length-
of-stay for a portion of women, it would significantly improve the quality of care 
through ensuring pregnant women receive essential antenatal services and 
counselling. Resource neutral strategies to reduce healthcare worker absenteeism, 
and improve their motivation and performance should be explored to ensure limited 
resources are used efficiently without over-stretching the system. 
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6 Chapter 6 Discussion 
This chapter presents a summary of the main findings and how the three studies 
informed implementation of integrated point-of-care testing strategy. It then draws 
important insights from these findings, and reflects on their implications for health 
systems. It discusses on study strengths and limitations and gives recommendations 
for the future.  
6.1 Summary of main findings  
The intervention of providing integrated point-of-care testing for four important 
conditions in dispensary level antenatal care (ANC) services addressed a gap in 
implementation of antenatal guidelines in Kenya. Baseline testing coverages (chapter 
3) in dispensary level was high for HIV but low for syphilis and anaemia because of 
low test availability. The number of women tested for malaria at baseline could not 
be assessed because no data were captured in ANC registers. In practice, women are 
referred to facilities with laboratories for malaria microscopy screening together with 
their syphilis and anaemia screening requirements. However, data on referral uptake 
were not available. These baseline findings were not surprising given that previous 
studies had identified low test availability for syphilis and anaemia as a common 
barrier to testing coverage among health systems in sub-Saharan Africa (SSA) [1, 2]. 
The review also found that preventive strategies for malaria using intermittent 
preventive therapy (IPTp) with sulfadoxine pyrimethamine (SP) and bednets were 
poorly covered.  The reasons for inadequate coverage of services for these antenatal 
conditions are summarised in Table 6.1 using Tanahashi’s 3-stage conditional 
implementation pathway [3, 4]. 
The intervention provided some of the critical early components on the 
implementation pathway by availing tests, training and supervision. Three studies 
then assessed the its implementation outcomes (Chapter 3: Study 1 and Chapter 4: 
Study 2) and the service delivery impact (  
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Chapter 5: Study 3). Adoption was high during the intervention period: the number 
tests done and the number of cases of syphilis, anaemia and malaria that were 
detected in these small rural dispensaries increased significantly among first 
antenatal visits, without affecting the already high rates of HIV testing in pregnant 
women. Adoption was slightly diminished in facilities that had more frequent 
turnover of healthcare workers perhaps because new staff had to be re-trained and 
oriented with the intervention which led to slower uptake. When interviewed 
healthcare workers and pregnant women were highly enthusiastic about testing and 
found the innovation acceptable and appropriate. While more women received tests 
and correct treatment because of the intervention, fidelity to clinical management 
guidelines can still be improved. Our qualitative findings provide some explanations 
for the gaps in fidelity: poor working conditions, stock-outs, inadequate training, high 
workload and stress, delayed salaries, and devolution were common sentiments 
perceived to be barriers to providing quality care found among interviews with 
healthcare workers (Chapter 4: Study 2).  
During interviews with healthcare workers (Chapter 4: Study 2), concerns of high 
workload affecting the ability to give quality care frequently appeared. Human 
resource shortages have been a major concern for scaling of the interventions 
needed to achieve the health outcomes of the Sustainable Development Goals 
(SDGs) in SSA health systems. However, there is also evidence to suggest that the 
existing workforce is not operating optimally [5-7]. When we modelled data on client 
flow and staffing resources (Chapter 5: Study 3) we found healthcare workers were 
often under-utilized.  We tested a ‘what-if’ scenario where consultation times were 
increased to sufficient durations for delivering ANC’s essential services 
recommended by WHO. Our model suggested that nurses should, in theory, have 
sufficient time to deliver ANC services fully in dispensaries. However, healthcare 
workers were often absent and when this happened, the remaining healthcare 
worker would be strained. These studies demonstrate that integrated POCT is an 
appropriate and acceptable strategy but additional health systems solutions are 
needed to ensure test availability, healthcare worker retention, and quality of care. 
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Table 6.1  Synthesis of findings on coverage of antenatal testing for HIV, syphilis, malaria & anaemia 
Chapter 2: Literature review  (what we know) Intervention  (what we did) Coverage level Determinants of coverage Assessment indicators of coverage determinants Integrated POCT intervention Access coverage   expensive transport costs  geographical distance  socio-cultural factors provider attitudes 
 All mothers during pregnancy attend ANC  Early ANC attendance  Sufficient number of ANC contacts  Partners are involved with treatment of syphilis and HIV 
By availing and integrating POCTs at peripheral facilities, the strategy brings coverage closer to the community 
Availability coverage  poor stock-management systems  funding and international donor priorities and lack of co-ordination  human resource planning  political economy  transnational influence  policies  vertical systems inter-sectoral response and activism 
 Tests, drugs, and commodities are available  Sufficient and rightly skilled human resources at the facilities that corresponds to the facilities’ workloads 
Baseline revealed that low availability of tests was the main reason for poor testing coverage. The study supplied tests for syphilis, malaria, anaemia and penicillin drugs for syphilis treatment. 
Clinical practice   funding and international donor priorities  socio-political economy vertical systems 
 Competence: Healthcare workers have sufficient knowledge, right skills mix, training and supervision to deliver quality services  Motivation:  Healthcare workers are motivated to give sufficient and quality services 
The study provided training for testing and treatment of syphilis, anaemia and malaria, and supervision for testing quality  
 What we found 
 Chapter 3 Chapter 4  Chapter 5 
Access coverage   20% of women attended ANC visits in their 3rd trimesters 
 Pregnant women found POCTs acceptable and appropriate as testing for conditions satisfied their reasons for going for ANC visits.   Some facilities noticed an increase in pregnant women  socio-cultural factors delayed ANC attendance   stigma and gender disparities impeded partner involvement   poor healthcare worker attitudes decrease health seeking behaviour 
 
Availability coverage  High testing adoption   inadequate fidelity to management of conditions  High healthcare worker turnover had implications for training and supervision 
Factors that threaten feasibility:  Stock-outs, funds and salary delays threatens healthcare workers’ ability to offer antenatal services  Government devolution interrupted financial and stock flows 
 suggests that human resource numbers may be sufficient in some small facilities to manage the client load   healthcare workers are absent often which disrupts the resource needs of the facilities for those days and over-burden the staff who remain 
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Clinical practice  Healthcare workers could perform testing with training and supervision 
 Healthcare workers found testing to be appropriate as it satisfied their work requirements  Healthcare workers found testing to be acceptable as POCTS were easy to use  training and supervision were welcomed if constructive, non-critical feedback was given.  Factors that threaten feasibility:  staff are demotivated from workload, job grade stagnation, delayed salaries, poor working conditions and stock-outs  adequate training and supervision are lacking   unhappy healthcare workers have trickle-down effect on women: poor healthcare worker attitudes make pregnant women demotivated to seek health services 
 
POCT: point-of-care testing; POCTs: point-of-care tests 
 
6.2 The limits of ANC for controlling diseases in pregnancy 
This integrated POCT strategy addressed a facility-level accessibility coverage gap by 
bringing essential testing services to peripheral facilities, circumventing the need for 
women to be referred to distant facilities for testing. However, it still rests upon the 
condition that women attend ANC at these facilities in the first place, attend early 
enough, have sufficient number of contacts, and involve partners in the treatment of 
HIV and syphilis. Although ANC attendance in Kenya is high (>90%), a third of those 
who did not use ANC at last pregnancy cited distance as the main reason in the 2012 
Kenya AIDS Indicator Survey (KAIS) [8]. Moreover, a quarter of pregnant women seek 
ANC after the first trimester (our study found 20% of women visited ANC in their 3rd 
trimester, chapter 3) and fewer yet return for re-visits [9], precluding full protection 
against illnesses that require early interventions or several interventions over time. 
Moreover, sexually transmitted infections such as HIV and syphilis require 
involvement from male partners which ANC has not been good at capturing [10].  
Narratives from pregnant women describe the difficulties of disclosing HIV status to 
their husbands (Chapter 4). To address these gaps in accessibility coverage and 
improve partner involvement, a community based healthcare strategy may help [11, 
12].  Kenya launched a community health strategy in 2006 [11] which has 
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demonstrated success for some health indicators such as health facility delivery, 
antenatal care usage, water treatment, latrine and  insecticide treated nets use [13]. 
However, challenges with high community healthcare worker attrition and quality of 
care still need to be resolved [14].  
6.3 The need for overall health system strengthening  
Developing nations make up 80% of the global population, contains 90% of the 
world’s disease burden but accounts for only 12% of global health expenditure 
(Figure 6.1Error! Reference source not found.) [15].  
Figure 6.1 Mismatch between global health spending and global disease burden [15] 
 
 
The conditions of the poor and the disparity in wealth distribution has spurred a 
united global pledge (Millennium Development Goals, MDGs) to improve the health 
and livelihood of those in low and middle-income countries [16]. However, instead of 
abiding to the Alma Ata of 1978 which committed to health improvement by building 
strong health systems through comprehensive primary care, short-cut focuses on 
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instituting selective programmes to tackle the most severe diseases were adopted 
based on the argument that comprehensive care would be too costly [17]. It was 
believed that disease-specific efforts would lead indirectly strengthen the system as 
a whole.  Major global health initiatives were created around priority areas to tackle 
the major diseases including Global Fund to Fight AIDS, TB and Malaria, The 
Presidential Emergency Plan for AIDS Relief (PEPFAR), Stop TB, Roll Back Malaria, and 
the Global Alliance for Vaccines and Immunization. While achievements were made 
in the health focused MDGs, targets were still under-reached.  Reflecting from the 
experience, there is growing recognition that fragile systems cannot be bypassed and 
their inherent shortfall in key areas renders them incapable to thrive and sustain on 
the opportunities that global interventions bring [18]. In the age of the Sustainable 
Development Goals (SDGs), integration and system-wide collaborations are now 
emphasized to overcome the limitations that plagued the MDGs [19]. 
Not only are there endemic constraints related to the healthcare workforce, 
commodity supply chains, health financing, and information infrastructure, but also 
the existence of disease specific focuses additionally crowd-out resources for other 
equally important areas [18]. Analysis of health system barriers to improving  
coverage and service delivery of different health inducing interventions or 
programmes have yielded similar results which our study attests to [18]. The 
disparate coverage among HIV, syphilis, malaria and anaemia services found in our 
baseline analysis (Chapter 3) are the results of PMTCT programmes being financed 
and carried out by PEPFAR and external partners which has led to wide coverage of 
HIV care [20]. While this is laudable, conditions such as syphilis and anaemia that 
have not received strong international advocacy remain poorly managed. Having 
supplies available improves healthcare worker motivation and pregnant women’s 
desire to seek services. Findings from Chapter 4 and elsewhere [21-25] show that 
healthcare workers are enthusiastic about providing testing services to pregnant 
women as it allowed them to perform their jobs and increased their satisfaction. 
Indeed, the lack of supplies was one of the reasons for healthcare worker strikes in 
Kenya (chapter 4) [26]. A well-resourced facility will improve working conditions and 
healthcare worker motivation [27].  
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The existence of parallel systems likely result in distortions [18] where separate 
cadres of staff with higher salaries paid for by specific programmes are created, 
draining human resources away from other core tasks or demotivating those not in 
higher salaried positions [18, 28, 29]. We saw this during our study when HIV care 
providers (supported by PEPFAR) did not participate in country-wide healthcare 
worker strikes demanding on-time and better pay which may lead to further 
demotivation of core staff who were striking.   
Parallel programmes also cause disruptions [18] where many uncoordinated 
programmes pull staff away from the facilities for trainings, workshops, and outreach 
[28]. A study of polio eradication in Tanzania, Nepal and Lao found that healthcare 
staff had their regular work disrupted around immunisation campaigns which 
happens several times a year [30]. While a few training workshops or outreach a year 
may be manageable, the combined number of in-service training to deliver various 
disease programmes means healthcare workers are absent frequently making this 
strategy more and more unsustainable. These extra-curricular trainings are often 
supplemented with per diems and generous transport reimbursements, providing 
extra incentives to be away. A disturbing finding from Chapter 5 was how often 
nurses were absent from the facility and that rarely do two nurses work 
simultaneously together, causing excessive workload to be shifted onto one nurse. 
This also came up in the narratives (Chapter 4) where healthcare workers 
complained of being ‘alone’ and unable to give quality when they were over-
stretched.  
International players influence norms and shape countries’ policy preferences [31, 
32]. Overseas development assistance (ODA) funds are usually provided on short-
term cyclical basis and drive health ministries to create disease specific silos to 
expedite the scale-up of priority services with short term targets [33]. Also, there are 
often weak synergies among programmes which lead to inefficiencies and 
duplications [18]. In Kenya, the National Malaria Control Program (NMCP), the 
National AIDS and STIs Control Programme (NASCOP) and the Division of Family 
Health manage and create policies for malaria, HIV and reproductive health 
programmes respectively [34, 35]. While there are inter-agency coordination 
committees (ICCs) and technical working groups (TWGs) that meet to co-ordinate 
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across programmes, the 2013 Health Sector Strategic Plan found too many ICCs, 
poor programme alignments and weak linages (chapter 2) [36]. This type of 
environment does not nurture the development of long term strategies to enhance 
strengthening health infrastructure which would require strategic long term planning 
with less tangible short term benefits [37]. 
This disintegration is also commonplace in the organization of research monies and 
institutes which are divided into disease specific departments. For example, there 
was no obvious place to lead this integrated testing study from within the host 
institution of KEMRI/CDC because the study’s focus did not fit strictly within the 
branch concentrations of either malaria, HIV, TB or emerging infectious diseases. It is 
important to be cautionary against continued investments in disease specific 
interventions without concurrently building knowledge on how to improve basic 
health system infrastructure as almost all studies identified shared health system 
related barriers to the successful implementation of their disease specific 
programmes (chapter 2). Changing this trend would require funding bodies and 
champions to influence agendas from the top down. 
Broader approaches to tackling system failures will take long-term planning, political 
will and an understanding that several root causes may need to be addressed 
simultaneously and that benefits may not be evident for a long time [18]. 
Committing to achieving long haul gains is advantageous as health-system barriers 
cut across disease profiles: procurement and distribution systems, healthcare 
workforce, training and supervision are shared resources. A shift from disease-
specific responses to system-wide responses will create efficiencies and raise the 
common good. While we may still need a deeper understanding of how and what 
broader system strategies can and to what extent contribute to overall health system 
strengthening, it is important to be guided by this collective vision so we can start 
shifting our intentions toward long-term goals [18]. The simple fable of the three 
little pigs can remind us that foundations built from brick are sturdier and better 
prepared for catastrophic forces than those built from sticks and hay. 
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6.4 Addressing the political economy  
While the above section discussed how vertical structures within global health 
initiatives and the international donor agendas may contribute to an inadequate 
system strengthening response to population health needs, this section will discuss 
some endemic health system weaknesses rooted in the institutional environment. 
These constraints may not have simple stand-alone technical solutions but would 
require institutional reform.  
Political changes and upheavals affect the functioning country’s health systems. 
During the time of this study, politics motivated the Kenyan government to rapidly 
execute the decentralization process of transferring decision-making power to the 
counties. The county governments were unprepared for the transition and their 
limited technical capacity created disruptions in the county’s financial flows causing 
stock-outs, salary delays and insufficient funding (Chapter 4) [38, 39]. After 
devolution is complete, healthcare decisions would involve local politicians and 
technical actors. To sustain antenatal testing, county authorities involved with 
selecting priorities will need to see the importance of antenatal screening and 
allocate resources towards it. This would require civil society pressure and policy 
champions to push antenatal care priority amongst several competing social 
demands from agriculture, transport, education et cetera [37].  
A country needs good checks and balances to make effective use of foreign 
investments and  ODA [40]. Within a good policy environment with robust economic 
management, a 1% of GDP in assistance translates to 1% reduction in poverty and 
infant mortality [40]. Many SSA countries have poor governance and corrupt 
politicians who squander or misappropriate development assistance funds, usually 
through fake contracts [41, 42]. It is estimated that stolen money from seven Kenyan 
government officials exposed in 2005 could have paid for the entire countries’ 
antiretroviral drugs needs for a decade [43]. Development assistance should 
strengthen institutions so that important services can be absorbed and the 
performance of these institutions are the key to poverty reduction [40].  Solutions to 
address institutional and environmental constraints are beyond the realm of health 
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alone and might require a disruption in innovation or the political economy to 
change the status quo [37].  
6.5 Systems thinking and the need to go beyond trial designs 
Increasingly, policymakers and implementers are looking beyond trial outcomes of 
efficacy to consider the operational feasibility of interventions within the local 
environment [44]. While controlled trials are robust in estimating the efficacy of 
treatment effects, they are more limited in their evaluation of effectiveness of 
population health interventions [45]. Public health is the emergent product of 
behaviours, policy environments and disease contexts evolve and interact in complex 
ways that can affect the sustainability of the intervention. This creates an adaptive 
complexity that is best understood through systems thinking and applying multi-
disciplinary enquiry [46]. The reductionist approaches of experimental methodology 
where linear causal patterns are to be predicted through regression in controlled 
comparisons are limiting and we need to shift beyond randomized control trials as 
the gold standard for capturing valuable information [45]. Rather, the goal of 
implementation research is to understand how an intervention functions within its 
contextual environment and the range of factors that mediate its impact [47]. As 
such generalizability cannot always be produced because the environment in which 
the interventions are implemented highly determines the outcomes [18, 47].  
This study demonstrated the application of multi-methods to progressively 
investigate a health service gap. Implementation outcomes of adoption and fidelity 
were measured quantitatively using exit interviews, antenatal registers and 
proficiency scores. Acceptability, appropriateness and feasibility were assessed 
qualitatively through social science perspectives which captured the textured layers 
of experiences and behaviour [48]. An operational simulation method [49] that 
introduced competition at discrete events was applied to describe the service 
delivery environment and emergent consequences of the intervention introduction 
and virtually experiment ‘what-if’ scenarios without the cost of real-life 
experimentation. They each contribute essential information towards answering 
questions around the implementation of strategies in complex systems.  
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Methodological challenges of health systems research need to be addressed and 
developed more thoroughly to incorporate a wide range of quantitative, qualitative 
and multi-disciplinary approaches. Effectiveness-implementation hybrid designs that 
blend testing clinical effectiveness and measurements of implementation outcomes 
can help close the translational gaps between research and practice early in the 
research process [50]. Combining multi-disciplinary perspectives and methods would 
require expanding paradigms and acknowledging that no one method is sufficient in 
itself to understand complex systems [46, 48].  
6.6 Limitations of point-of-care tests (POCTs)  
Point-of-care tests (POCTs) should be ASSURED: affordable, sensitive, specific, user-
friendly, robust and rapid, equipment-free and deliverable to those who need them 
[51]. The HIV and malaria POCTs used in this study followed national guidelines and 
the tests for syphilis and haemoglobin concentrations have been evaluated and 
recommended by WHO according to the ASSURED criteria [52, 53]. POCTs are not 
gold standards and their sensitivities and specificities are not 100% meaning there 
will always be false positives and negatives when testing at the population scale. This 
may be mitigated by establishing testing algorithms which requires either parallel or 
serial testing to guard against false positives, especially in populations that are tested 
often [54]. Those who test negative often do not require re-testing but it is 
important to make an accurate risk assessment to identify populations who may 
have exposure or on-going risks [54].   
The rapid test for syphilis detects antibodies against Treponema which remains 
positive even after successful treatment which may lead to overtreatment. In places 
with the capacity (electricity for refrigeration of reagents, rotator and blood 
centrifugation) to perform a Rapid Plasma Reagin (RPR), a testing algorithm 
beginning with a treponemal rapid diagnostic screening test followed by an RPR 
confirmatory test can be considered [55]. However, in most peripheral facilities, the 
use of RPR is not possible or practical and over-treatment is more beneficial than the 
risk of congenital syphilis.  
The use of POCTs will still require some central laboratory support for quality control 
because new batches of tests need to be validated with positive and negative 
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controls per standard operating procedures. HemoCue© machines also need to be 
calibrated once every 3 months using standard known haemoglobin concentrations. 
These supportive networks would need to be organized to ensure quality should 
programmes be scaled nationally. Tests should also be stored under 30oC and there 
may be days well over this temperature at the facilities. Although we did not monitor 
the average temperatures where the tests were stored, temperature control would 
be important to ensure tests are not damaged and retain their quality.  
The currently used standard malaria rapid diagnostic tests have limited sensitivity 
and were designed to diagnose malaria in clinical patients and not to detect low-
density or subclinical parasitaemia in asymptomatic women, which would be the 
main target population in antenatal screening strategies. The limitations of the 
current generation of malaria rapid diagnostic tests (RDT) when used to screen 
asymptomatic pregnant women were recently shown in four trials of intermittent 
screen and treat strategies in pregnancy (ISTp), which suggested that regular 
screening with malaria RDTs is inferior to the existing preventive strategy of 
intermittent preventive strategy (IPTp) with sulfadoxine pyrimethamine (SP) [56]. 
This is likely explained by the high number of low-density infections missed by 
malaria RDTs and the absence of prophylactic protection from SP for test-negative 
women [57, 58]. However, these studies also showed that the performance of 
malaria RDT relative to PCR is best at the antenatal first visits when the prevalence of 
RDT detectable parasitaemia and parasite densities were highest. New ultra-sensitive 
diagnostic tests such as the Alere Malaria Ag P.f RDT ULTRA SENSITIVE (SD/Alere, 
Yongin-si, Republic of Korea) that are reportedly 10 times more sensitive may change 
the efficacy of ISTp and they are currently under-going performance evaluations in 
the field [59]. These ultra-sensitive tests would be increasingly important as we move 
towards elimination and eradication goals when all parasite reservoirs need to be 
destroyed. 
6.7 Limitations of the study and gaps  
 
We used a quasi-experimental before-and-after design with no concurrent controls 
to measure adoption of testing. These designs are considered weak because without 
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concurrent controls they cannot account for secular trends; any improvements seen 
cannot be categorically attributed to the intervention. However, this weakness may 
not be applicable to this study.  Our baseline measure revealed that testing was low 
because of no test availability and so our objectives were formed around 
understanding the implementation process if tests were made available. Since the 
intervention was the availability of tests, it was pointless to compare adoption with 
control facilities where tests were not available because by definition it meant 
testing could not be done.  
When Chapter 3: Study 1 went out to peer review with Plos Med, the reviewers 
questioned why random sampling was not applied as purposive sampling reduces 
external validity. However, our goal was to capture a range of different environments 
where testing is done to understand the range of factors that could influence 
implementation success. There were only 24 dispensaries in the KEMRI HDSS area 
with some receiving less than 10 antenatal clients per month and some with other 
antenatal studies ongoing. A random sample may not have given us enough 
variations in implementation environments. Therefore, after conducting a baseline 
assessment of all facilities in the KEMRI HDSS area, we selected facilities with the 
greatest geographical spread, and medium to high patient volume. 
The study is likely to have over-estimated the adoption of the integrated testing 
strategy because of the study (Hawthorne) effect on primary and other outcomes. 
During the time of the study, data collectors were present to interview ANC women 
and their presence may have influenced healthcare worker behaviour. Moreover, 
data collectors inadvertently end up helping with menial tasks around the facility 
which distorts the real-life working conditions. 
Our qualitative findings (Chapter 4: Study 2) were context specific and may not 
generalize to other settings. Kenya was experiencing government devolution and 
many of the grievances healthcare workers expressed may have been related to 
devolution challenges. Staff turnover was high and some healthcare workers who 
were involved with the intervention in the beginning and later transferred were not 
interviewed which may have missed some information. The findings from the 
healthcare worker interviews and focus group discussions were not surprising and 
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are mostly supported by the literature. As an early qualitative researcher, I may not 
have had the experience and skills to obtain as rich of data as more experienced 
researchers.  
 
The idea for introducing an integrated testing strategy was also not locally conceived, 
and our study lacked sufficient engagement with stakeholders and policy makers at 
the design stage. Understanding decision-makers’ priorities and advocating the 
importance of integrated testing would ensure relevant research outputs and higher 
policy impact. Early engagement with HIV, malaria and reproductive programmes 
and their implementation partners would be essential to ensure uptake and policy 
change. Since the country was undergoing devolution during the time of the 
research, working closely with the county management team would have been ideal 
to understand the county priorities and assess intentions to improve antenatal care. 
During the research period, three of the facilities added new laboratory technicians 
and research staff had to encourage facilities to continue implementing testing 
within the ANC with the ANC nurse or HTC counsellor and not refer the women to 
the laboratories. These conflicts in practice of where integrated ANC testing would 
take place and who should be responsible for testing would need to be clearly 
delineated by management and communicated to front-line workers so healthcare 
workers would not feel they are being asked to perform outside their duties.  
The original study budget was reduced significantly after some institutional financial 
challenges at KEMRI and we did not have the budget to sufficiently disseminate the 
research finding to obtain feedback from the healthcare workers and the county 
health management teams. Modelling of operational impact of integrated testing 
(Chapter 5: Study 3) should have been visually presented to healthcare workers to 
assess the accuracy of the model. Policy makers and frontline healthcare workers 
should have been consulted to understand their concerns on service delivery, 
identify bottlenecks, and devise potential resource neutral solutions that could be 
viable and acceptable. These strategies should then be tested and assessed for 
improvement. These steps are vital to translating research to practice. 
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The study did not do a costing analysis of the integrated testing strategy. While a 
costing exercise may be informative, multiple studies have already established that 
syphilis testing is one of the most cost-effective interventions in pregnancy, even in 
low prevalence settings [54, 60]. Moreover, maternal syphilis is a co-factor for 
mother-to-child transmission of HIV and the importance of its integration with HIV 
management is well established and uncontended. HIV/syphilis multiplex tests are 
now available in the market and their use will likely lead to more cost-savings 
because of efficiencies in procurement and service delivery [54]. Cost-effectiveness 
studies of intermittent screening and treatment of malaria in pregnancy (ISTp) 
currently show that the strategy is not superior to chemoprophylaxis with 
sulfadoxine pyrimethamine (SP) and bednet use but modelling work suggests that as 
SP resistance increases, ISTp can potentially be a beneficial and suitable option [61]. 
Successful management of malaria will also help reduce cases of anaemia and these 
benefits need to be accounted for as well. HemoCue© has been shown to be the 
most accurate and appropriate method for haemoglobin measurements compared 
to others such as pallor and colour scales [62-64] but also the most expensive at 
approximately US$0.75/test [53, 62]. Haemoglobin testing with haemoglobinometer 
is the recommended method for diagnosing anaemia in pregnancy [65] despite the 
lack of studies weighing accuracy and cost-benefit considerations of different 
anaemia detection strategies in different prevalence environments. 
6.8 Conclusion and recommendations for future work 
This thesis demonstrates that an integrated testing strategy for HIV, syphilis, malaria 
and anaemia was well received by healthcare workers and pregnant women and may 
fill an important gap in antenatal testing requirements. The high adoption, increased 
number of cases detected, and good performance of healthcare workers are 
testaments to the potential that can be achieved when test supplies, training and 
supervision are available. It also highlights some of the healthcare system 
deficiencies that exist and the need for concurrent strengthening of these service 
delivery channels in order for coverage to be effective, that is, to achieve desired 
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health outcomes. Table 6.2 suggests some health system level responses to 
overcome some of the identified constraints to antenatal testing coverage. 
Table 6.2 Potential health system responses to overcome constraints to antenatal testing coverage  Barrier Strategy Pregnant women accessibility of antenatal testing including early attendance and multiple contacts 
-Development of community based care -Availing POCTs at peripheral facilities -Addressing social-cultural barriers  
Lack of male partner involvement -Understanding male barriers to reproductive health involvement and targeting men to participate in antenatal care through community based and gender-integrated interventions [10, 66]  Vertical funding structures -Global health community, researchers, implementers and development assistance funding bodies must work together to address overall health system strengthening and refrain from favouring disease specific programmes [18, 67].  Inadequate financing for reproductive health -County governments to commit more of their budgets to health and antenatal care. This would require policy champions and advocacy to raise reproductive health agenda in face of competing social demands.  Lack of inter-departmental partnerships and communication 
-Improving communication across departments and strengthening the inter-agency coordination committees (ICCs) and technical working groups (TWGs).  -Strive towards integration of programmes and guidelines to avoid duplications and ensure co-infections are addressed and managed properly.  Ineffective procurement and commodity distribution systems 
-Improve and integrate procurement and transport of commodities so ordering channels are streamlined and benefit from economies of scale. Poorly motivated healthcare workers -Review of salaries, job grades and promotions, improve working condition, invest in training and supervision, ensure no stock-outs and invest in non-financial incentives [68] Staff shortages and workload -Integration of healthcare worker training and supervision so healthcare workers are not pulled out of duty for programme specific trainings.  -Ensure basic comprehensive antenatal care services should be part of nurse training curricula to decreases the length and frequency of long in-service training. -Reducing healthcare worker shortages and absences through long-term investment in human resource development and retention [37].  Neglect of health systems and policy research -Diversify research funding sources to encourage more multi-disciplinary systems research [18].  -Stipulate studies to incorporate implementation and translational component into their design and budget. -Encourage the use of multi-methods to answer a range of implementation questions [48]. -High impact journals should call for and publish more implementation research studies [44]. 
 
It is important to recognize that no one single strategy is sufficient but that each may 
be a necessary contribution. Long term strategic planning and political will is needed. 
A systems’ thinking perspective should be adopted and interdisciplinary creativity 
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encouraged to guide future implementation work. There is also a need for 
consistency and conceptual distinction of implementation outcomes so the field can 
be more robust and findings more comparable. Finally, we must keep in mind that 
great achievements take time and sustained effort. Researchers should remember 
that our work is not just speculative in nature, but rather to place us in better 
position to improve the human condition through successful implementation.  
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7 Appendices 
7.1 Appendix 1 Integration operating procedure placemat 
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7.2 Appendix 2 Text proficiency testing monitoring checklist 
IPOCT EXTERNAL MONITORING CHECKLIST 
Name of facility: 
Name of staff:  
Date: 
  Y N  Y N Safety: Sharps container   Gloves    Biohazard waste bin/bag       
PERFORMANCE OF PROCEDURES 
  Y N  Y N Preparation Label initials onto cassette   Check lot number    Correct use of timer   Check expiration date   Finger prick Sterile lancet   Correct position of prick     Correct massage    Dispose lancet in sharps    Correct disinfection   Correct wiping of first drop       Sufficient volume of blood for IPOCT using 1 prick (4 tests) 
  
 
  Y N  Y N 
Syphilis Testing: Syphilis pipette   Deposit all blood onto sample well without touching sample pad 
  
 Syphilis buffer   Dispose pipette in sharps   
 Syphilis cassette   Correct number of buffer drops into sample well   
 Correct pipetting   Starting timer immed’ly after buffer   
 Sufficient volume drawn to line (20µl)   Waiting full time to read -ve result   
    Correctly interpret result   
       
  Y N  Y N 
HIV Testing: HIV pipette   Deposit all blood onto sample well without touching sample pad 
  
 HIV buffer   Dispose pipette in sharps   
 HIV cassette   Correct number of buffer drops into sample well   
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 Correct pipetting   Starting timer immed’ly after buffer   
 Sufficient volume drawn to line (40µl)   Waiting full time to read -ve result   
    Correctly interpret result   
       
  Y N  Y N 
Malaria Testing: Malaria pipette   Deposit all blood onto sample well touching sample pad   
 Malaria buffer   Dispose pipette in sharps   
 Malaria cassette   Correct number of buffer drops into buffer well   
 Correct pipetting   Starting timer immed’ly after buffer   
 Sufficient volume drawn to line (5µl)   Waiting full time to read -ve result   
    Correctly interpret result   
       
  Y N  Y N 
HB testing: Hemocuvettes   Correct wiping of cuvette on both sides   
 Hemocue machine   Gently closing machine    
 Kimwipe   Correctly reading result   
 Correctly turn on hemocue machine   Taking cuvette out of machine   
 Correct drawing of blood into cuvette   Dispose cuvette in sharps   
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7.3 Appendix 3 Focus group discussion guide with pregnant women 
Focus group discussion guide for pregnant women who completed first ANC visits in 
participating antenatal clinics (ENG) 
FGD ID No [___]___]___]    Moderator Initials [___]___]___]  Note-taker Initials [___]___]___] Recorder Number: _____________ Folder/File Name (location on recorder): _________________ Date [___]___]/[___]___]/[___]___]    Interview location _________________________________ Time: Start ____________________ Time: Stop________________________  No. Participants at start of FGD: ___________ No. Participants at the end of FGD: ______ Introduction  I am __________from _______(moderator) I am __________from_______(note-taker)  General purpose of the study   We are trying to find out what health checks and blood tests are done in the antenatal clinic, what you understand and are told about these checks in the clinics and what care you get if the tests show you need treatment. We would like to know about the care you and other pregnant women have experienced and in particular what difficulties you experience when you try to get the care you need. This information will help us understand what issues are important to you and other pregnant women, and if there are any problems.  Aims of the interview and expected duration   Perceptions of ANC service and health workers  Perceptions of HIV, syphilis, malaria and anaemia in pregnancy  Perceptions of blood tests and treatment   Identify best way to provide diagnosis and treatment at a single ANC visit.  We will have a discussion that will from 1-2 hours  Who is involved in the process (other participants)   We will hold discussions with women early in their pregnancies who have visited one of the antenatal clinics for their 1st ANC visit.  Why the participant’s cooperation is important   We are asking you to help us better understand what health checks and blood tests are now done in pregnancy, and if pregnant women receive the treatment that they need. We want to learn about what more you think is needed for antenatal care and what you do when you get ill. We will also talk about care that is needed for pregnant women with health needs such as infections with HIV and syphilis. We also want to know about the experiences of you and other pregnant women with local health staff or other providers of health care or medicines, such as traditional healers or shop keepers. This knowledge will help us understand how to improve the care available in your community.    What will happen with the collected information and how the participant/target group will benefit   Ground rules:   Only one person talks at a time.  
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 It is important for us to hear everyone’s ideas and opinions. There are no right or wrong answers to questions – just ideas, experiences and opinions, which are all valuable.   You do not need to share experiences that make you feel uncomfortable. You can leave at any time.   It is important for us to hear all sides of an issue – the positive and the negative.   Confidentiality is assured. “What is shared in the room stays in the room.”   Turn off mobile phones  Any questions?   Consent to record We would like to use a tape recorder so that information is collected correctly – please let us        know if this is acceptable  Please note the questions here:   
Demographic information for every FGD participant [to be completed on a one-to-one basis, immediately after consent is obtained] 
Participant no. Age Date of 1
st ANC Gravidity Gestation age Marital status Education Ethnic group 
        
        
        
        
        
        
        
        
        
        MODERATOR: Allow group to decide; assign fake names or use participant numbers. Make sure to use these fake names or participant numbers in note-taking and transcription. Make name tags using the fake names or participant numbers. * REMEMBER – you MUST ask same questions for all groups or you are biasing results  
COMMENTS – reasons for withdrawal, refusal, ambience of FG, level of interest, 
disagreements, etc 
Warm up  Can we go around the room and say which village you are from and whether this is this your first pregnancy?   Now I am going to introduce some topics I hope you can discuss together, about your experiences during pregnancy. Theme  Opening questions and Probes Services received at ANC You all recently attended ANC at ____. Why do pregnant women choose to attend ANC at _____?  
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Are you aware of what should be given to pregnant women at their first ANC visit? Can you tell us? Did you receive these services?   Do pregnant women feel comfortable in asking for services they know they should have but did not receive from the healthcare worker?  
Do you know the blood tests that should be done for pregnant women at their first ANC visit? Can you mention them? What kind of blood tests were pregnant women given at the ANC at _____?      What was your experience about counselling offered at the ANC?             Probe: HIV counselling, blood test counselling, birth plan counselling,                   nutrition counselling Knowledge of HIV, syphilis, malaria and anaemia and the blood tests 
What do you know about HIV and how it affects the unborn child?  Probe: risk of infection during pregnancy, risk of infection during childbirth, risk of infection during breast feeding?  Syphilis?  Probe: risk of infection during first/second trimester? Risk of infection during 3rd trimester? Assess knowledge of syphilis (A bacterial infection usually spread by sexual contact/blood transfusion/congenital,that starts as a painless sore on genitals, mouth or rectum. If transmitted to the baby during pregnancy, can cause malformations)   Malaria?   Anaemia? Probe: knowledge of different levels of anaemia: >8-10g/dl: Mild anaemia, 6-8g/dl: Moderate anaemia, <6g/dl: Severe anaemia  
 What was pregnant women’s experience of the blood tests they do at the ANC?  Probe: How do you feel about the amount of explanation received about blood tests given by healthcare worker? How many times were the fingers pricked? Is that acceptable?  
How do pregnant women feel about the amount of explanation received about a positive result from the blood tests if done? Probe: How do the healthcare workers communicate the results?  Do   women understand what the results mean for them and their baby? Do pregnant women accept the results?   If a blood test result is positive, what should be done for pregnant women?    For HIV? Are pregnant women given the treatment they need?  Probe: Do healthcare workers give enough counselling to pregnant   women so they can accept their results? When are pregnant women  
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given care for HIV?  Syphilis? Are pregnant women given the treatment they need?  Probe: Do pregnant women know the right treatment for syphilis? Do  healthcare workers give adequate explanation for the treatment?   Malaria? Are pregnant women given the treatment they need?  Probe: Availability of quinine, co-artem in facilities? Availability of SP?  Given bednets? Advised to sleep under bednet?  Anaemia? Are pregnant women given the treatment they need?  Probe: Do the healthcare workers tell pregnant women their blood level and give advice/treatment? Availability of iron/folic acid? Do pregnant women know the different levels of Hb and how much iron pills to take depending on blood level? Do pregnant women experience side effects of the iron pill? Are pregnant women referred for blood transfusion if blood level is very low? 
If positive for HIV or syphilis, it is important to treat the spouse as well. What is pregnant women’s experience of talking to their spouse about testing and treatment at the health facility?  Quality of services received at ANC What are pregnant women’s experiences of the ANC at _____? 
Probe: How did you feel about the waiting time? Did you receive everything you expected? Do they prefer male or female health workers?  
How do the healthcare workers at ____ treat pregnant women? 
Probe: What advice do they give pregnant women? How is the attitude of the healthcare workers? Do you spend enough time with the healthcare workers? How do healthcare worker attitude influence where pregnant women seek advice? Were pregnant women asked to pay anything? Do pregnant women feel they can discuss their pregnancy with the healthcare worker? 
  Closing  We are now approaching the end of our discussion. Is there anything else anyone would like to add about the blood tests that you get from ANC or health facilities that we have not talked about?   Summarise   Thank participants   Provide extra information and contacts to participants  
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7.4 Appendix 4 Semi-structured interviews with healthcare workers  
Integrated point of care testing for HIV, syphilis, malaria and anaemia in dispenaries in western Kenya  Interview Guide  Objectives: To explore health workers’ perceptions and experiences of the implementation integrated point of care testing services for HIV, syphilis, malaria and anaemia  A. Introduce the purpose of the study – its aims and scope  Assure participant of confidentiality and how it will be maintained  As for their consent to participate B. Note details of participant. 1. Interviewee ID   6. Gender Male  Female  2. Date of Interview   7. Age 3. Name of RHs or HCs   8. # of children 4. Province    9. Family members 5. Title interviewee   10. Education  Questions  Probes:  When was that?  Why did you do that?  What did you enjoy about that?  How did you manage in that situation?  Where did you go next?  1. Tell me a bit about yourself? How did you come to work in the health field? 2. How did you get this job? 3. Describe what you do now 4. How long have you been working here? 5. How do you feel about your current job? 6. What do you like and dislike about it? 7. Are you planning to stay? What are your plans for your future career? 8. Do you do other jobs as well, or other activities to make money? Tell me about them 9. Tell me about the different kinds of pay which you receive (probe: salary; allowances; user fees; 1. payments from patients; incentives for deliveries; private business etc.). a. Which ones are most valuable for you? b. Why? c. How do they change the way you work? 10. What are the main challenges you face in your professional life? a. How do you cope with them? 11. What sort of changes have you seen over your period of working? 12. Do you know about any policies to encourage health workers to stay in rural areas? Tell me 2. about them a. Have they worked? 
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b. What do you think about them? 13. What do you think is the most important thing for the government to do to get health workers 3. to work and stay in rural areas? 4. Before Ipoc what kind of testing was done at this facility? Who does it? 5. Do you receive training for that test? By whom? How often do you have retraining?  6. When a new healthcare worker comes who trains them in doing the testing? Are they expected to know? 7. Do you feel comfortable in training new healthcare workers? 8. Which Ipoc process most challenging? 9. How did they view ipoc initially? 10. How do they view ipoc now? 11. What are the challenges? 12. Which part do you find most challenging 13. Blood prick/timer using/pipette/waiting for the full time? 14. How do you usually treat syphilis 15. How do you treat anaemia/do you have time to tell the client their anaemia status/syphilis status? 16. Do you have time to counsel the women? 17. Many women do not know what syphilis is around this area…Do you have time to tell them about syphilis?    
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7.5 Appendix 5 Sample data collection for time-motion data 
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7.6 Appendix 6 Dispensary patient pathways for MCH women 
Visi
t pu
rpo
se 
Id y
yyy
mm
dd#
# 
N=1
83 Activity sequence 
 
acti
vity
 
loca
tion
 
reso
urc
e 
AN 2015090801 2 2 11 4 8 50     1 RGW MCH N1/N2 U5 2015090802 2 6 11 4 5 50     2 RGW MCH SS U5 2015090803 11 4 2 5 6 50     3 BL MCH   U5 2015090804 11 4 1 9 50       4 TR MCH   U5 2015090805 11 4 2 5 6 50     5 IM MCH   PM/U5 2015090806 11 4 5 2 17 50     6 VA MCH   U5 2015090807 2 2 5 50        7 FP MCH   U5 2015090808 2 5 50         8 CN MCH   AR 2015090809 2 8 50         9 CSL MCH   AR 2015090810 2 8 50         10 LB MCH   AR 2015090811 2 8 8 50        11 HT MCH N2 U5 2015090812 2 50          12 RGW OP   AR 2015090813 2 8 50         13 BL OP   U5 2015090814 2 5 50         14 CN OP   U5 2015090815 2 5 50         15 FP OP   U5 2015090816 2 5 6 50        16 DR OP   U5 2015090817 2 50          17 RGW PSC   U5 2015090818 2 50             18 VL PSC   AN 2015090901 2 2 8 50       19 CN PSC N1/N2 AN 2015090902 2 2 8 50       20 CSL PSC   FP/OPD 2015090903 12 13 14 50       21 CN PSC CO U5 2015090904 2 50         50 exit   U5/OPD 2015090905 2 12 13 14 50          AR 2015090906 2 8 50        Legend:  RGW: registration BL: blood test TR: waiting for test results IM: immunization VA: receiving vitamin  FP: family planning CN: consultation CSL: counselling LB: labour HT: health talk DR: waiting for drugs VL: viral load  OPD: out-patient room MCH: maternal and child health room PSC: patient support care room  N1: OPD nurse N2: MCH nurse CO: clinical officer SS: support staff  
SP 2015090907 2 8 50        U5/OPD 2015090908 2 12 13 14 50      LB 2015090909 10 50         FP 2015090910 7 50         PM/AR 2015091001 17 19 8 50       U5 2015091002 2 2 50        PM/U5 2015091003 17 2 20 21 50      PM 2015091004 20 17 20 21 50      U5 2015091005 2 50         PM/U5 2015091006 17 2 21 50       PM/U5 2015091007 2 5 3 8 50      PM/U5/OPD 2015091008 2 17 3 21 14 16 50    AR 2015091009 1 8 50        U5 2015091101 2 50         U5 2015091102 2 50         U5 2015091103 2 50         U5 2015091104 2 50         U5 2015091401 2 50         AN 2015091402 2 8 50        U5 2015091403 2 5 50        U5 2015091404 2 50         AN/NP 2015091405 8 4 8 50       U5 2015091501 2 5 50        U5 2015091502 2 5 50        U5 2015091503 2 6 50        AR 2015091504 2 8 50        AR 2015091505 2 8 50        U5 2015091506 2 5 50        U5 2015091507 2 5 50        U5 2015091508 2 50         U5 2015091509 2 5 50        U5/FP 2015091510 2 2 7 50       U5 2015091511 2 50             U5 2015091512 2 5 50            U5 2015091513 2 9 50            U5 2015091514 2 5 50            U5 2015091601 2 50             
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U5 2015091602 2 5 50            U5/FP 2015091603 12 15 50            U5/FP 2015091604 2 7 50            PM/AN 2015091701 17 19 8 50           U5 2015091702 2 5 50            U5 2015091703 2 5 50            FP 2015091704 2 7 50            U5/OPD 2015091705 2 6 12 14 50          U5 2015091706 2 5 50            FP 2015091707 2 7 50            FP 2015091708 2 7 50            U5 2015091801 2 50             U5/OPD 2015091802 2 13 14 50           U5 2015091803 2 6 50            U5/OPD 2015091804 2 2 14 50           AR 2015092101 2 8 50            U5/OPD 2015092102 1 5 12 13 14 50         AN 2015092103 8 4 8 2 8 50         FP 2015092104 7 50             AR/OPD 2015092105 2 8 13 14 50          U5 2015092106 1 5 50            U5 2015092201 2 50             U5 2015092202 2 11 4 5 50          U5 2015092203 2 11 4 5 50          U5 2015092204 2 6 11 4 5 50         U5/OPD 2015092205 2 11 4 5 8 50         U5 2015092206 2 6 50            U5 2015092207 11 4 2 2 5 9 50        U5 2015092208 11 4 2 9 50          U5 2015092209 11 4 2 5 50          U5 2015092210 2 5 50            U5 2015092211 2 5 50            U5 2015092212 2 50             U5 2015092213 2 5 5 50           U5 2015092214 2 5 50            U5 2015092215 2 5 50            AR 2015092216 1 8 50            AR 2015092217 1 8 50            AR 2015092218 1 8 50            U5 2015092219 2 5 50            FP 2015092220 7 50             AR 2015092301 2 8 50            AR 2015092302 2 8 50            AR 2015092303 2 8 50            AN 2015092304 2 2 8 50           AR 2015092305 2 8 50            U5 2015092306 2 50             FP 2015092307 3 7 50            U5 2015092308 2 5 50            U5 2015092309 2 50             U5/OPD 2015092310 2 5 8 50           PM/U5 2015092401 2 18 5 3 21 50         PM/U5 2015092402 2 21 50            PM/U5/OPD 2015092403 2 2 12 21 50          PM/U5 2015092404 2 2 21 5 3 20 50        PM/U5 2015092405 2 2 21 50           PM/U5 2015092406 2 21 50            PM/U5 2015092407 2 5 3 20 21 3 4 8 50      PM/U5 2015092408 2 21 50            PM/U5 2015092409 2 21 50            PM/U5/FP 2015092410 2 5 2 15 21 50         PM 2015092411 17 21 50            AR 2015092412 2 8 4 50           AN 2015092413 2 2 8 4 50          PM/U5 2015092414 17 2 5 3 20 21 50        PM/U5 2015092415 2 17 21 50           AN 2015092416 2 2 8 50           U5 2015092501 1 50             U5 2015092502 1 50             U5 2015092503 2 50             
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AR 2015092504 2 8 11 4 50            AR 2015092505 2 8 4 11 4 50          U5 2015092506 2 50              AR 2015092507 2 8 4 8 11 4 50        AR 2015092508 2 8 11 4 50           U5 2015092509 11 4 2 5 50            U5 2015092510 2 50             AR 2015092801 2 8 50            FP/OPD 2015092802 2 7 14 50           U5 2015092803 1 5 9 50           U5 2015092804 1 6 50            U5 2015092805 1 8 50            U5 2015092806 1 6 50            FP 2015092807 2 7 50            U5 2015092808 1 6 50            U5 2015092809 2 1 5 50           FP 2015092810 2 7 50            AN 2015092901 2 8 50            U5 2015092902 2 5 50            U5 2015092903 2 5 6 50           U5 2015092904 2 5 50            U5 2015092905 2 5 50            U5 2015092906 2 5 50            U5 2015092907 2 5 8 50           U5 2015092908 2 5 50            AN 2015092909 2 8 50            U5/OPD 2015092910 2 6 12 13 14 5 50        U5 2015093001 2 50             PM/U5 2015093002 2 19 50            AR 2015093003 2 50             U5 2015093004 2 50             PM 2015100101 17 21 50            U5 2015100102 2 50             AR 2015100103 2 8 50            FP 2015100104 2 3 7 50           FP 2015100105 1 7 50            U5 2015100106 2 5 50            AR 2015100107 2 8 50            PM/U5 2015100108 2 2 21 50           U5 2015100201 2 50             U5 2015100202 2 50             U5 2015100203 2 50             U5 2015100204 2 5 50            U5 2015100501 2 50             U5 2015100502 2 2 50            U5 2015100503 2 5 50            AR 2015100504 2 8 50            U5 2015100505 1 5 50            AR/U5 2015100506 2 2 8 50           AN 2015100507 2 2 8 50           U5 2015100508 2 50             U5 2015100509 2 50             
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7.7 Appendix 7 Screen shot of DES modelling in WITNESS©  
 
 
 
